<html lang="en"><head><!-- Shady DOM styles for custom-style --><!-- Shady DOM styles for dom-template --><!-- Shady DOM styles for dom-repeat --><!-- Shady DOM styles for array-selector --><!-- Shady DOM styles for dom-if --><!-- Shady DOM styles for state-modifier --><style scope="state-modifier">a[inherit].state-modifier {
  color: inherit;
}</style><!-- Shady DOM styles for browser-ui --><!-- Shady DOM styles for outlined-text-field --><style scope="outlined-text-field">outlined-text-field {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: column;
}

outlined-text-field span.outlined-text-field {
  display: flex;
  flex-direction: row;
  align-items: center;
}

outlined-text-field input.outlined-text-field {
  height: 40px;
  padding: 0 33px 0 16px;
  
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  flex-grow: 1;
}

outlined-text-field[orig] input.outlined-text-field {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-text-field[dense] input.outlined-text-field {
  height: 32px;
}

outlined-text-field[uppercase] input.outlined-text-field {
  text-transform: uppercase;
}

outlined-text-field:not([wizard-focused]):hover input.outlined-text-field {
  border-color: #737375;
  color: #414447;
}

outlined-text-field:not([wizard-focused]):focus-within input.outlined-text-field,outlined-text-field[wizard-focused] input.outlined-text-field {
  border-color: #3574e0;
  caret-color: #80a5f1;
}

outlined-text-field[wizard-focused] input.outlined-text-field {
  border-width: 2px;
}

outlined-text-field input.outlined-text-field::placeholder {
  color: #65686c;
}

outlined-text-field[uppercase] input.outlined-text-field::placeholder {
  text-transform: none;
}</style><!-- Shady DOM styles for mat-keyword-editor --><!-- Shady DOM styles for mat-chips-input --><!-- Shady DOM styles for mat-input-chip --><!-- Shady DOM styles for pat-dialog --><style scope="pat-dialog">pat-dialog {
  background: white;
  position: absolute;
  border-radius: 8px;
  
  box-shadow: 0 24px 38px 3px rgb(0 0 0 / 14%),
              0 9px 46px 8px rgb(0 0 0 / 12%),
              0 11px 15px -7px rgb(0 0 0 / 20%);
  z-index: 1;
  display: flex;
  flex-direction: column;
}

pat-dialog:not([open]) {
  display: none;
}</style><!-- Shady DOM styles for mat-tabs --><!-- Shady DOM styles for filter-chip --><style scope="filter-chip">filter-chip {
  align-items: center;
  background-color: #fff;
  border-color: #dadce0;
  border-radius: 8px;
  border-style: solid;
  border-width: 1px;
  color: #606368;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 32px;
  letter-spacing: 0.2px;
  padding: 0 16px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

filter-chip[disabled] {
  background-color: #e8e8e8;
  border-color: #e8e8e8;
  color: #a9abad;
  cursor: auto;
}

filter-chip svg.filter-chip {
  visibility: collapse;
  font-size: 18px;
  width: 0;
  height: 18px;
}

filter-chip[selected] svg.filter-chip {
  visibility: visible;
  margin: 0 8px;
  width: 18px;
}

filter-chip[selected] svg.filter-chip path.filter-chip {
  fill: #4577d1;
}

filter-chip:not([disabled]):hover {
  background-color: #f7f8f8;
  border-color: #d7d9dc;
  color: #454649;
}

filter-chip:not([disabled]):hover:active {
  background-color: #eff0f0;
  border-color: #d2d5d8;
  color: #222326;
}

filter-chip:not([disabled]):focus {
  background-color: #e7e8e8;
  border-color: #232528;
  color: #202124;
}

filter-chip:not([disabled])[selected] {
  background-color: #e9f0fd;
  border-color: #e9f0fd;
  color: #4577d1;
  padding-left: 0;
}

filter-chip:not([disabled]):focus[selected] {
  background-color: #d5e1fb;
  border-color: #d5e1fb;
  color: #2550a0;
}

filter-chip:not([disabled]):hover[selected] {
  box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 1px -2px,
    rgba(0, 0, 0, 0.14) 0px 2px 2px 0px, rgba(0, 0, 0, 0.12) 0px 1px 5px 0px;
}

filter-chip:not([disabled]):hover:active[selected] {
  background-color: #abc8f2;
  border-color: #abc8f2;
  color: #2a54a3;
}</style><!-- Shady DOM styles for figure-callout --><!-- Shady DOM styles for mat-button --><style scope="mat-button-0">.mat-button-0 {
  ;
  align-items: center;
  border-radius: 4px;
  color: hsl(217 4% 39%); 
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: 0.2px;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

.mat-button-0[filled] {
  background-color: hsl(217 73% 54%); 
  color: white;
}

.mat-button-0[filled]:hover {
  background-color: hsl(217 60% 47%);
}

.mat-button-0[filled]:focus {
  background-color: hsl(217 59% 44%);
}

.mat-button-0[filled]:active {
  background-color: hsl(217 59% 45%);
}

.mat-button-0[filled][disabled] {
  background-color: hsl(217 2% 90%); 
  color: hsl(217 1% 65%);
}</style><!-- Shady DOM styles for search-term-wizard --><style scope="search-term-wizard">search-term-wizard:not([open]) {
  display: none;
}

search-term-wizard .header.search-term-wizard {
  border-bottom: 1px solid #e5e5e5;
  padding: 24px;
  padding-bottom: 0;
}

search-term-wizard .title.search-term-wizard {
  color: #3c4043;
  font-family: Google Sans,Roboto,Arial,sans-serif;
  font-size: 22px;
  user-select: none;
  margin: 0 48px;
}

search-term-wizard #panels.search-term-wizard > *.search-term-wizard:not([selected]) {
  display: none;
}</style><!-- Shady DOM styles for outlined-textarea --><style scope="outlined-textarea">outlined-textarea {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: row;
  
  position: relative;
}

outlined-textarea span.outlined-textarea {
  display: flex;
  flex-direction: column;
  flex-grow: 1;
  justify-content: center;
}

outlined-textarea span.right-button-container.outlined-textarea {
  position: absolute;
  right: 0;
  height: 100%;
}

outlined-textarea textarea.outlined-textarea {
  padding: 16px 16px 0 16px;
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  resize: none;
}

outlined-textarea[dense] textarea.outlined-textarea {
  padding: 8px;
}

outlined-textarea[has-icon] textarea.outlined-textarea {
  padding-right: 38px;
}

outlined-textarea[orig] textarea.outlined-textarea {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-textarea:not([rows]) textarea.outlined-textarea {
  height: 40px;
}

outlined-textarea textarea.resizable.outlined-textarea {
  resize: vertical;
}

outlined-textarea textarea.outlined-textarea:focus,outlined-textarea[wizard-focused] textarea.outlined-textarea,outlined-textarea textarea.outlined-textarea:focus:hover {
  border-color: #3574e0 !important;
  
  outline: none !important;
}

outlined-textarea textarea.outlined-textarea:hover {
  border-color: #202124;
  color: #414447;
}

outlined-textarea.hasValue textarea.outlined-textarea {
  border-color: #888d91;
  color: #45474a;
}

outlined-textarea #helperText.outlined-textarea {
  color: #6a6c71;
  font-size: 12px;
  letter-spacing: 0.3px;
  margin-left: 17px;
  margin-top: 6px;
  user-select: none;
}

outlined-textarea:not([helper-text]) #helperText.outlined-textarea {
  display: none;
}

outlined-textarea[error] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
  color: #3d4043;
}

outlined-textarea textarea.outlined-textarea::placeholder {
  font-size: 14px;
  font-weight: 400;
}

outlined-textarea:not([error]):not([disabled]) textarea.outlined-textarea::placeholder {
  color: #6a6c71;
}

outlined-textarea[error] textarea.outlined-textarea::placeholder {
  color: #c84132;
}

outlined-textarea[error] #helperText.outlined-textarea {
  color: #cd5648;
}

outlined-textarea[error] textarea.outlined-textarea:focus {
  border-color: #c84031;
  border-width: 2px;
  outline: none !important;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover {
  border-color: #97231b;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover::placeholder,outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover + #helperText.outlined-textarea {
  color: #a94945;
}

outlined-textarea[disabled] textarea.outlined-textarea {
  border-color: #e9e9e9;
  color: #b5b6b8;
}

outlined-textarea[disabled] #helperText.outlined-textarea {
  color: #c4c6c7;
}

outlined-textarea[error][disabled] {
  opacity: 50%;
}

outlined-textarea[error][disabled] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
}

outlined-textarea[error][disabled] #helperText.outlined-textarea,outlined-textarea[error][disabled] textarea.outlined-textarea {
  color: #a94945;
}

outlined-textarea[error][disabled] textarea.outlined-textarea::placeholder {
  color: #c84132;
}</style><!-- Shady DOM styles for chemistry-search-term-wizard --><style scope="chemistry-search-term-wizard">chemistry-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

chemistry-search-term-wizard .suggestions.chemistry-search-term-wizard {
  margin-top: 4px;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard svg.chemistry-search-term-wizard {
  margin-right: 24px;
}

chemistry-search-term-wizard path.chemistry-search-term-wizard {
  fill: #5f6368;
}

chemistry-search-term-wizard .help.chemistry-search-term-wizard {
  margin-left: 12px;
  margin-right: 0;
  cursor: pointer;
}

chemistry-search-term-wizard outlined-text-field.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard mat-button.chemistry-search-term-wizard {
  margin-left: 48px;
}

chemistry-search-term-wizard filter-chip.chemistry-search-term-wizard {
  margin-right: 4px;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard outlined-text-field[batchMode].chemistry-search-term-wizard {
  display: none;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard:not([batchMode]) {
  display: none;
}</style><!-- Shady DOM styles for text-search-term-wizard --><style scope="text-search-term-wizard">text-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

text-search-term-wizard > span.text-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

text-search-term-wizard > span.text-search-term-wizard svg.text-search-term-wizard {
  margin-right: 24px;
}

text-search-term-wizard path.text-search-term-wizard {
  fill: #5f6368;
}

text-search-term-wizard outlined-text-field.text-search-term-wizard {
  flex-grow: 1;
}

text-search-term-wizard mat-button.text-search-term-wizard {
  margin-left: 48px;
}

text-search-term-wizard filter-chip.text-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for classification-wizard --><style scope="classification-wizard">classification-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

classification-wizard > span.classification-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

classification-wizard .suggestions.classification-wizard {
  margin-top: 4px;
}

classification-wizard > span.classification-wizard svg.classification-wizard {
  margin-right: 24px;
}

classification-wizard path.classification-wizard {
  fill: #5f6368;
}

classification-wizard outlined-text-field.classification-wizard {
  flex-grow: 1;
}

classification-wizard mat-button.classification-wizard {
  margin-left: 48px;
}

classification-wizard filter-chip.classification-wizard {
  margin-right: 4px;
}

classification-wizard .no-matches.classification-wizard {
  margin-left: 64px;
}

classification-wizard .table-container.classification-wizard {
  max-height: 300px;
  overflow: scroll;
  margin-top: 8px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar {
  -webkit-appearance: none;
  width: 10px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar-thumb {
  border-radius: 5px;
  background-color: #5f636880;
  -webkit-box-shadow: 0 0 1px rgba(255,255,255,.5);
}

classification-wizard table.classification-wizard {
  margin-left: 51px;
  max-width: 575px;
}

classification-wizard tr.classification-wizard {
  margin-top: 4px;
}

classification-wizard tr.classification-wizard suggestive-chip.classification-wizard {
  margin-right: 8px;
}

classification-wizard #spinner.classification-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}</style><!-- Shady DOM styles for suggestive-chip --><!-- Shady DOM styles for mat-checkbox --><!-- Shady DOM styles for measure-search-term-wizard --><style scope="measure-search-term-wizard">measure-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

measure-search-term-wizard > span.measure-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

measure-search-term-wizard .suggestions.measure-search-term-wizard {
  margin-top: 4px;
}

measure-search-term-wizard > span.measure-search-term-wizard svg.measure-search-term-wizard {
  margin-right: 24px;
}

measure-search-term-wizard path.measure-search-term-wizard {
  fill: #5f6368;
}

measure-search-term-wizard outlined-text-field.measure-search-term-wizard {
  flex-grow: 1;
}

measure-search-term-wizard mat-button.measure-search-term-wizard {
  margin-left: 48px;
}

measure-search-term-wizard filter-chip.measure-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for numerical-search-term-wizard --><style scope="numerical-search-term-wizard">numerical-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

numerical-search-term-wizard .suggestions.numerical-search-term-wizard {
  margin-top: 4px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard svg.numerical-search-term-wizard {
  margin-right: 24px;
}

numerical-search-term-wizard path.numerical-search-term-wizard {
  fill: #5f6368;
}

numerical-search-term-wizard outlined-text-field.numerical-search-term-wizard,numerical-search-term-wizard outlined-textarea.numerical-search-term-wizard {
  flex-grow: 1;
}

numerical-search-term-wizard mat-button.numerical-search-term-wizard {
  margin-left: 48px;
}

numerical-search-term-wizard filter-chip.numerical-search-term-wizard {
  margin-right: 4px;
}

numerical-search-term-wizard #spinner.numerical-search-term-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}

numerical-search-term-wizard #suggestions.numerical-search-term-wizard {
  margin-left: 58px;
  display: flex;
  flex-direction: column;
  align-items: flex-start;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard mat-checkbox.numerical-search-term-wizard {
  margin-right: 8px;
}</style><!-- Shady DOM styles for text-button --><style scope="text-button">text-button {
  align-items: center;
  border-radius: 4px;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: .25px;
  margin: 6px 0;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
  line-height: 36px;
  text-decoration: none;
  text-transform: none;
  color: #5f6368;
}

text-button:hover {
  background-color: #f8f9fa;
}

text-button:active {
  background-color: #d5e2fa;
}

text-button[selected] {
  background-color: #e8f0fe;
  color: #1967d2;
}

text-button[selected]:active {
  background-color: #d2e3fc;
}</style><!-- Shady DOM styles for mat-spinner --><!-- Shady DOM styles for requery-tile --><style scope="requery-tile">requery-tile {
  display: flex;
  justify-content: space-between;
  align-items: center;
  box-sizing: border-box;
  min-height: 40px;
  padding: 8px 12px 8px 8px;
  gap: 8px;

  border-radius: 16px;
  background: #f7f8f9;
  color: #1f1f1f;
}

requery-tile:hover {
  background: #d7d8d9;
}

requery-tile > [slot="image"] {
  flex-shrink: 0;

  border-radius: 8px;

  background: #fff;
}

.label.requery-tile {
  flex-grow: 999;

  font: 16px/20px "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
}

.search-icon.requery-tile {
  flex-shrink: 0;

  width: 24px;
  height: 24px;
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/search/default/24px.svg');
}</style><!-- Shady DOM styles for s-more-inline --><style scope="s-more-inline">s-more-inline {
  display: block;
  margin-top: 24px;
  padding: 16px;
  padding-top: 0;
  position: relative;

  line-height: 18px;
  text-overflow: ellipsis;
  white-space: nowrap;
  cursor: pointer;
}

hr.s-more-inline {
  background-color: #dadce0;
  margin-top: 18px;
  position: absolute;
  border: 0;
  height: 1px;
  left: 0;
  width: 100%;
}

.button.s-more-inline {
  display: flex;
  align-items: center;
  justify-content: center;

  position: relative; 
  margin: 0 auto;

  font: 400 14px Roboto, arial, sans-serif;
  height: 36px;
  width: 300px;
  border-radius: 18px;
  background-color: #f1f3f4;
}

.button.s-more-inline:hover {
  background-color: #d8d7dc;
}

.button.s-more-inline > [slot] {
  padding-right: 8px;
}

.expand.s-more-inline {
  display: inline-block;
  width: 20px;
  height: 20px;
}

.expand.less.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_less/default/20px.svg');
}

.expand.more.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_more/default/20px.svg');
}</style><!-- Shady DOM styles for workspace-ui-search --><!-- Shady DOM styles for keyword-wizard --><style scope="keyword-wizard">keyword-wizard {
  display: inline-block;
}

iron-icon.keyword-wizard {
  height: 20px;
    width: 20px;
    color: #999;
    cursor: pointer;
}

iron-icon[active].keyword-wizard {
  color: #4285f4 !important;
}

iron-icon.keyword-wizard:hover {
  color: #ccc;
}

#wizardIcon.keyword-wizard {
  padding-left: 1px;
    height: 16px;
    width: 16px;
    margin: 4px 1px 1px 1px;
}

#wizard.keyword-wizard {
  padding: 0;
    left: 0;
    top: 37px;
    position: absolute;
    background-color: white;
    z-index: 2;
    overflow: hidden;
}

.wizard-header.keyword-wizard {
  display: block;
    width: 100%;
    color: #737373;
    text-transform: uppercase;
    font-size: 13px;
    margin: 16px 0 6px 12px;
}

.filter-chips.keyword-wizard {
  margin-left: 20px;
}

.chip.keyword-wizard {
  background-color: #ebebeb;
    color: #6a6a6a;
    display: inline-block;
    font-size: 13px;
    font-family: inherit;
    border-radius: 12px;
    padding: 6px 12px;
}

.chip.keyword-wizard:hover {
  cursor: pointer;
}

.chip[selected].keyword-wizard {
  background-color: #4285f4;
    color: white;
}

.input-label.keyword-wizard {
  display: inline-block;
    font-size: 13px;
    font-family: inherit;
}

.keyword-input.keyword-wizard {
  display: inline-block;
    border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    padding: 3px;
}

.keyword-input.keyword-wizard::placeholder {
  font-style: italic;
}

.keyword-input.keyword-wizard:hover,.keyword-input.keyword-wizard:focus {
  border-color: #4284f4;
    border-width: 1px;
    outline: none;
}

.cpc-field.keyword-wizard {
  display: inline-block;
    margin: 6px 0 0 24px;
}

#checkboxCPC.keyword-wizard:hover {
  cursor: pointer;
}

.checkbox-label.keyword-wizard {
  font-size: 13px;
    font-style: italic;
    color: #737373;
}

.chemistry-field.keyword-wizard {
  display: block;
}

#inputChem.input-batch.keyword-wizard {
  height: 150px;
    border: 1px solid #dfe1e5;
    padding: 6px;
}

#inputChem.keyword-wizard {
  resize: none;
    height: 15px;
    vertical-align: text-top;
    font-size: 13px;
    font-family: inherit;
    padding: 2px;
}

.chem-type-label.keyword-wizard {
  display: inline;
    font-size: 13px;
    margin-left: 12px;
    margin-right: 4px;
}

#chemType.keyword-wizard {
  border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    margin: 6px;
    padding: 2px;
    outline: none;
    font-family: inherit;
    font-size: 13px;
}

.import.keyword-wizard {
  font-size: 13px;
    font-family: inherit;
}

.import-text.keyword-wizard {
  vertical-align: middle;
    display: inline-block;
}

.import-button.keyword-wizard {
  margin: 6px 0 0 24px;
}

.import-button.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.import-button.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard {
  float: right;
    padding: 12px;
}

.wizard-buttons.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    margin: 2px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
}

@media screen and (max-width: 700px) {
#wizard.keyword-wizard {
  width: 275px;
}

.chip.keyword-wizard {
  margin: 4px 2px;
}

.keyword-input.keyword-wizard {
  width: 82%;
      margin: 4px 12px 12px 24px;
}

.search-within.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 225px;
      margin: 12px 0 6px 0;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  margin-top: 6px;
}

#inputChem.keyword-wizard {
  width: 82%;
      padding: 2px;
      margin: 8px 12px 12px 24px;
}

#inputChem.input-batch.keyword-wizard {
  width: 220px;
      padding: 4px;
}

#chemType.keyword-wizard {
  width: 150px;
}

.import-text.keyword-wizard {
  margin: 6px 12px 6px 24px;
      width: 220px;
}

iron-icon.help-header.keyword-wizard {
  display: none;
}

}

@media screen and (min-width: 700px) {
#wizard.keyword-wizard {
  width: 540px;
}

.chip.keyword-wizard {
  margin: 0 2px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 240px;
      margin: 12px 16px 6px 6px;
}

.cpc-inputs.keyword-wizard {
  display: inline;
}

.find-patents.keyword-wizard .keyword-input.keyword-wizard {
  width: 53%;
      margin: 4px 10px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard::placeholder,#inputAnd.keyword-wizard::placeholder,#inputExact.keyword-wizard::placeholder,#inputOr.keyword-wizard::placeholder,#inputMinus.keyword-wizard::placeholder {
  color: white;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  width: 35%;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  width: 42%;
      margin: 6px 4px;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

#inputChem.keyword-wizard {
  width: 290px;
      margin: 2px 12px 2px 6px;
}

#inputChem.input-batch.keyword-wizard {
  width: 280px;
      padding: 6px;
}

.import-text.keyword-wizard {
  margin: 6px 12px;
      width: 415px;
}

#chemType.keyword-wizard {
  width: 105px;
}

iron-icon.keyword-wizard:hover.help-header {
  cursor: default;
}

iron-icon.help-header.keyword-wizard {
  height: 16px;
      padding: 0 2px 2px 2px;
      color: #a3a3a3;
}

.help.keyword-wizard p.keyword-wizard {
  margin: 0 0 8px 0
}

.help.keyword-wizard .q.keyword-wizard {
  font-family: monospace;
      color: #0b8043;
      white-space: nowrap;
}

.help.keyword-wizard {
  z-index: 4;
      position: absolute;
      right: 10px;
      padding: 12px;
      border-radius: 2px;
      border: 1px solid #e0e0e0;
      box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2), 0 6px 10px 0 rgba(0, 0, 0, 0.3);
      background: white;
      font-size: 13px;
      line-height: 20px;
      width: 450px;
      max-height: 400px;
      overflow: auto;
}

#withinHelp.keyword-wizard {
  top: 75px;
}

#chemHelp.keyword-wizard {
  top: 0;
}

#searchBooleanHelp.keyword-wizard {
  top: 140px;
}

}</style><!-- Shady DOM styles for bottom-bar --><style scope="bottom-bar">.fixed.bottom-bar {
  display: block;
  position: fixed;
  height: 46px;
  bottom: 0;
}

.fixed[medium].bottom-bar {
  height: 280px;
}

.fixed[large].bottom-bar {
  height: 480px;
}

.shadow.bottom-bar {
  background: white;
  padding: 16px;
  border-radius: 8px 8px 0px 0px;
  box-shadow: 0px 8px 10px 1px rgba(0,0,0,.14), 0px 3px 14px 2px rgba(0,0,0,.12), 0px 5px 5px -3px rgba(0,0,0,.2);
}

.oneline.bottom-bar {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
  cursor: pointer;
}

.button.bottom-bar {
  cursor: pointer;
}

.buttonAlign.bottom-bar {
  margin-top: -4px;
}

.header.bottom-bar {
  height: 30px;
  font-family: 'Google Sans';
  font-size: 18px;
  padding-bottom: 8px;
}

.list.bottom-bar {
  overflow-y: auto;
  line-height: 20px;
}

.definition.bottom-bar {
  padding: 0px 0px 4px 0px;
  cursor: pointer;
}

[medium].bottom-bar .content.bottom-bar {
  height: 230px;
}

[large].bottom-bar .content.bottom-bar {
  height: 430px;
}

[medium].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 200px;
}

[large].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 400px;
}

[hidden].bottom-bar {
  display: none;
}

.label.bottom-bar {
  font-family: 'Google Sans';
  font-size: 12px;
  line-height: 16px;
  font-weight: 400;
  padding: 6px 0px 4px 0px;
  color: #1f1f1f;
}

[pad].bottom-bar {
  margin-left: 16px;
}

.layout.vertical.bottom-bar {
  display: flex;
  flex-direction: column;
}

.layout.horizontal.bottom-bar {
  display: flex;
  flex-direction: row;
}

.flex.bottom-bar {
  flex: 1;
  flex-basis: 0.000000001px;
}

.layout.start.bottom-bar {
  align-items: flex-start;
}

.layout.center.bottom-bar {
  align-items: center;
}

.layout.end.bottom-bar {
  align-items: flex-end;
}

.flex-2.bottom-bar {
  flex: 2;
}

.flex-3.bottom-bar {
  flex: 3;
}

.flex-4.bottom-bar {
  flex: 4;
}

.flex-5.bottom-bar {
  flex: 5;
}

.flex-6.bottom-bar {
  flex: 6;
}

.flex-7.bottom-bar {
  flex: 7;
}

.flex-8.bottom-bar {
  flex: 8;
}

.flex-9.bottom-bar {
  flex: 9;
}

.flex-10.bottom-bar {
  flex: 10;
}

.flex-11.bottom-bar {
  flex: 11;
}

.flex-12.bottom-bar {
  flex: 12;
}</style><!-- Shady DOM styles for landscape-link --><!-- Shady DOM styles for landscape-summary-box --><!-- Shady DOM styles for search-state --><!-- Shady DOM styles for iron-overlay-backdrop --><!-- Shady DOM styles for opaque-animation --><!-- Shady DOM styles for iron-dropdown --><style scope="iron-dropdown">iron-dropdown {
  position: fixed;
}

#contentWrapper.iron-dropdown  > * {
  overflow: auto;
}

#contentWrapper.animating.iron-dropdown  > * {
  overflow: hidden;
}</style><!-- Shady DOM styles for iron-meta --><!-- Shady DOM styles for iron-icon --><style scope="iron-icon-0">.iron-icon-0 {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;-ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;-ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
        position: relative;

        vertical-align: middle;

        fill: currentcolor;
        stroke: none;

        width: 24px;
        height: 24px;;
}

.iron-icon-0[hidden] {
  display: none;
}</style><!-- Shady DOM styles for iron-iconset-svg --><!-- Shady DOM styles for iron-list --><!-- Shady DOM styles for paper-icon-item --><!-- Shady DOM styles for paper-item-body --><!-- Shady DOM styles for paper-item --><!-- Shady DOM styles for dropdown-menu --><style scope="dropdown-menu">dropdown-menu {
  display: inline-block;
        line-height: 24px;
}

.label.dropdown-menu {
  cursor: pointer;
        color: #666;
        align-items: center;
        margin-right: 8px;
        display: inline-block;
        padding: 2px 0;
}

#selected.dropdown-menu {
  color: #212121;
}

.label[open].dropdown-menu {
  border-color: #e0e0e0;
}

iron-dropdown.dropdown-menu {
  margin-top: 26px;
}

iron-icon.dropdown-menu {
  height: 15px;
        width: 15px;
}

#menu.dropdown-menu {
  max-height: 300px;
        padding: 8px 0;
        background: white;
        display: block;
        border-radius: 2px;
        box-shadow: 0 0 2px rgba(0,0,0,0.12), 0 2px 2px rgba(0,0,0,0.24);
}

.item.dropdown-menu {
  cursor: pointer;
        color: rgba(0,0,0,.87);
        font-size: 13px;
        line-height: 18px;
        padding: 6px 18px;
}

.item.dropdown-menu:hover {
  background-color: #e0e0e0;
}

.item[selected].dropdown-menu {
  background-color: #e0e0e0;
}

[multi].dropdown-menu .item.dropdown-menu {
  padding: 6px 18px 6px 34px;
}

[multi].dropdown-menu .item[selected].dropdown-menu {
  background-image: url('https://www.gstatic.com/images/icons/material/system/2x/done_grey600_24dp.png');
        background-position: 8px center;
        background-size: 16px;
        background-repeat: no-repeat;
}</style><!-- Shady DOM styles for chips-input --><!-- Shady DOM styles for input-chip --><!-- Shady DOM styles for keyword-editor --><!-- Shady DOM styles for paper-ripple --><!-- Shady DOM styles for paper-button --><!-- Shady DOM styles for date-editor --><!-- Shady DOM styles for metadata-editor --><!-- Shady DOM styles for restrict-editor --><!-- Shady DOM styles for overlay-tooltip --><style scope="overlay-tooltip">overlay-tooltip {
  display: none;
        color: #fff;
        background-color: #000;
        padding: 10px 12px;
        border-radius: 3px;
        font-size: 13px;
        font-weight: normal;
        line-height: normal;
        position: fixed;
        z-index: 100;
}

#arrow.overlay-tooltip {
  width: 0;
        height: 0;
        border-style: solid;
        border-width: 0 6px 8px 6px;
        border-color: transparent transparent #000 transparent;
        position: absolute;
        top: -8px;
        left: calc(50% - 6px);
}</style><!-- Shady DOM styles for query-renderer --><!-- Shady DOM styles for result-nav --><style scope="result-nav">result-nav {
  display: block;
        white-space: nowrap;
        padding: 0 30px;
        line-height: 30px;
        height: 30px;
        margin-top: 17px;
        font-weight: 500;
        font-size: 15px;
}

state-modifier.result-nav {
  color: #333;
}

state-modifier[disabled].result-nav {
  pointer-events: none;
        color: #ccc;
}</style><!-- Shady DOM styles for raw-html --><!-- Shady DOM styles for paper-material --><style scope="paper-material-0">.paper-material-0 {
  display: block;
        position: relative;
}

.paper-material-0[elevation="1"] {
  box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14),
                    0 1px 5px 0 rgba(0, 0, 0, 0.12),
                    0 3px 1px -2px rgba(0, 0, 0, 0.2);
}

.paper-material-0[elevation="2"] {
  box-shadow: 0 4px 5px 0 rgba(0, 0, 0, 0.14),
                    0 1px 10px 0 rgba(0, 0, 0, 0.12),
                    0 2px 4px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="3"] {
  box-shadow: 0 6px 10px 0 rgba(0, 0, 0, 0.14),
                    0 1px 18px 0 rgba(0, 0, 0, 0.12),
                    0 3px 5px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="4"] {
  box-shadow: 0 8px 10px 1px rgba(0, 0, 0, 0.14),
                    0 3px 14px 2px rgba(0, 0, 0, 0.12),
                    0 5px 5px -3px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="5"] {
  box-shadow: 0 16px 24px 2px rgba(0, 0, 0, 0.14),
                    0  6px 30px 5px rgba(0, 0, 0, 0.12),
                    0  8px 10px -5px rgba(0, 0, 0, 0.4);
}

.paper-material-0[animated] {
  transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
}

.paper-material-0 {
  ;
}</style><!-- Shady DOM styles for search-box --><style scope="search-box">.layout.horizontal.search-box,.layout.vertical.search-box {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-box {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-box {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-box {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-box {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-box {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-box,.layout.center-center.search-box {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-box,.layout.center-center.search-box {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-box {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-box {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-box {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.inputbox.search-box {
  border: 1px solid #ccc;
        padding: 0 12px;
        background: white;
}

.inputbox[focused].search-box {
  border: 1px solid #4285f4 !important;
}

.inputbox.search-box:hover {
  border: 1px solid #999;
}

#searchInput.search-box {
  font-family: inherit;
        font-size: 16px;
        padding: 8px 0;
        outline: none;
        border-right: none;
        width: 100%;
        margin-right: 0;
        border: 0;
}

#searchButton.search-box {
  cursor: pointer;
        background-color: #4285f4;
        border: none;
        color: #fff;
        vertical-align: top;
        width: 70px;
        height: 37px;
        outline: none;
}

.suggest-bg.search-box {
  display: inline-block;
        min-width: 0;
        white-space: nowrap;
}

#suggestMenu.search-box {
  position: absolute;
        margin-top: 38px;
        width: 100%;
        background: white;
        z-index: 1;
}

#suggestMenu.search-box .row.search-box {
  font-size: 13px;
        line-height: 28px;
        white-space: nowrap;
        overflow: hidden;
        text-overflow: ellipsis;
        padding: 4px 2px;
        cursor: pointer;
}

.row[selected].search-box {
  background: rgba(0, 0, 0, 0.05);
}

.suggest-icon.search-box {
  height: 20px;
        width: 20px;
        padding: 0 12px 0 6px;
        transition: transform .15s linear;
        transform: scale(1);
}

.suggest-icon[hide].search-box {
  transform: scale(0);
}

#corpora.search-box {
  padding: 6px 0;
        user-select: none;
}

#corpora.search-box iron-icon.search-box {
  height: 20px;
        width: 20px;
        color: #ccc;
        cursor: pointer;
}

#corpora.search-box iron-icon[active].search-box {
  color: #4285f4 !important;
}

#corpora.search-box iron-icon.search-box:hover {
  color: #999;
}</style><!-- Shady DOM styles for iron-media-query --><!-- Shady DOM styles for paper-header-panel --><!-- Shady DOM styles for iron-a11y-announcer --><style scope="iron-a11y-announcer">iron-a11y-announcer {
  display: inline-block;
        position: fixed;
        clip: rect(0px,0px,0px,0px);
}</style><!-- Shady DOM styles for iron-autogrow-textarea --><!-- Shady DOM styles for iron-input --><!-- Shady DOM styles for paper-input-char-counter --><!-- Shady DOM styles for paper-input-container --><!-- Shady DOM styles for paper-input-error --><!-- Shady DOM styles for paper-input --><!-- Shady DOM styles for paper-textarea --><!-- Shady DOM styles for paper-toast --><style scope="paper-toast-0">.paper-toast-0 {
  display: block;
        position: fixed;
        background-color: #323232;
        color: #f1f1f1;
        min-height: 48px;
        min-width: 288px;
        padding: 16px 24px;
        box-sizing: border-box;
        box-shadow: 0 2px 5px 0 rgba(0, 0, 0, 0.26);
        border-radius: 2px;
        margin: 12px;
        font-size: 14px;
        cursor: default;
        -webkit-transition: -webkit-transform 0.3s, opacity 0.3s;
        transition: transform 0.3s, opacity 0.3s;
        opacity: 0;
        -webkit-transform: translateY(100px);
        transform: translateY(100px);font-family: 'Roboto', 'Noto', sans-serif;
        -webkit-font-smoothing: antialiased;
}

.paper-toast-0.capsule {
  border-radius: 24px;
}

.paper-toast-0.fit-bottom {
  width: 100%;
        min-width: 0;
        border-radius: 0;
        margin: 0;
}

.paper-toast-0.paper-toast-open {
  opacity: 1;
        -webkit-transform: translateY(0px);
        transform: translateY(0px);
}</style><!-- Shady DOM styles for paper-toolbar --><!-- Shady DOM styles for search-footer --><style scope="search-footer">#footer.search-footer {
  font-size: 13px;
        margin-top: 10px;
        background: #fafafa;
        padding: 20px 10px;
        align-items: center;
        border-top: 1px solid #ebebeb;
}

#footer.search-footer .links.search-footer > *.search-footer {
  display: inline-block;
        margin: 0 12px;
}

.layout.horizontal.search-footer,.layout.vertical.search-footer {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-footer {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-footer {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-footer {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-footer {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-footer {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-footer {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-footer {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-footer {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-footer {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-footer {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-footer {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-footer {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-footer {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-footer {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-footer {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-footer {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-footer {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-footer {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-footer {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-footer {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-footer {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-footer {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-footer {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-footer {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-footer {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-header --><style scope="search-header">search-header {
  display: block;
}

.lockup-logo.search-header,.lockup-text.search-header {
  display: inline-block;
}

.lockup-logo.search-header {
  width: 74px;
        height: 24px;
        background-image: url('https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_74x24dp.png');
        background-size: 74px 24px;
}

.lockup-text.search-header {
  font-family: "Product Sans", Arial, Helvetica, sans-serif;

        
        font-size: 22.1px;

        
        text-rendering: optimizeLegibility;

        
        position: relative;
        top: -6px;
        left: -5px;

        
        -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
}

.lockup-brand.search-header {
  opacity: 0.54;
}

@media (-webkit-min-device-pixel-ratio: 1.5), (min-resolution: 144dpi) {
.lockup-logo.search-header {
  background-image: url('https://www.gstatic.com/images/branding/googlelogo/2x/googlelogo_color_74x24dp.png');
}

.lockup-text.search-header {
  font-size: 21.3px;
          left: -7px;
}

}

header.search-header {
  background-color: #fafafa;
        border-bottom: 1px solid #ebebeb;
        color: #333;
        height: 60px;
        width: 100%;
        z-index: 1;
        display: block;
}

[latestStyle].search-header header.search-header {
  background-color: transparent;
}

.headerpad.search-header {
  margin-left: 16px;
}

[wide].search-header .headerpad.search-header {
  margin-left: 32px;
}

.leftheader.search-header {
  width: 322px;
}

header.search-header h1.search-header {
  display: none;
}

header.search-header h1.search-header state-modifier.search-header {
  color: #777;
        text-decoration: none;
        display: inline-block;
}

[wide].search-header header.search-header h1.search-header {
  box-sizing: border-box;
        margin: 0;
        padding: 20px 0 10px;
        font-size: 20px;
        font-weight: 400;
        white-space: nowrap;
        display: block;
}

search-box.search-header {
  height: 37px;
        padding: 0 16px;
        width: 900px;
        align-self: center;
}

.layout.horizontal.search-header,.layout.vertical.search-header {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-header {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-header {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-header {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-header {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-header {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-header {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-header {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-header {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-header {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-header {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-header {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-header {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-header {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-header {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-header {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-header {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-header {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-header {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-header {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-header {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-header {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-header {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-header {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-header {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-header {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-ui --><style scope="search-ui-0">.search-ui-0 paper-button.search-ui {
  display: inline-block;
        text-align: center;
        font-family: inherit;
}

.search-ui-0 .layout.horizontal.search-ui,.search-ui-0 .layout.vertical.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.search-ui-0 .layout.inline.search-ui {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.search-ui-0 .layout.horizontal.search-ui {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.search-ui-0 .layout.vertical.search-ui {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.search-ui-0 .layout.wrap.search-ui {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.search-ui-0 .layout.no-wrap.search-ui {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .flex.search-ui {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.search-ui-0 .flex-auto.search-ui {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.search-ui-0 .flex-none.search-ui {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.search-ui-0 .layout.start.search-ui {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.end.search-ui {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.search-ui-0 .layout.baseline.search-ui {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.search-ui-0 .layout.start-justified.search-ui {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .layout.end-justified.search-ui {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.search-ui-0 .layout.around-justified.search-ui {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.search-ui-0 .layout.justified.search-ui {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.search-ui-0 .self-start.search-ui {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.search-ui-0 .self-center.search-ui {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.search-ui-0 .self-end.search-ui {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.search-ui-0 .self-stretch.search-ui {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.search-ui-0 .self-baseline.search-ui {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.search-ui-0 .layout.start-aligned.search-ui {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.search-ui-0 .layout.end-aligned.search-ui {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.search-ui-0 .layout.center-aligned.search-ui {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.search-ui-0 .layout.between-aligned.search-ui {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.search-ui-0 .layout.around-aligned.search-ui {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.search-ui-0 {
  display: block;
        min-width: 350px;
        height: 100%;
}

.search-ui-0 #content.search-ui {
  height: 100%;
}

.search-ui-0 #leftBarOverflow.search-ui {
  padding-right: 16px;
}

.search-ui-0 [wide].search-ui #leftBarOverflow.search-ui {
  overflow: auto;
}

.search-ui-0 #leftBar.search-ui {
  box-sizing: border-box;
        color: #666;
        font-size: 13px;
        padding: 16px 0 16px 16px;
        border-bottom: 1px solid #e5e5e5;
}

.search-ui-0 [wide].search-ui #leftBar.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;

        -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
        position: relative;
        width: 350px;
        margin-bottom: 0;
        padding-bottom: 0;
        border-bottom: none;
}

@media print {
.search-ui-0 #leftBar.search-ui {
  display: none !important;
}

}

.search-ui-0 #leftBar.search-ui h3.search-ui {
  text-transform: uppercase;
        font-size: 13px;
        font-weight: normal;
        margin-top: 6px;
        margin-bottom: 6px;
        cursor: default;
        display: inline-block;
        color: #a3a3a3;
}

.search-ui-0 #closeButton.search-ui {
  position: absolute;
        right: 0;
}

.search-ui-0 #searchTermsHeader.search-ui {
  position: relative;
}

.search-ui-0 #searchTermsQ.search-ui iron-icon.search-ui {
  height: 16px;
        padding: 0 2px 2px 2px;
        color: #a3a3a3;
}

.search-ui-0 #searchTermsHeader.search-ui:hover iron-icon.search-ui {
  color: #4285f4;
}

.search-ui-0 #closeLeftBar.search-ui {
  height: 16px;
        width: 16px;
        padding: 0 0 8px 0;
        cursor: pointer;
}

.search-ui-0 #compactQuery.search-ui iron-icon.search-ui {
  height: 20px;
}

.search-ui-0 #backToResultsButton.search-ui {
  color: #fff;
        background: #4285f4;
        margin-top: 20px;
        text-align: center;
}

.search-ui-0 #main.search-ui {
  display: block;
        min-height: calc(100vh - 127px);
}

@media print {
.search-ui-0 [wide].search-ui main.search-ui {
  margin-left: 0;
}

}</style><!-- Shady DOM styles for import-list --><!-- Shady DOM styles for iron-request --><!-- Shady DOM styles for iron-ajax --><!-- Shady DOM styles for paper-dialog --><!-- Shady DOM styles for coverage-stats --><!-- Shady DOM styles for iron-image --><!-- Shady DOM styles for iron-selector --><!-- Shady DOM styles for paper-card --><!-- Shady DOM styles for paper-checkbox --><!-- Shady DOM styles for landing-page --><!-- Shady DOM styles for remote-fetch --><!-- Shady DOM styles for paper-spinner --><style scope="paper-spinner-0">.paper-spinner-0 {
  display: inline-block;
        position: relative;
        width: 28px;
        height: 28px;
}

.paper-spinner-0 #spinnerContainer.paper-spinner {
  width: 100%;
        height: 100%;

        
        direction: ltr;
}

.paper-spinner-0 #spinnerContainer.active.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite;
        animation: container-rotate-paper-spinner-0 1568ms linear infinite;
}

@-webkit-keyframes container-rotate-paper-spinner-0 {
to {
  -webkit-transform: rotate(360deg)
}

}

@keyframes container-rotate-paper-spinner-0 {
to {
  transform: rotate(360deg)
}

}

.paper-spinner-0 .spinner-layer.paper-spinner {
  position: absolute;
        width: 100%;
        height: 100%;
        opacity: 0;
        white-space: nowrap;
        color: #4285f4;
}

.paper-spinner-0 .layer-1.paper-spinner {
  color: #4285f4;
}

.paper-spinner-0 .layer-2.paper-spinner {
  color: #db4437;
}

.paper-spinner-0 .layer-3.paper-spinner {
  color: #f4b400;
}

.paper-spinner-0 .layer-4.paper-spinner {
  color: #0f9d58;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0;
        -webkit-animation-duration: 5332ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-name: fill-unfill-rotate-paper-spinner-0;
        animation-duration: 5332ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
        opacity: 1;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-1.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-2.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-3.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-4.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
}

@-webkit-keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  -webkit-transform: rotate(135deg)
}

25% {
  -webkit-transform: rotate(270deg)
}

37.5% {
  -webkit-transform: rotate(405deg)
}

50% {
  -webkit-transform: rotate(540deg)
}

62.5% {
  -webkit-transform: rotate(675deg)
}

75% {
  -webkit-transform: rotate(810deg)
}

87.5% {
  -webkit-transform: rotate(945deg)
}

to {
  -webkit-transform: rotate(1080deg)
}

}

@keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  transform: rotate(135deg)
}

25% {
  transform: rotate(270deg)
}

37.5% {
  transform: rotate(405deg)
}

50% {
  transform: rotate(540deg)
}

62.5% {
  transform: rotate(675deg)
}

75% {
  transform: rotate(810deg)
}

87.5% {
  transform: rotate(945deg)
}

to {
  transform: rotate(1080deg)
}

}

@-webkit-keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@-webkit-keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

.paper-spinner-0 .circle-clipper.paper-spinner {
  display: inline-block;
        position: relative;
        width: 50%;
        height: 100%;
        overflow: hidden;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after {
  left: 45%;
        width: 10%;
        border-top-style: solid;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after,.paper-spinner-0 .circle-clipper.paper-spinner::after {
  content: '';
        box-sizing: border-box;
        position: absolute;
        top: 0;
        border-width: 3px;
        border-radius: 50%;
}

.paper-spinner-0 .circle-clipper.paper-spinner::after {
  bottom: 0;
        width: 200%;
        border-style: solid;
        border-bottom-color: transparent !important;
}

.paper-spinner-0 .circle-clipper.left.paper-spinner::after {
  left: 0;
        border-right-color: transparent !important;
        -webkit-transform: rotate(129deg);
        transform: rotate(129deg);
}

.paper-spinner-0 .circle-clipper.right.paper-spinner::after {
  left: -100%;
        border-left-color: transparent !important;
        -webkit-transform: rotate(-129deg);
        transform: rotate(-129deg);
}

.paper-spinner-0 .active.paper-spinner .gap-patch.paper-spinner::after,.paper-spinner-0 .active.paper-spinner .circle-clipper.paper-spinner::after {
  -webkit-animation-duration: 1333ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-duration: 1333ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.left.paper-spinner::after {
  -webkit-animation-name: left-spin-paper-spinner-0;
        animation-name: left-spin-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.right.paper-spinner::after {
  -webkit-animation-name: right-spin-paper-spinner-0;
        animation-name: right-spin-paper-spinner-0;
}

@-webkit-keyframes left-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(130deg)
}

50% {
  -webkit-transform: rotate(-5deg)
}

to {
  -webkit-transform: rotate(130deg)
}

}

@keyframes left-spin-paper-spinner-0 {
0% {
  transform: rotate(130deg)
}

50% {
  transform: rotate(-5deg)
}

to {
  transform: rotate(130deg)
}

}

@-webkit-keyframes right-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(-130deg)
}

50% {
  -webkit-transform: rotate(5deg)
}

to {
  -webkit-transform: rotate(-130deg)
}

}

@keyframes right-spin-paper-spinner-0 {
0% {
  transform: rotate(-130deg)
}

50% {
  transform: rotate(5deg)
}

to {
  transform: rotate(-130deg)
}

}

.paper-spinner-0 #spinnerContainer.cooldown.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
        animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
}

@-webkit-keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}</style><!-- Shady DOM styles for paper-spinner-lite --><!-- Shady DOM styles for concept-card --><!-- Shady DOM styles for concept-mention --><style scope="concept-mention">.block.concept-mention {
  display: block;
}

[hidden].concept-mention {
  display: none !important;
}

.invisible.concept-mention {
  visibility: hidden !important;
}

.relative.concept-mention {
  position: relative;
}

.fit.concept-mention {
  position: absolute;
        top: 0;
        right: 0;
        bottom: 0;
        left: 0;
}

body.fullbleed.concept-mention {
  margin: 0;
        height: 100vh;
}

.scroll.concept-mention {
  -webkit-overflow-scrolling: touch;
        overflow: auto;
}

.fixed-bottom.concept-mention,.fixed-left.concept-mention,.fixed-right.concept-mention,.fixed-top.concept-mention {
  position: fixed;
}

.fixed-top.concept-mention {
  top: 0;
        left: 0;
        right: 0;
}

.fixed-right.concept-mention {
  top: 0;
        right: 0;
        bottom: 0;
}

.fixed-bottom.concept-mention {
  right: 0;
        bottom: 0;
        left: 0;
}

.fixed-left.concept-mention {
  top: 0;
        bottom: 0;
        left: 0;
}

#target.concept-mention:hover {
  background-color: #e8f0fe;
}

#target[noicon].concept-mention {
  padding: 1px;
}

#target.concept-mention:hover[noicon] {
  border: 1px solid #e8f0fe;
        padding: 0;
}

#target.concept-mention {
  display: inline-block;
}

.inline-icon.concept-mention {
  cursor: pointer;
        height: 12px;
        width: 12px;
        padding-left: 4px;
        color: #5e6368;
}

concept-card.concept-mention {
  z-index: 1;
        position: absolute;
}</style><!-- Shady DOM styles for fterm-concept-card --><!-- Shady DOM styles for fterm-concept-mention --><!-- Shady DOM styles for paper-fab --><!-- Shady DOM styles for paper-icon-button --><!-- Shady DOM styles for paper-icon-button-light --><!-- Shady DOM styles for classification-tree --><style scope="classification-tree">.layout.horizontal.classification-tree,.layout.vertical.classification-tree {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.classification-tree {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.classification-tree {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.classification-tree {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.classification-tree {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.classification-tree {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.classification-tree {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.classification-tree {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.classification-tree {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

classification-tree {
  display: block;
        line-height: 20px;
}

.wrap.classification-tree {
  padding: 6px 12px;
}

.wrap.classification-tree:hover {
  background: #fafafa;
}

.description.classification-tree {
  padding-left: 4px;
}

iron-icon.classification-tree {
  color: #eaeaea;
}

.code[first].classification-tree {
  font-weight: 500;
}

.code[additional].classification-tree {
  font-style: italic;
}</style><!-- Shady DOM styles for classification-viewer --><style scope="classification-viewer">.table.classification-viewer {
  border: 1px solid #eaeaea;
        display: block;
}

.more.classification-viewer {
  padding: 6px 12px;
        cursor: pointer;
        font-style: italic;
        color: #aaa;
}

.more.classification-viewer:hover {
  background: #fafafa;
}

.chip.classification-viewer {
  display: inline-block;
        padding: 4px 6px;
        border-radius: 2px;
}

.chip[additional].classification-viewer {
  font-style: italic;
}</style><!-- Shady DOM styles for image-carousel --><!-- Shady DOM styles for image-viewer --><!-- Shady DOM styles for patent-result --><style scope="patent-result">#wrapper.patent-result {
  padding: 20px;
        max-width: 1050px;
        outline: 0;
}

.scroll-target.patent-result:before {
  display: block;
        content: '';
        visibility: hidden;
}

h1.patent-result {
  font-weight: 500;
        font-size: 20px;
        margin: 0 0 20px 0;
}

h3.patent-result {
  font-size: 15px;
        font-weight: 500;
        margin: 28px 0 18px 0;
}

dl.patent-result {
  line-height: 1.5;
        font-size: 0;
}

dt.patent-result,dd.patent-result {
  display: inline;
        font-size: 13px;
        margin: 0;
}

dt.patent-result {
  font-weight: 500;
        color: #000;
}

dt.patent-result::after {
  content: ': ';
}

dd.patent-result {
  color: #aaa;
}

dd.patent-result ~ dd.patent-result::before {
  content: ', ';
}

dt.patent-result + dd.patent-result::before {
  content: '';
}

dd.patent-result ~ dt.patent-result::before {
  display: block;
        content: '';
        margin-top: 8px;
}

dd.patent-result core-icon.patent-result {
  width: 14px;
        height: 14px;
        vertical-align: top;
        color: inherit;
}

.table.patent-result {
  display: table;
        border-collapse: collapse;
        border-spacing: 0;
        border: 1px solid #eaeaea;
        width: 100%;
        box-sizing: border-box;
}

.tr.patent-result {
  display: table-row;
        border-bottom: 1px solid #eaeaea;
}

.th.patent-result,.td.patent-result {
  display: table-cell;
        padding: 10px 12px;
}

.thead.patent-result {
  display: table-header-group;
}

.tbody.patent-result {
  display: table-row-group;
}

.th.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.td.patent-result {
  vertical-align: top;
}

.td.patent-result > p.patent-result {
  margin-top: 0;
}

.nowrap.patent-result {
  white-space: nowrap;
}

.knowledge-card.patent-result {
  border: 1px solid #e5e5e5;
        border-radius: 2px;
}

.knowledge-card.patent-result > header.patent-result {
  -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
        background: #4285f4;
        color: #fff;
        padding: 20px 12px;
}

.knowledge-card.patent-result > header.patent-result state-modifier.patent-result,.knowledge-card.patent-result > header.patent-result a.patent-result {
  color: inherit;
        margin: 0 12px 0 0;
        display: inline-block;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result,.knowledge-card.patent-result > header.patent-result .tagline.patent-result {
  margin: 0;
        font-weight: normal;
        padding-top: 4px;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result {
  font-size: 20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result {
  background: #3367d6;
        padding: 10px 12px;
        margin: 20px -12px -20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result core-icon.patent-result {
  margin-right: 12px;
        width: 24px;
        height: 24px;
}

.knowledge-card.patent-result dl.patent-result {
  padding: 16px 12px;
}

.knowledge-card.patent-result hr.patent-result {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 0;
}

.main-link.patent-result {
  margin: 14px;
        font-weight: 500;
}

.footer.patent-result h3.patent-result state-modifier.patent-result,.footer.patent-result h3.patent-result a.patent-result {
  float: right;
        font-weight: 400;
        font-size: 13px;
        line-height: 24px;
}

.footer.patent-result dl.patent-result {
  margin-left: 30px;
}

.footer.patent-result > ul.patent-result > li.patent-result {
  margin-bottom: 8px;
}

h3.patent-result .righthead.patent-result {
  color: #aaa;
        font-weight: 400;
        font-size: 13px;
        cursor: help;
}

.tooltip-hint.patent-result {
  border-bottom: 1px dotted #ccc;
}

[marginRight].patent-result {
  margin-right: 60px;
}

.flex-width.patent-result {
  min-width: 0;
        word-break: break-word;
}

.responsive-table.patent-result {
  width: 100%;
        overflow-x: auto;
        overflow-y: hidden;
}

.layout.horizontal.patent-result,.layout.vertical.patent-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.flex.patent-result,.flex-1.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-2.patent-result {
  -ms-flex: 2;
        -webkit-flex: 2;
        flex: 2;
}

.flex-3.patent-result {
  -ms-flex: 3;
        -webkit-flex: 3;
        flex: 3;
}

.flex-4.patent-result {
  -ms-flex: 4;
        -webkit-flex: 4;
        flex: 4;
}

.flex-5.patent-result {
  -ms-flex: 5;
        -webkit-flex: 5;
        flex: 5;
}

.flex-6.patent-result {
  -ms-flex: 6;
        -webkit-flex: 6;
        flex: 6;
}

.flex-7.patent-result {
  -ms-flex: 7;
        -webkit-flex: 7;
        flex: 7;
}

.flex-8.patent-result {
  -ms-flex: 8;
        -webkit-flex: 8;
        flex: 8;
}

.flex-9.patent-result {
  -ms-flex: 9;
        -webkit-flex: 9;
        flex: 9;
}

.flex-10.patent-result {
  -ms-flex: 10;
        -webkit-flex: 10;
        flex: 10;
}

.flex-11.patent-result {
  -ms-flex: 11;
        -webkit-flex: 11;
        flex: 11;
}

.flex-12.patent-result {
  -ms-flex: 12;
        -webkit-flex: 12;
        flex: 12;
}

@media print {
#text.patent-result {
  flex-direction: column-reverse !important;
}

}

patent-result-ref-list.patent-result {
  width: 100%;
}

patent-result-ref-list.patent-result + patent-result-ref-list.patent-result {
  margin-left: 10px;
}

[narrow].patent-result {
  flex-direction: column-reverse !important;
}

.famheader.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.collapse.patent-result {
  color: #616161;
        font-size: 13px;
        cursor: pointer;
}

#imageDrag.patent-result {
  position: fixed;
        cursor: col-resize;
}

#imageDrag.patent-result div.patent-result {
  width: 4px;
        height: 100%;
        margin: 0 4px;
        background: #eee;
}

#imageDrag.patent-result:hover {
  background: #eee;
}

#imageDrag.patent-result:hover div.patent-result {
  background: #ccc;
}

.imageWrapper.patent-result {
  position: fixed;
        top: 60px;
        background: white;
        margin-left: 12px;
}

#notices.patent-result {
  padding: 20px;
}

#figures.patent-result {
  background: #efefef;
}

.headerButton.patent-result {
  color: #3c80f6;
        cursor: pointer;
        display: inline-block;
        padding: 0 14px;
        line-height: 27px;
}

.headerButton.patent-result iron-icon.patent-result {
  width: 16px;
        height: 16px;
}

.tr.conceptDomain.patent-result {
  display: table-row;
}

.responsive-grid.patent-result {
  display: grid;
        gap: 8px;
        grid-template-columns: none;
}</style><!-- Shady DOM styles for family-viewer --><!-- Shady DOM styles for app-row --><!-- Shady DOM styles for application-timeline --><style scope="application-timeline">.layout.horizontal.application-timeline,.layout.vertical.application-timeline {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.application-timeline {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.application-timeline {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.application-timeline {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.application-timeline {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.application-timeline {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.application-timeline {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.application-timeline {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.application-timeline {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.wrap.application-timeline {
  padding: 16px 12px;
}

.event.application-timeline {
  padding: 3px 0;
}

[date].application-timeline {
  color: #5f6368;
        font-size: 13px;
        padding: 3px 0;
        width: 70px;
        line-height: 16px;
}

[critical].application-timeline [date].application-timeline {
  color: #202124;
        font-weight: 500;
        line-height: 18px;
}

.line.application-timeline {
  margin: 9px 6px;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
}

.dot.application-timeline {
  margin: 3px 0;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
        display: inline-block;
}

[critical].application-timeline .line.application-timeline {
  background: #4285f4;
}

[current].application-timeline .line.application-timeline {
  background: #81c995;
}

[current][critical].application-timeline .line.application-timeline {
  background: #81c995;
}

.title.application-timeline {
  font-size: 13px;
        padding: 3px 0;
        line-height: 16px;
}

.title-text.application-timeline {
  color: #5f6368;
}

.description-item.application-timeline {
  font-size: 12px;
        padding: 6px 0;
        max-width: 300px;
}

#legal.application-timeline {
  height: 14px;
        width: 14px;
        padding: 0 3px 1px 3px;
        vertical-align: text-bottom;
}

#icon.application-timeline {
  height: 12px;
        width: 12px;
        padding: 0 3px 3px 3px;
        vertical-align: text-bottom;
}

.unknown.application-timeline {
  font-style: italic;
}

.not_active.application-timeline {
  text-decoration: line-through;
}

.active.application-timeline {
  font-weight: 500;
}

#cc[this].application-timeline {
  color: #202124 !important;
        text-decoration: underline;
}

#cc[this].not_active.application-timeline {
  text-decoration: line-through underline;
}

hr.application-timeline {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 10px 0 16px 0;
}

.header.application-timeline {
  font-size: 13px;
        line-height: 20px;
        font-weight: 500;
        color: #202124;
        padding-bottom: 8px;
}

.block.application-timeline {
  padding: 0 6px 0 0;
}

.year.application-timeline {
  color: #5f6368;
        font-size: 13px;
        font-weight: 500;
        padding: 3px 1px;
        width: 70px;
}

.expand.application-timeline {
  cursor: pointer;
        padding: 6px 0 3px 0;
}</style><!-- Shady DOM styles for patent-text --><style scope="patent-text">.layout.horizontal.patent-text,.layout.vertical.patent-text {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-text {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-text {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-text {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-text {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-text {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-text {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-text {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-text {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-text {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-text {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-text {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-text {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-text {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-text {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-text {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-text {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-text {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-text {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-text {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-text {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-text {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-text {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-text {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-text {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-text {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

patent-text {
  display: block;
}

#text.patent-text {
  line-height: 20px;
        min-width: 0;
}

#margin.patent-text {
  width: 16px;
}

#createHighlight.patent-text {
  position: relative;
        width: 16px;
        height: 16px;
        cursor: pointer;
}

.notranslate.patent-text > .google-src-text.patent-text {
  display: none;
}

.notranslate.patent-text:hover,mark.patent-text {
  background-color: #fbfcae;
}

.description-paragraph.patent-text {
  margin-block-start: 1em;
        margin-block-end: 1em;
}

.claim-text.patent-text {
  margin: 14px 0 0 20px;
}

.claim-dependent.patent-text {
  margin-left: 40px;
        color: #888;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim-text.patent-text {
  height: 0;
        width: 0;
        visibility: hidden;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim.patent-text:after {
  content: ""
}

.patent-full-image.patent-text {
  max-width: 100%;
        height: auto;
}

.small-patent-image.patent-text {
  display: inline;
}

ul.patent-text {
  padding: 0 0 0 50px;
}

li.patent-text {
  list-style-type: none;
        position: relative;
}

ol.claims.patent-text li.patent-text {
  list-style-type: decimal;
        font-weight: bold;
}

ol.claims.patent-text li.patent-text > *.patent-text {
  font-weight: normal;
}

li.patent-text > para-num.patent-text {
  position: absolute;
        left: -45px;
        color: #888;
}

mark.patent-text {
  background: #fff59d;
}

mark.searchText.patent-text {
  background: #80deea;
}

.searchTextHeader.patent-text {
  font-weight: 500;
}

pre.patent-text {
  white-space: pre-wrap;
}

heading.patent-text {
  display: block;
        font-weight: 500;
        font-size: 13px;
}

#comment.patent-text {
  width: 16px;
        height: 16px;
}

[has-search][no-results].patent-text {
  display: none;
}

.highlight.patent-text {
  background-color: #fef7e0;
}</style><!-- Shady DOM styles for para-num --><!-- Shady DOM styles for result-container --><style scope="result-container">paper-spinner.result-container {
  position: absolute;
        
        top: calc(50%  + 56px - 16px);
        left: calc(50% + 175px - 16px);
}</style><!-- Shady DOM styles for scholar-result --><!-- Shady DOM styles for search-result --><style scope="search-result">.layout.horizontal.search-result,.layout.vertical.search-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

search-result {
  display: block;
        font-size: 13px;
}

#mainContainer.search-result {
  min-height: calc(100vh - 127px);
        color: #333;
}

#compactQuery.search-result {
  padding: 18px 20px 10px 20px;
        cursor: pointer;
}

#compactQuery.search-result > span.search-result {
  padding: 0 14px 0 0;
}

#compactQuery.search-result iron-icon.search-result {
  padding-right: 6px;
        height: 16px;
        width: 16px;
}</style><!-- Shady DOM styles for webdoc-result --><!-- Shady DOM styles for iron-pages --><!-- Shady DOM styles for paper-tab --><!-- Shady DOM styles for paper-tabs --><!-- Shady DOM styles for debug-info --><!-- Shady DOM styles for search-paging --><!-- Shady DOM styles for search-result-item --><!-- Shady DOM styles for search-result-image --><!-- Shady DOM styles for search-result-entities --><!-- Shady DOM styles for search-result-measures --><!-- Shady DOM styles for search-results --><!-- Shady DOM styles for summary-box --><!-- Shady DOM styles for timeline-page --><!-- Shady DOM styles for iron-localstorage --><!-- Shady DOM styles for search-app --><style scope="search-app">search-app {
  display: block;
        height: 100%;
}

#toast.search-app {
  min-height: 64px;
        min-width: 742px;
}</style><style>body {transition: opacity ease-in 0.2s; } 
body[unresolved] {opacity: 0; display: block; overflow: hidden; position: relative; } 
</style>
    <title>JP4913588B2 - 
  Process for producing farnesyl benzodiazepinone and its use as a drug
 
        - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/JP4913588B2/en">
    
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="
  Process for producing farnesyl benzodiazepinone and its use as a drug
 
       ">
    <meta name="DC.date" content="2004-01-21" scheme="dateSubmitted">
    <meta name="DC.description" content="">
    <meta name="citation_patent_application_number" content="JP:2006500437A">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/87/b4/b6/f1b8cba6116e64/JP4913588B2.pdf">
    <meta name="citation_patent_number" content="JP:4913588:B2">
    <meta name="DC.date" content="2012-04-11" scheme="issue">
    <meta name="DC.contributor" content="   " scheme="inventor">
    <meta name="DC.contributor" content="   " scheme="inventor">
    <meta name="DC.contributor" content=" " scheme="inventor">
    <meta name="DC.contributor" content="   " scheme="inventor">
    <meta name="DC.contributor" content=" " scheme="inventor">
    <meta name="DC.contributor" content="Thallion Pharmaceuticals Inc" scheme="assignee">
    <meta name="DC.relation" content="US:5541181" scheme="references">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      body { transition: none; }
    </style>

    <script src="https://apis.google.com/_/scs/abc-static/_/js/k=gapi.lb.en.IKZeRvoAYNY.O/m=client/rt=j/sv=1/d=1/ed=1/am=AAAQ/rs=AHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw/cb=gapi.loaded_0?le=scs" async=""></script><script>
      window.version = 'patent-search.search_20240531_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <style>[hidden]:not([style-scope]):not(.style-scope) {
  display: none !important;
}

</style><style></style><style></style><style></style><style></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic,500,500italic,700,700italic"><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,700"><style></style><style></style><style>
  html, body {
    min-width: 100%;
    width: 100%;
    min-height: 100%;
    height: 100%;
  }

  body {
    background-color: #fff;
    font-family: 'Roboto', sans-serif;
    color: #333;
    margin: 0;
    padding: 0;
    /*
     * Turn off https://github.com/WICG/ScrollAnchoring/blob/master/explainer.md
     * https://memegen.googleplex.com/5230756293246976
     */
    overflow-anchor: none;
  }

  body h1, body h2, body h3 {
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
  }

  body a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  body a:visited {
    color: #3c80f6;
  }

  body a[open-result]:visited {
    color: #7e57c2;
  }

  /* For Firefox */
  a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  a:visited {
    color: #3c80f6;
  }

  a[open-result]:visited {
    color: #7e57c2;
  }

  ::selection , body ::selection {
    background-color: #c6dafc;
    color: #333;
  }
</style><link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.html">
  <style>[hidden] { display: none !important; }</style><script type="text/javascript" charset="UTF-8" src="https://apis.google.com/js/client.js" gapi_processed="true"></script></head>
  <body>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.js"></script><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span>
    <search-app>
    
    <remote-fetch class="style-scope search-app"></remote-fetch>
    <search-state class="style-scope search-app"></search-state>
    <browser-ui class="style-scope search-app"></browser-ui>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    
      <search-result id="result" class="style-scope search-app">
    
    
    <search-ui mode="result" class="style-scope search-result x-scope search-ui-0">
    
    
    
    <div id="content" class="style-scope search-ui" wide="">
      <search-header show-search="" class="style-scope search-ui">
    
    
    <div class="style-scope search-header" wide="">
      <header class="style-scope search-header">
        <div class="layout horizontal headerpad style-scope search-header">
          <div class="layout horizontal leftheader style-scope search-header">
            <h1 class="style-scope search-header">
              <state-modifier inherit="" act="{&quot;type&quot;: &quot;HOME&quot;}" class="style-scope search-header"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                <div class="lockup style-scope search-header">
                  <span class="lockup-logo style-scope search-header"></span>
                  <span class="lockup-text style-scope search-header">
                    <span class="lockup-brand style-scope search-header">&nbsp;Patents</span>
                  </span>
                </div>
              </a></state-modifier>
            </h1>
          </div>
          
            <search-box class="style-scope search-header">
    
    <div class="layout horizontal style-scope search-box" style="position: relative;">
      <div class="inputbox flex layout horizontal style-scope search-box">
        <div class="suggest-bg flex style-scope search-box">
          <input name="q" id="searchInput" data-proto="SEARCH_INPUT" autocomplete="off" class="style-scope search-box">
        </div>
        <div id="corpora" class="style-scope search-box">
          <iron-icon icon="icons:lightbulb-outline" id="patentIcon" class="style-scope search-box x-scope iron-icon-0" active=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M9 21c0 .55.45 1 1 1h4c.55 0 1-.45 1-1v-1H9v1zm3-19C8.14 2 5 5.14 5 9c0 2.38 1.19 4.47 3 5.74V17c0 .55.45 1 1 1h6c.55 0 1-.45 1-1v-2.26c1.81-1.27 3-3.36 3-5.74 0-3.86-3.14-7-7-7zm2.85 11.1l-.85.6V16h-4v-2.3l-.85-.6C7.8 12.16 7 10.63 7 9c0-2.76 2.24-5 5-5s5 2.24 5 5c0 1.63-.8 3.16-2.15 4.1z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#patentIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include patents
    </div>
  </overlay-tooltip>
          <iron-icon icon="social:school" id="nplIcon" class="style-scope search-box x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M5 13.18v4L12 21l7-3.82v-4L12 17l-7-3.82zM12 3L1 9l11 6 9-4.91V17h2V9L12 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#nplIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include non-patent literature
    </div>
  </overlay-tooltip>
          <keyword-wizard id="wizardIcon" class="style-scope search-box">


<div id="wizardContainer" class="style-scope keyword-wizard">
  <iron-icon icon="image:tune" id="wizardIcon" class="style-scope keyword-wizard x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M3 17v2h6v-2H3zM3 5v2h10V5H3zm10 16v-2h8v-2h-8v-2h-2v6h2zM7 9v2H3v2h4v2h2V9H7zm14 4v-2H11v2h10zm-6-4h2V7h4V5h-4V3h-2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
  <paper-material elevation="2" id="wizard" class="style-scope keyword-wizard x-scope paper-material-0" hidden="">
    
    

    
    
    <div class="search-within style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Search within
        <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="within"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="withinHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search within the title, abstract, claims, or full patent document</b>: You can
          restrict your search to a specific field using field names.</p>
        <p class="style-scope keyword-wizard">Use <span class="q style-scope keyword-wizard">TI=</span> to search in the title, <span class="q style-scope keyword-wizard">AB=</span> for the
          abstract, <span class="q style-scope keyword-wizard">CL=</span> for the claims, or <span class="q style-scope keyword-wizard">TAC=</span> for
          all three. For example, <span class="q style-scope keyword-wizard">TI=(safety belt)</span>.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search by Cooperative Patent Classifications (CPCs)</b>: These are commonly used to
          represent ideas in place of keywords, and can also be entered in a search term box. If
          you're searching for<span class="q style-scope keyword-wizard">seat belts</span>, you could also search for
          <span class="q style-scope keyword-wizard">B60R22/00</span> to retrieve documents that mention safety belts or body
          harnesses. <span class="q style-scope keyword-wizard">CPC=B60R22</span> will match documents with exactly this CPC,
          <span class="q style-scope keyword-wizard">CPC=B60R22/low</span> matches documents with this CPC or a child
          classification of this CPC.
        </p>
          <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="filter-chips style-scope keyword-wizard">
        <span class="chip style-scope keyword-wizard" id="title" selected="">Title</span>
        <span class="chip style-scope keyword-wizard" id="abstract" selected="">Abstract</span>
        <span class="chip style-scope keyword-wizard" id="claims" selected="">Claims</span>
        <span class="chip style-scope keyword-wizard" id="fullDoc" selected="">Full Document</span>
      </div>
      
      <div class="cpc-field style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputCPC" class="style-scope keyword-wizard">or CPC</label></span>
        <div class="cpc-inputs style-scope keyword-wizard">
          <input class="keyword-input style-scope keyword-wizard" id="inputCPC" placeholder="Or search with CPC">
          <input type="checkbox" id="childCPC" checked="" class="style-scope keyword-wizard">
          <label class="checkbox-label style-scope keyword-wizard" for="childCPC">
            Include child classifications
          </label>
        </div>
      </div>
    </div>
    
    <div class="find-patents style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Find patents
        <iron-icon class="help-header style-scope keyword-wizard x-scope iron-icon-0" icon="icons:help-outline" id="searchBoolean"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="searchBooleanHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Keywords and boolean syntax (USPTO or EPO format)</b>:
          <span class="q style-scope keyword-wizard">seat belt</span> searches these two words, or their plurals and close
          synonyms. <span class="q style-scope keyword-wizard">"seat belt"</span> searches this exact phrase, in order.
          <span class="q style-scope keyword-wizard">-seat -belt</span> searches for documents not containing either word.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">For searches using boolean logic</b>, the default operator is
          <span class="q style-scope keyword-wizard">AND</span> with left associativity. <i class="style-scope keyword-wizard">Note:</i> this means
          <span class="q style-scope keyword-wizard">safety OR seat belt</span> is searched as <span class="q style-scope keyword-wizard">(safety OR seat)
          AND belt</span>. Each word automatically includes plurals and close synonyms. Adjacent
          words that are implicitly ANDed together, such as <span class="q style-scope keyword-wizard">(safety belt)</span>,
          are treated as a phrase when generating synonyms.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputAnd" class="style-scope keyword-wizard">with ALL of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputAnd" placeholder="with ALL of the words">
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputExact" class="style-scope keyword-wizard">with the EXACT PHRASE</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputExact" placeholder="with the EXACT PHRASE"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputOr" class="style-scope keyword-wizard">with AT LEAST ONE of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputOr" placeholder="with AT LEAST ONE of the words"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputMinus" class="style-scope keyword-wizard">WITHOUT the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputMinus" placeholder="WITHOUT the words"></div>
    </div>
    <div class="search-by style-scope keyword-wizard">
      <div class="wizard-header style-scope keyword-wizard">
          Search by
          <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="chem"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </div>
      
      <div class="help style-scope keyword-wizard" id="chemHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Chemistry searches</b> match terms (trade names, IUPAC names, etc.
          extracted from the entire document, and processed from .MOL files.)
        </p>
        <p class="style-scope keyword-wizard">Substructure (use <span class="q style-scope keyword-wizard">SSS=</span>) and similarity (use
          <span class="q style-scope keyword-wizard">~</span>) searches are limited to one per search at the top-level
          <span class="q style-scope keyword-wizard">AND</span> condition. Exact searches can be used multiple times throughout
          the search query.
        </p>
        <p class="style-scope keyword-wizard">Searching by SMILES or InChi key requires no special syntax. To search by SMARTS, use
          <span class="q style-scope keyword-wizard">SMARTS=</span>.
        </p>
        <p class="style-scope keyword-wizard">To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple
          molecules separated by whitespace or by comma.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      
      <div class="chemistry-field style-scope keyword-wizard">
          <span class="input-label style-scope keyword-wizard"><label for="inputChem" class="style-scope keyword-wizard">Chemistry</label></span>
          <span class="chem-type-label style-scope keyword-wizard"><label for="chemType" hidden="" class="style-scope keyword-wizard">Type</label></span>
          <select id="chemType" class="style-scope keyword-wizard">
            <option value="identical" class="style-scope keyword-wizard">Identical</option>
            <option value="substructure" class="style-scope keyword-wizard">Substructure</option>
            <option value="smarts" class="style-scope keyword-wizard">SMARTS</option>
            <option value="similarity" class="style-scope keyword-wizard">Similarity</option>
            <option value="batch" class="style-scope keyword-wizard">Batch</option>
          </select>
          <textarea class="keyword-input style-scope keyword-wizard" id="inputChem" placeholder="Trade name, SMILES, InChiKey"></textarea>
      </div>
      <div class="import style-scope keyword-wizard">
        <div class="wizard-header style-scope keyword-wizard">
          Patent numbers
        </div>
        <span class="import-button style-scope keyword-wizard">
          <a href="https://patents.google.com/import" class="style-scope keyword-wizard"><button class="style-scope keyword-wizard">Import</button></a>
        </span>
        <p class="import-text style-scope keyword-wizard">
          Search specific patents by importing a CSV or list of patent publication or application numbers.
        </p>
      </div>
    </div>
    
    <div class="wizard-buttons style-scope keyword-wizard">
      <button type="reset" class="style-scope keyword-wizard">Close</button>
      <button type="button" autofocus="" class="style-scope keyword-wizard">Add</button>
    </div>
  
  </paper-material>
</div>
</keyword-wizard>
          <overlay-tooltip positioning-target="#wizardIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Display advanced search options
    </div>
  </overlay-tooltip>
        </div>
      </div>
      <paper-material id="suggestMenu" class="style-scope search-box x-scope paper-material-0" elevation="1" hidden="">
    
    

    
        <template is="dom-repeat" class="style-scope search-box"></template>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Sorry, we couldn't find this patent number.
        </div>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> 
        </div>
      
  </paper-material>
      <button id="searchButton" class="style-scope search-box"><iron-icon class="style-scope search-box x-scope iron-icon-0" icon="search"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></button>
    </div>
  </search-box>
          <template is="dom-if" class="style-scope search-header"></template>
          <div class="flex style-scope search-header"></div>
          
            <div id="header-container" class="style-scope search-header">
              <result-nav class="style-scope search-header">
    
    <div class="style-scope result-nav" hidden="">
      <state-modifier id="current" act="{&quot;type&quot;: &quot;BACK_TO_RESULTS&quot;}" inherit="" class="style-scope result-nav"><a id="link" href="#" class="style-scope state-modifier" inherit=""><span class="style-scope result-nav"></span> of
      <template is="dom-if" class="style-scope result-nav"></template>
      0<template is="dom-if" class="style-scope result-nav"></template></a></state-modifier>
      <state-modifier id="prevResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-left" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.41 7.41L14 6l-6 6 6 6 1.41-1.41L10.83 12z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier><state-modifier id="nextResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-right" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M10 6L8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier>
      <overlay-tooltip positioning-target="#prevResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Previous result
    </div>
  </overlay-tooltip>
      <overlay-tooltip positioning-target="#nextResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Next result
    </div>
  </overlay-tooltip>
    </div>
  </result-nav>
            </div>
          <template is="dom-if" class="style-scope search-header"></template>
        </div>
      </header>
    </div>
  </search-header>

      <div class="layout horizontal style-scope search-ui">
        <template is="dom-if" class="style-scope search-ui"></template>

        <div id="main" class="style-scope search-ui">
          <search-term-wizard class="style-scope search-ui"><pat-dialog open="" class="style-scope search-term-wizard">
  <span class="header style-scope search-term-wizard">
    <span class="title style-scope search-term-wizard">Search tools</span>
    <span id="language" class="style-scope search-term-wizard">
      <text-button id="textButton" selected="" class="style-scope search-term-wizard">Text
</text-button>
      <text-button id="classificationButton" class="style-scope search-term-wizard">Classification
</text-button>
      <text-button id="chemistryButton" class="style-scope search-term-wizard">Chemistry
</text-button>
      <text-button id="measureButton" class="style-scope search-term-wizard">Measure
</text-button>
      <text-button id="numbersButton" class="style-scope search-term-wizard">Numbers
</text-button>
    </span>
  </span>
  <span id="panels" class="style-scope search-term-wizard">
    <text-search-term-wizard id="textPanel" class="style-scope search-term-wizard" selected=""><span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Type a concept you want to search for here" class="style-scope text-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Type a concept you want to search for here">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="title" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Title</filter-chip>
  <filter-chip id="abstract" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Abstract</filter-chip>
  <filter-chip id="claims" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="all" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
All</filter-chip>
  <filter-chip id="any" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Any</filter-chip>
  <filter-chip id="exact" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="not" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Not</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope text-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope text-search-term-wizard">Add AND condition</span></mat-button></span></text-search-term-wizard>
    <classification-wizard id="classificationPanel" class="style-scope search-term-wizard"><span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope classification-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Enter a CPC here" uppercase="" class="style-scope classification-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Enter a CPC here">
  
</span>
</outlined-text-field>
</span>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope classification-wizard"></path>
  </svg>
  <filter-chip id="notExact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These CPCs and their children
  </filter-chip>
  <filter-chip selected="" id="exact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These exact CPCs
  </filter-chip>
</span>
<span class="style-scope classification-wizard">
  <mat-button id="button" filled="" class="style-scope classification-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope classification-wizard">Add AND condition</span></mat-button>
</span></classification-wizard>
    <chemistry-search-term-wizard id="chemistryPanel" class="style-scope search-term-wizard"><span class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Trade name, SMILES, InChI Key" class="style-scope chemistry-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Trade name, SMILES, InChI Key">
  
</span>
</outlined-text-field>
  <outlined-textarea id="textArea" placeholder="Enter multiple SMILES or InChI Keys, one per line" rows="4" class="style-scope chemistry-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple SMILES or InChI Keys, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
  <a href="https://support.google.com/faqs/answer/7049475#zippy=%2Csearching-by-chemistry" target="_blank" class="style-scope chemistry-search-term-wizard">
    <svg class="help style-scope chemistry-search-term-wizard" xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49">
      <path d="M11.95 18q.525 0 .888-.363.362-.362.362-.887t-.362-.887q-.363-.363-.888-.363t-.888.363q-.362.362-.362.887t.362.887q.363.363.888.363Zm-.9-3.85h1.85q0-.825.188-1.3.187-.475 1.062-1.3.65-.65 1.025-1.238.375-.587.375-1.412 0-1.4-1.025-2.15T12.1 6q-1.425 0-2.312.75-.888.75-1.238 1.8l1.65.65q.125-.45.563-.975Q11.2 7.7 12.1 7.7q.8 0 1.2.437.4.438.4.963 0 .5-.3.937-.3.438-.75.813-1.1.975-1.35 1.475-.25.5-.25 1.825ZM12 22q-2.075 0-3.9-.788-1.825-.787-3.175-2.137-1.35-1.35-2.137-3.175Q2 14.075 2 12t.788-3.9q.787-1.825 2.137-3.175 1.35-1.35 3.175-2.138Q9.925 2 12 2t3.9.787q1.825.788 3.175 2.138 1.35 1.35 2.137 3.175Q22 9.925 22 12t-.788 3.9q-.787 1.825-2.137 3.175-1.35 1.35-3.175 2.137Q14.075 22 12 22Zm0-2q3.35 0 5.675-2.325Q20 15.35 20 12q0-3.35-2.325-5.675Q15.35 4 12 4 8.65 4 6.325 6.325 4 8.65 4 12q0 3.35 2.325 5.675Q8.65 20 12 20Zm0-8Z" class="style-scope chemistry-search-term-wizard"></path>
    </svg>
  </a>
</span>
<span id="chemQuantifiers" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M5 21.2q-1.4 0-2-1.25-.6-1.25.3-2.325l5.5-6.7V5.15h-.825q-.475 0-.8-.338Q6.85 4.475 6.85 4q0-.475.325-.813.325-.337.8-.337h8.05q.475 0 .8.337.325.338.325.813 0 .475-.325.812-.325.338-.8.338H15.2v5.775l5.5 6.7q.9 1.075.3 2.325-.6 1.25-2 1.25Zm2.15-3.275h9.7l-3.275-3.85h-3.15Zm-2 1h13.7l-5.925-7.2V5.15h-1.85v6.575Zm6.85-6.9Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="exact" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="exactBatch" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact Batch</filter-chip>
  <filter-chip id="similar" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Similar</filter-chip>
  <filter-chip id="substructure" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure</filter-chip>
  <filter-chip id="smarts" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure (SMARTS)</filter-chip>
</span>
<span id="location" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="claims" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims only</filter-chip>
</span>
<span class="style-scope chemistry-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope chemistry-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope chemistry-search-term-wizard">Add AND condition</span></mat-button>
</span>
</chemistry-search-term-wizard>
    <measure-search-term-wizard id="measurePanel" class="style-scope search-term-wizard"><span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M4.1 18.15q-.95 0-1.612-.663-.663-.662-.663-1.612v-7.75q0-.95.663-1.613Q3.15 5.85 4.1 5.85h15.8q.95 0 1.613.662.662.663.662 1.613v7.75q0 .95-.662 1.612-.663.663-1.613.663Zm0-2.275h15.8v-7.75H17V12h-2V8.125h-2V12h-2V8.125H9V12H7V8.125H4.1v7.75ZM7 12h2Zm4 0h2Zm4 0h2Zm-3 0Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="measureExpression" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M3.875 20.15V8.85h4.25v11.3Zm6 0V3.85h4.25v16.3Zm6 0v-7.3h4.25v7.3Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="context" placeholder="activity, wavelength, embossing depth, absorption" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="activity, wavelength, embossing depth, absorption">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope measure-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope measure-search-term-wizard">Add AND condition</span></mat-button>
</span>
</measure-search-term-wizard>
    <numerical-search-term-wizard id="numericalPanel" class="style-scope search-term-wizard"><span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-textarea id="batch" placeholder="Enter multiple Patent Application and Publication Numbers, one per line" rows="4" class="style-scope numerical-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple Patent Application and Publication Numbers, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
</span>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="m10.825 23.45-1.6-1.625L10.9 20.15H8q-.35.9-1.162 1.488-.813.587-1.838.587-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.025.588-1.837Q2.95 16.35 3.85 16V8q-.9-.35-1.487-1.163Q1.775 6.025 1.775 5q0-1.35.938-2.288Q3.65 1.775 5 1.775q1.025 0 1.838.587Q7.65 2.95 8 3.85h2.9L9.225 2.175l1.6-1.625L15.275 5l-4.45 4.45-1.6-1.625L10.9 6.15H8q-.25.65-.725 1.125T6.15 8v8q.65.25 1.125.725T8 17.85h2.9l-1.675-1.675 1.6-1.625 4.45 4.45ZM19 22.225q-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.05.588-1.863.587-.812 1.487-1.137V8q-.9-.325-1.487-1.137-.588-.813-.588-1.863 0-1.35.938-2.288.937-.937 2.287-.937 1.35 0 2.288.937.937.938.937 2.288 0 1.05-.587 1.863Q21.05 7.675 20.15 8v8q.9.35 1.488 1.163.587.812.587 1.837 0 1.35-.937 2.288-.938.937-2.288.937ZM5 19.95q.4 0 .675-.275T5.95 19q0-.4-.275-.675T5 18.05q-.4 0-.675.275T4.05 19q0 .4.275.675T5 19.95Zm14 0q.4 0 .675-.275T19.95 19q0-.4-.275-.675T19 18.05q-.4 0-.675.275T18.05 19q0 .4.275.675t.675.275Zm-14-14q.4 0 .675-.275T5.95 5q0-.4-.275-.675T5 4.05q-.4 0-.675.275T4.05 5q0 .4.275.675T5 5.95Zm14 0q.4 0 .675-.275T19.95 5q0-.4-.275-.675T19 4.05q-.4 0-.675.275T18.05 5q0 .4.275.675T19 5.95ZM5 19Zm14 0ZM5 5Zm14 0Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <filter-chip id="applicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Application Numbers</filter-chip>
  <filter-chip id="publicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Publication Numbers</filter-chip>
  <filter-chip id="either" selected="" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Either</filter-chip>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M12 22.2q-2.1 0-3.962-.8-1.863-.8-3.25-2.175Q3.4 17.85 2.6 15.988 1.8 14.125 1.8 12t.8-3.988q.8-1.862 2.188-3.237Q6.175 3.4 8.038 2.6 9.9 1.8 12 1.8q2.125 0 3.988.8 1.862.8 3.237 2.175Q20.6 6.15 21.4 8.012q.8 1.863.8 3.988t-.8 3.988q-.8 1.862-2.175 3.237Q17.85 20.6 15.988 21.4q-1.863.8-3.988.8Zm-1-2.325v-1.95q-.8 0-1.387-.575-.588-.575-.588-1.4v-.975L4.275 10.2q-.075.45-.137.9-.063.45-.063.9 0 3 1.975 5.25T11 19.875Zm6.85-2.525q.5-.55.888-1.175.387-.625.65-1.313.262-.687.4-1.412.137-.725.137-1.45 0-2.425-1.338-4.438-1.337-2.012-3.612-2.887v.375q0 .825-.587 1.4-.588.575-1.388.575h-2v2q0 .4-.287.687-.288.288-.688.288h-2v2h5.95q.425 0 .713.287.287.288.287.688v2.975h1q.65 0 1.163.387.512.388.712 1.013Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryFilter" placeholder="Restrict search to these countries" class="style-scope numerical-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Restrict search to these countries">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M2.85 18.225V15.95h6.3v2.275Zm0-5.075v-2.3h12.3v2.3Zm0-5.1V5.775h18.3V8.05Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryOrder" placeholder="Prefer results from these countries in this order" class="style-scope numerical-search-term-wizard" value="US, EP, WO, JP, CN"><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Prefer results from these countries in this order">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope numerical-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope numerical-search-term-wizard">Add AND condition</span></mat-button>
</span>
</numerical-search-term-wizard>
  </span>

</pat-dialog>
</search-term-wizard>
          
      <div content="" class="style-scope search-result">
        <div id="mainContainer" class="vertical layout style-scope search-result">
          <template is="dom-if" class="style-scope search-result"></template>
          <result-container class="style-scope search-result">
    

    <paper-spinner class="style-scope result-container x-scope paper-spinner-0" aria-hidden="true" hidden=""><div id="spinnerContainer" class="  style-scope paper-spinner"><div class="spinner-layer layer-1 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-2 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-3 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-4 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div></div></paper-spinner>
    
      <patent-result class="style-scope result-container">
    
    
    <div class="layout horizontal style-scope patent-result">
      <div style="width: 1200px; height: auto; overflow: auto;" class="style-scope patent-result">
        <div id="wrapper" tabindex="0" class="style-scope patent-result">
          <result-tags class="style-scope patent-result"></result-tags>
          <h1 id="title" class="scroll-target style-scope patent-result">
            
  Process for producing farnesyl benzodiazepinone and its use as a drug
 
       </h1>
          <div class="horizontal layout style-scope patent-result">
            
            <div class="flex-3 style-scope patent-result" style="margin-top:-20px;overflow:hidden;" marginright="">
              <section id="abstract" class="style-scope patent-result" hidden="">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Abstract</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="abstract" class="style-scope patent-result">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"></section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <section id="classifications" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Classifications</div>
                  <div id="machineClassifiedWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">machine-classified</div>
                  <div id="machineClassifiedCPCWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">cpc-machine-classified</div>
                  <div id="machineClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-machine-classified</div>
                  <div class="style-scope patent-result" hidden="">&nbsp;</div>
                  <div id="familyClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-family-classified</div>
                </h3>
                <overlay-tooltip positioning-target="#machineClassifiedWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedCPCWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The CPC classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#familyClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned based on a patent family member containing these classification codes.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <classification-viewer class="style-scope patent-result">
    
    <div class="table style-scope classification-viewer">
      
        <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/00"><a id="link" href="#" class="style-scope state-modifier">C12N9/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="C12N9/93"><a id="link" href="#" class="style-scope state-modifier">C12N9/93</a></state-modifier>
                  <span class="description style-scope classification-tree">Ligases (6)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
      <template is="dom-repeat" class="style-scope classification-viewer"></template>
      
      <div class="style-scope classification-viewer">
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P29/00"><a id="link" href="#" class="style-scope state-modifier">A61P29/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/00"><a id="link" href="#" class="style-scope state-modifier">A61P31/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/04"><a id="link" href="#" class="style-scope state-modifier">A61P31/04</a></state-modifier>
                  <span class="description style-scope classification-tree">Antibacterial agents</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P35/00"><a id="link" href="#" class="style-scope state-modifier">A61P35/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antineoplastic agents</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D"><a id="link" href="#" class="style-scope state-modifier">C07D</a></state-modifier>
                  <span class="description style-scope classification-tree">HETEROCYCLIC COMPOUNDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D243/00"><a id="link" href="#" class="style-scope state-modifier">C07D243/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D243/06"><a id="link" href="#" class="style-scope state-modifier">C07D243/06</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D243/10"><a id="link" href="#" class="style-scope state-modifier">C07D243/10</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D243/38"><a id="link" href="#" class="style-scope state-modifier">C07D243/38</a></state-modifier>
                  <span class="description style-scope classification-tree">[b, e]- or [b, f]-condensed with six-membered rings</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D"><a id="link" href="#" class="style-scope state-modifier">C07D</a></state-modifier>
                  <span class="description style-scope classification-tree">HETEROCYCLIC COMPOUNDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D405/00"><a id="link" href="#" class="style-scope state-modifier">C07D405/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D405/02"><a id="link" href="#" class="style-scope state-modifier">C07D405/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D405/06"><a id="link" href="#" class="style-scope state-modifier">C07D405/06</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D"><a id="link" href="#" class="style-scope state-modifier">C07D</a></state-modifier>
                  <span class="description style-scope classification-tree">HETEROCYCLIC COMPOUNDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D405/00"><a id="link" href="#" class="style-scope state-modifier">C07D405/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D405/14"><a id="link" href="#" class="style-scope state-modifier">C07D405/14</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N1/00"><a id="link" href="#" class="style-scope state-modifier">C12N1/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N1/20"><a id="link" href="#" class="style-scope state-modifier">C12N1/20</a></state-modifier>
                  <span class="description style-scope classification-tree">Bacteria; Culture media therefor</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N1/205"><a id="link" href="#" class="style-scope state-modifier">C12N1/205</a></state-modifier>
                  <span class="description style-scope classification-tree">Bacterial isolates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/00"><a id="link" href="#" class="style-scope state-modifier">C12N15/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/09"><a id="link" href="#" class="style-scope state-modifier">C12N15/09</a></state-modifier>
                  <span class="description style-scope classification-tree">Recombinant DNA-technology</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/11"><a id="link" href="#" class="style-scope state-modifier">C12N15/11</a></state-modifier>
                  <span class="description style-scope classification-tree">DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/52"><a id="link" href="#" class="style-scope state-modifier">C12N15/52</a></state-modifier>
                  <span class="description style-scope classification-tree">Genes encoding for enzymes or proenzymes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/00"><a id="link" href="#" class="style-scope state-modifier">C12N9/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/0004"><a id="link" href="#" class="style-scope state-modifier">C12N9/0004</a></state-modifier>
                  <span class="description style-scope classification-tree">Oxidoreductases (1.)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/00"><a id="link" href="#" class="style-scope state-modifier">C12N9/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/10"><a id="link" href="#" class="style-scope state-modifier">C12N9/10</a></state-modifier>
                  <span class="description style-scope classification-tree">Transferases (2.)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/00"><a id="link" href="#" class="style-scope state-modifier">C12N9/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/10"><a id="link" href="#" class="style-scope state-modifier">C12N9/10</a></state-modifier>
                  <span class="description style-scope classification-tree">Transferases (2.)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/12"><a id="link" href="#" class="style-scope state-modifier">C12N9/12</a></state-modifier>
                  <span class="description style-scope classification-tree">Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/00"><a id="link" href="#" class="style-scope state-modifier">C12N9/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/14"><a id="link" href="#" class="style-scope state-modifier">C12N9/14</a></state-modifier>
                  <span class="description style-scope classification-tree">Hydrolases (3)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/00"><a id="link" href="#" class="style-scope state-modifier">C12N9/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/88"><a id="link" href="#" class="style-scope state-modifier">C12N9/88</a></state-modifier>
                  <span class="description style-scope classification-tree">Lyases (4.)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/00"><a id="link" href="#" class="style-scope state-modifier">C12N9/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/90"><a id="link" href="#" class="style-scope state-modifier">C12N9/90</a></state-modifier>
                  <span class="description style-scope classification-tree">Isomerases (5.)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P"><a id="link" href="#" class="style-scope state-modifier">C12P</a></state-modifier>
                  <span class="description style-scope classification-tree">FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P17/00"><a id="link" href="#" class="style-scope state-modifier">C12P17/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P17/10"><a id="link" href="#" class="style-scope state-modifier">C12P17/10</a></state-modifier>
                  <span class="description style-scope classification-tree">Nitrogen as only ring hetero atom</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="A61K38/00"><a id="link" href="#" class="style-scope state-modifier">A61K38/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations containing peptides</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12R"><a id="link" href="#" class="style-scope state-modifier">C12R</a></state-modifier>
                  <span class="description style-scope classification-tree">INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12R2001/00"><a id="link" href="#" class="style-scope state-modifier">C12R2001/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Microorganisms ; Processes using microorganisms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12R2001/01"><a id="link" href="#" class="style-scope state-modifier">C12R2001/01</a></state-modifier>
                  <span class="description style-scope classification-tree">Bacteria or Actinomycetales ; using bacteria or Actinomycetales</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="C12R2001/29"><a id="link" href="#" class="style-scope state-modifier">C12R2001/29</a></state-modifier>
                  <span class="description style-scope classification-tree">Micromonospora</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="Y"><a id="link" href="#" class="style-scope state-modifier">Y</a></state-modifier>
                  <span class="description style-scope classification-tree">GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="Y02"><a id="link" href="#" class="style-scope state-modifier">Y02</a></state-modifier>
                  <span class="description style-scope classification-tree">TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="Y02A"><a id="link" href="#" class="style-scope state-modifier">Y02A</a></state-modifier>
                  <span class="description style-scope classification-tree">TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="Y02A50/00"><a id="link" href="#" class="style-scope state-modifier">Y02A50/00</a></state-modifier>
                  <span class="description style-scope classification-tree">TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="Y02A50/30"><a id="link" href="#" class="style-scope state-modifier">Y02A50/30</a></state-modifier>
                  <span class="description style-scope classification-tree">Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        <template is="dom-repeat" class="style-scope classification-viewer"></template>
        <div class="more style-scope classification-viewer" style="" hidden="">View 18 more classifications</div>
        <div class="more style-scope classification-viewer">Hide more classifications</div>
      </div>
      <template is="dom-if" class="style-scope classification-viewer"></template>
    </div>
  </classification-viewer>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              
                <section class="style-scope patent-result">
                  <h3 class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Landscapes</div>
                  </h3>
                  <div class="responsive-grid style-scope patent-result">
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Chemical &amp; Material Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Chemical &amp; Material Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Health &amp; Medical Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Health &amp; Medical Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    <template is="dom-repeat" class="style-scope patent-result"></template>
                  </div>
                  <s-more-inline class="style-scope patent-result"><hr aria-hidden="true" class="style-scope s-more-inline">

<div class="button style-scope s-more-inline">
  <span slot="expand_text" class="style-scope patent-result">Show more</span>
  <span class="expand more style-scope s-more-inline"></span>
</div>
<div class="button style-scope s-more-inline" hidden="">
  <span slot="collapse_text" class="style-scope patent-result">Show less</span>
  <span class="expand less style-scope s-more-inline"></span>
</div>
</s-more-inline>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
            <div class="flex-2 style-scope patent-result">
              <section class="knowledge-card style-scope patent-result">
                <header class="style-scope patent-result">
                  <h2 id="pubnum" class="style-scope patent-result">JP4913588B2</h2>
                  <p class="tagline style-scope patent-result">Japan</p>
                  <overlay-tooltip positioning-target="#pubnum" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                    <div style="max-width: 300px;" class="style-scope patent-result">Published granted patent (Second level)</div>
                  
    </div>
  </overlay-tooltip>

                  <div class="knowledge-card-action-bar style-scope patent-result">
                    <a target="_blank" class="style-scope patent-result" href="https://patentimages.storage.googleapis.com/87/b4/b6/f1b8cba6116e64/JP4913588B2.pdf"><iron-icon icon="description" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download PDF</a>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_FIND_PRIOR_ART&quot;, &quot;keywords&quot;: $keywords, &quot;before&quot;: &quot;$before&quot;}" class="style-scope patent-result" data-keywords="[&quot;compound&quot;,&quot;seq&quot;,&quot;pharmaceutically acceptable&quot;,&quot;acceptable salt&quot;,&quot;formula&quot;]" data-before="20030121"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="find-in-page" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 19.59V8l-6-6H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c.45 0 .85-.15 1.19-.4l-4.43-4.43c-.8.52-1.74.83-2.76.83-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5c0 1.02-.31 1.96-.83 2.75L20 19.59zM9 13c0 1.66 1.34 3 3 3s3-1.34 3-3-1.34-3-3-3-3 1.34-3 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Find Prior Art
                    </a></state-modifier>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_SIMILAR_DOCUMENTS&quot;, &quot;id&quot;: &quot;$id&quot;}" class="style-scope patent-result" data-id="patent/JP4913588B2"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="editor:functions" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M18 4H6v2l6.5 6L6 18v2h12v-3h-7l5-5-5-5h7z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Similar
                    </a></state-modifier>
                  </div>
                </header>

                <dl class="important-people style-scope patent-result">
                  
                    <dt class="style-scope patent-result">Other languages</dt>
                    <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP4913588B2/ja"><a id="link" href="#" class="style-scope state-modifier">Japanese</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                  
                  <dt class="style-scope patent-result">Inventor</dt>
                  <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="   "><a id="link" href="#" class="style-scope state-modifier">   </a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="   "><a id="link" href="#" class="style-scope state-modifier">   </a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor=" "><a id="link" href="#" class="style-scope state-modifier"> </a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="   "><a id="link" href="#" class="style-scope state-modifier">   </a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor=" "><a id="link" href="#" class="style-scope state-modifier"> </a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>

                  
                  <dt class="style-scope patent-result">
                    <span class="tooltip-hint style-scope patent-result" id="assigneeWarning">Current Assignee</span>
                    <overlay-tooltip positioning-target="#assigneeWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                      The listed assignees may be inaccurate.<br class="style-scope patent-result">
                      Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.
                    
    </div>
  </overlay-tooltip>
                  </dt>
                  <dd class="style-scope patent-result">
                    
    Thallion Pharmaceuticals Inc
  
                  </dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                </dl>

                <hr class="style-scope patent-result">

                <application-timeline class="style-scope patent-result">
    
    
    <div class="wrap style-scope application-timeline">
      <div class="header style-scope application-timeline">Worldwide applications</div>
      <div class="event style-scope application-timeline">
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2004</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/NZ561169A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">NZ</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: NZ561169A</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AU2004206046B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">AU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: AU2004206046A</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: Expired</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/WO2004065591A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">WO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PCT/CA2004/000069</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: Application Filing</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CA2466340C/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">CA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CA002466340A</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: Expired - Lifetime</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/ES2483897T3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">ES</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: ES04703733.8T</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: Expired - Lifetime</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US7101872B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US10/762,107</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/MXPA05007743A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">MX</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: MXPA05007743A</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: IP Right Grant</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP1585814B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP04703733.8A</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: Expired - Lifetime</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP4913588B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline" this="">JP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: JP2006500437A</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: Expired - Lifetime</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/NZ541815A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">NZ</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: NZ541815A</div>
                <div class="style-scope application-timeline">Filing date: 2004-01-21</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2005</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US7304054B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US11/235,398</div>
                <div class="style-scope application-timeline">Filing date: 2005-09-27</div>
                <div class="style-scope application-timeline">Legal status: Expired - Fee Related</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US20060079512A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US11/253,658</div>
                <div class="style-scope application-timeline">Filing date: 2005-10-20</div>
                <div class="style-scope application-timeline">Legal status: Abandoned</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2006</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US7521222B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US11/511,586</div>
                <div class="style-scope application-timeline">Filing date: 2006-08-28</div>
                <div class="style-scope application-timeline">Legal status: Expired - Fee Related</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2007</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US20080131943A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US11/876,636</div>
                <div class="style-scope application-timeline">Filing date: 2007-10-22</div>
                <div class="style-scope application-timeline">Legal status: Abandoned</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2009</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US20090263886A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US12/400,509</div>
                <div class="style-scope application-timeline">Filing date: 2009-03-09</div>
                <div class="style-scope application-timeline">Legal status: Abandoned</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        <template is="dom-repeat" class="style-scope application-timeline"></template>
      </div>
      <hr class="style-scope application-timeline">
      <div class="header style-scope application-timeline">Application JP2006500437A events <iron-icon id="legal" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        <overlay-tooltip positioning-target="#legal" direction="right" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
          <div style="max-width: 300px;" class="style-scope application-timeline">
            A timeline of key events for this patent application, including priority claims, publications, legal status, reassignments, and litigation.<br class="style-scope application-timeline"><br class="style-scope application-timeline">
            Google has not performed a legal analysis and makes no representation as to the accuracy or completeness of the events listed.
          </div>
        
    </div>
  </overlay-tooltip>
      </div>
      <div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="filed style-scope application-timeline">2004-01-21</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="Thallion Pharmaceuticals Inc"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Application filed by Thallion Pharmaceuticals Inc</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2006-06-08</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP2006515874A/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of JP2006515874A</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="granted style-scope application-timeline">2012-04-11</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Application granted</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2012-04-11</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP4913588B2/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of JP4913588B2</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="legal-status style-scope application-timeline">2024-01-21</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Anticipated expiration</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" current="" critical=""><div date="" class="legal-status style-scope application-timeline">Status</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Expired - Lifetime</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><template is="dom-repeat" strip-whitespace="" class="style-scope application-timeline"></template>
      <template is="dom-if" class="style-scope application-timeline"></template>
    </div>
  </application-timeline>
                <hr class="style-scope patent-result">

                <dl class="links style-scope patent-result">
                  <dt class="style-scope patent-result">Info</dt>

                  
                  <dd class="style-scope patent-result"><a href="#patentCitations" class="style-scope patent-result">Patent citations (18)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#citedBy" class="style-scope patent-result">Cited by (17)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#legalEvents" class="style-scope patent-result">Legal events</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#similarDocuments" class="style-scope patent-result">Similar documents</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#relatedApplications" class="style-scope patent-result">Priority and Related Applications</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <dt class="style-scope patent-result">External links</dt>

                  <dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=JP&amp;NR=4913588B2&amp;KC=B2&amp;FT=D">Espacenet</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://globaldossier.uspto.gov/#/result/publication/JP/4913588/1">Global Dossier</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patents.stackexchange.com/questions/tagged/JP4913588B2">Discuss</a></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                </dl>
              </section>
            </div>
          </div>

          <div id="text" class="horizontal layout style-scope patent-result">
            <div class="flex flex-width style-scope patent-result" marginright="">
              <section id="description" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Description</div>
                  <div class="righthead style-scope patent-result">translated from Japanese</div>
                </h3>
                <patent-text name="description" id="descriptionText" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><description mxw-id="PDES46022446" lang="EN" load-source="google" class="style-scope patent-text">
  <technical-field class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  Micromonospora sp.Micromonospora sp.
</span> <u class="style-scope patent-text">[Related applications]</u> <br class="style-scope patent-text"> The present invention relates to US Provisional Application No. 60 / 441,126 filed on Jan. 21, 2003, U.S. Provisional Application No. 60 / 492,997 filed on Aug. 7, 2003, and Nov. 10, 2003. Claims priority to US Provisional Application No. 60 / 518,286. The entire teachings of the above provisional application are incorporated herein by reference. The present invention relates to a novel farnesylated dibenzodiazepinone named ECO-04601, pharmaceutically acceptable salts and derivatives thereof, and a method of obtaining the compound. Methods for obtaining the compound include a method of culturing a novel strain of Micromonospora sp., That is, 046-ECO11 or [S01] 046, and a method involving expression of biosynthetic pathway genes in transformed host cells. The invention further relates to Micromonospora sp. 046-ECO11 and (S01) 046 strains, the use of ECO-04601 and pharmaceutically acceptable salts and derivatives thereof as drugs, in particular cancer cell proliferation, bacterial cell proliferation. And its use as an inhibitor of mammalian lipoxygenase, its use for the treatment of acute and chronic inflammation, and a pharmaceutical composition comprising ECO-04601 or a pharmaceutically acceptable salt or derivative thereof. Finally, although the present invention relates to novel polynucleotide sequences and proteins encoded thereby, they are related to the biosynthesis of ECO-04601.</span>
    </p>
  </technical-field>
  <background-art class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
EuactinomycetesActinomycetes
</span>
Euactinomycetes is a subset of a large and complex Gram-positive bacterium group known as Actinomycetes. Due to the large number of compounds, particularly antibiotics, that are produced as secondary metabolites that are useful for treatment, people have become commercially and scientifically important to these organisms that are abundant in soil over the past few decades. I've been very interested. A thorough investigation of strains capable of producing new antibiotics identified hundreds of new species.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
EuactinomycetesSaccharopolyspora
</span>
Many of these Euactinomycetes, especially Streptomyces and related species, Saccharopolyspora genus, have been intensively studied. With these two genera, the diversity of bioactive metabolites is significant. Since these compounds are commercially important, much is known about the genetic characteristics and physiological functions of these organisms.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
EuactinomycetesMicromonosporaOhkuma et al.EuactinomycetesMicromonospora sp.Ohkuma et al.
</span>
As another representative Euactinomycetes genus, people have also had commercial interest in Micromonospora. For example, US Pat. No. 5,541,181 (Ohkuma et al.) Discloses dibenzodiazepinone compounds. Specifically, 5-farnesyl-4,7,9-trihydroxy-dibenzodiazepin-11-one (BU produced by Microactormycetes strain Micromonospora sp. M990-6 (Accession No. 55378). -4664L "). The Ohkuma et al. Patent reports that BU-4664L and its chemically synthesized di- or tri-alkoxy and acyloxy derivatives have anti-inflammatory and anti-tumor cell activity.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
<br class="style-scope patent-text">
Micromonospora<br class="style-scope patent-text">
<patcit num="1" class="style-scope patent-text"> <text class="style-scope patent-text">Ohkuma et al.</text> </patcit>
</span>Although many bioactive compounds have been identified from bacteria, there is still a need to obtain naturally occurring new compounds with enhanced properties. Current methods of obtaining these compounds include screening for natural isolates and chemical modifications of existing compounds, which are costly and time consuming. Current screening methods are based on the general biological properties of the compounds and require prior knowledge of the molecular structure. Although there are methods for chemically modifying known active compounds, the types of compounds obtained are actually still limited. <br class="style-scope patent-text"> Therefore, there is a great need to obtain pharmacologically active compounds in a high yield and cost effective manner. The present invention provides novel strains of Micromonospora capable of producing not only reagents (eg, polynucleotides, vectors containing the polynucleotides, and host cells containing the vectors), as well as potent new therapeutic compounds, and chemistry These problems are solved by providing a method for producing new compounds by novel biosynthesis rather than synthesis. <br class="style-scope patent-text"> <patcit num="1" class="style-scope patent-text"> <text class="style-scope patent-text"> US Pat. No. 5,541,181 (Ohkuma et al.) </text> </patcit> </span>
    </p>
  </background-art>
  <disclosure class="style-scope patent-text">
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
II
</span>
In the first embodiment, the present invention relates to a compound represented by the following formula (formula II) or a pharmaceutically acceptable salt thereof.
</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="1" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">

</span>
In another embodiment, the present invention relates to a pharmaceutical composition comprising a compound represented by the following formula or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier.
</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="2" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">

</span>
In yet another embodiment, the invention relates to the class of compounds of formula I.
</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="3" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">

</span>
(W1, W2, and W3 are each independently represented by the following formula:
</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="4" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
<br class="style-scope patent-text">
<br class="style-scope patent-text">
(alkene)<br class="style-scope patent-text">
<br class="style-scope patent-text">
<sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub>(alkalene)<br class="style-scope patent-text">
<sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub>
</span>Or the side chain from the tricycle may be terminated with W3, W2 or W1, wherein W3, W2 or W1 is CHO or CH2OH, respectively. <br class="style-scope patent-text"> A is selected from -NH-, -NCH2R1, -NC (O) R1, <br class="style-scope patent-text"> R1 is selected from C1-6 alkyl, C2-6 alkene, aryl or heteroaryl; <br class="style-scope patent-text"> R2, R3 and R4 are each independently selected from H, R5, -C (O) R6; <br class="style-scope patent-text"> R5 are each independently a <sub class="style-scope patent-text">C 1 to 6</sub> <sub class="style-scope patent-text">alkyl, C 2 to 7</sub> Arukaren (alkalene), is selected from aryl or heteroaryl, <br class="style-scope patent-text"> Each R6 is independently selected from H, C <sub class="style-scope patent-text">1-6</sub> alkyl, C <sub class="style-scope patent-text">2-7</sub> alkane, aryl or heteroaryl, or a pharmaceutically acceptable salt thereof).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">

</span>
In some embodiments, A is NH.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
<sub class="style-scope patent-text"></sub><sup class="style-scope patent-text"></sup>
</span>In another embodiment, A is NCH <sub class="style-scope patent-text">2</sub> R <sup class="style-scope patent-text">1</sup> .</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
<sup class="style-scope patent-text"></sup>
</span>In another embodiment, A is NC (O) R <sup class="style-scope patent-text">1</sup> .</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
<sup class="style-scope patent-text"></sup>
</span>In another embodiment, R <sup class="style-scope patent-text">2</sup> is H.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
<sup class="style-scope patent-text"></sup>
</span>In another embodiment, R <sup class="style-scope patent-text">3</sup> is H.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
<sup class="style-scope patent-text"></sup>
</span>In another embodiment, R <sup class="style-scope patent-text">4</sup> is H.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
<sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup>
</span>In another embodiment, R <sup class="style-scope patent-text">2</sup> , R <sup class="style-scope patent-text">3</sup> , and R <sup class="style-scope patent-text">4</sup> are each H.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
<sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup>
</span>In another embodiment, R <sup class="style-scope patent-text">2</sup> , R <sup class="style-scope patent-text">3</sup> , and R <sup class="style-scope patent-text">4</sup> are each H and W <sup class="style-scope patent-text">1</sup> is CHCH.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
<sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup>
</span>In another embodiment, R <sup class="style-scope patent-text">2</sup> , R <sup class="style-scope patent-text">3</sup> , and R <sup class="style-scope patent-text">4</sup> are each H and W <sup class="style-scope patent-text">2</sup> is CHCH.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
<sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup>
</span>In another embodiment, R <sup class="style-scope patent-text">2</sup> , R <sup class="style-scope patent-text">3</sup> , and R <sup class="style-scope patent-text">4</sup> are each H and W <sup class="style-scope patent-text">3</sup> is CHCH.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
<sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup>
</span>In another embodiment, A is NH and R <sup class="style-scope patent-text">2</sup> , R <sup class="style-scope patent-text">3</sup> , and R <sup class="style-scope patent-text">4</sup> are each H.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
<sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup>
</span>In another embodiment, A is NH and W <sup class="style-scope patent-text">1</sup> , W <sup class="style-scope patent-text">2</sup> , and W <sup class="style-scope patent-text">3</sup> are each CHCH.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">

</span>
The present invention further includes a compound selected from the following group.
</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="5" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;In certain embodiments, the present invention relates to a composition of compounds of formula I and pharmaceutically acceptable carriers thereof.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  <br class="style-scope patent-text">
Micromonospora sp.II
</span>The present invention further includes <br class="style-scope patent-text"> a) culturing Micromonospora sp. [S01] 046 strain characterized in that the culture is performed under aerobic conditions in a culture place containing at least one carbon atom source and at least one nitrogen atom source; and b) Farnesyl dibenzodiazepinone obtained by the method comprising the step of isolating farnesyl dibenzodiazepinone from the bacteria cultured in step (a). In certain embodiments, the farnesyl dibenzodiazepinone is a compound represented by Formula II.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  <sup class="style-scope patent-text"></sup><br class="style-scope patent-text">
Micromonospora sp.
</span>Basically, as shown in FIGS. 3, 4, 5, 6, and 7, in one embodiment, farnesyl dibenzodiazepinone generates an NMR spectrum. In another embodiment, farnesyl dibenzodizeapinone generates the <sup class="style-scope patent-text">1</sup> H NMR spectrum of FIG. <br class="style-scope patent-text"> The present invention further includes culturing Micromonospora sp. 046-ECO11 strain in a medium containing at least one carbon atom source and at least one nitrogen atom source, and farnesyl dibenzodiazepinone comprising isolating and purifying the compound. A method for producing the compound is included.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Micromonospora sp.<br class="style-scope patent-text">
<br class="style-scope patent-text">

</span>The present invention further includes culturing Micromonospora sp. [S01] 046 strain in a medium containing at least one carbon atom source and at least one nitrogen atom source, and farnesyl dibenzodiaze comprising isolating and purifying the compound. Includes methods for making pinone compounds. <br class="style-scope patent-text"> In certain embodiments, the culturing is performed under aerobic conditions. <br class="style-scope patent-text"> In another embodiment, the carbon atom source and the nitrogen atom source are selected from the components shown in Table 16.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;In another embodiment, the culturing is performed at a temperature of 18-40  C. In a further embodiment, the temperature range is 18-29  C.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;In another embodiment, the culturing is at pH 6-9.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Micromonospora sp.
</span>
&nbsp;&nbsp;The present invention further includes a Micromonospora sp. Strain having IDAC (Canadian International Depository Authority) accession number 231203-01.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  <br class="style-scope patent-text">

</span>The present invention further includes a method of inhibiting the growth of cancer cells, i.e., the method comprising contacting the cancer cells with a compound of formula I to inhibit the growth of cancer cells. <br class="style-scope patent-text"> In certain embodiments, the compound is ECO-04601.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The present invention further provides a method for inhibiting the growth of cancer cells in a mammal, ie, administering a compound of formula I to a mammal having cancer cells to inhibit the growth of cancer cells in the mammal. Including a method comprising:
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;In certain embodiments, the compound is ECO-04601.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The present invention further comprises the step of administering to the mammal a therapeutically effective amount of a compound of Formula I to treat the precancerous condition or cancerous disease. Including methods of treating.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;In certain embodiments, the compound is ECO-04601.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The invention further comprises a method of treating a bacterial infection in a mammal comprising administering to the mammal infected with the bacterium a therapeutically effective amount of a compound of formula I to treat the bacterial infection. including.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;In certain embodiments, the compound is ECO-04601.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The present invention further includes a method of reducing inflammation in a mammal comprising administering to the inflamed mammal a therapeutically effective amount of a compound of Formula I to reduce inflammation.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;In certain embodiments, the compound is ECO-04601.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The present invention further includes an isolated polynucleotide having one or more of SEQ ID NOs: 1, 64, and 73 that encode a polypeptide involved in the biosynthesis pathway of farnesyl dibenzodiazepinone.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The present invention further includes an isolated polynucleotide having SEQ ID NOs: 1, 64, and 73 that encodes a polypeptide involved in the farnesyl dibenzodiazepinone biosynthetic pathway.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The present invention further includes SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45. 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, and 89. An isolated polynucleotide encoding the polypeptide is included.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  <br class="style-scope patent-text">
<br class="style-scope patent-text">

</span>In certain embodiments, the isolated polynucleotide having SEQ ID NO: 1 is SEQ ID NO: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, It encodes a polypeptide selected from the group consisting of 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61 and 63. <br class="style-scope patent-text"> In certain embodiments, the isolated polynucleotide having SEQ ID NO: 64 encodes a polypeptide selected from the group consisting of SEQ ID NOs: 66, 68, 70, and 72. <br class="style-scope patent-text"> In certain embodiments, the isolated polynucleotide having SEQ ID NO: 73 encodes a polypeptide selected from the group consisting of SEQ ID NOs: 75, 77, 79, 81, 83, 85, 87, and 89.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The present invention further includes SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45. 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, or 89 Polypeptides.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;In certain embodiments, the polypeptide is involved in the biosynthesis pathway of farnesyl dibenzodiazepinone.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The invention further includes an expression vector comprising one or more of the polypeptides described herein.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The present invention further includes recombinant prokaryotes comprising one or more of the vectors.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Actinomycete
</span>
&nbsp;&nbsp;In certain embodiments, the organism is Actinomycete.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;In another embodiment, the organism requires an expression vector to synthesize farnesyl dibenzodiazepinone. That is, as described herein, the organism is deficient in the ability to synthesize farnesyl dibenzodiazepinone before being transformed with the polynucleotide.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The invention further includes (a) providing a prokaryote that is unable to synthesize farnesyl dibenzodiazepinone, (b) transforming the prokaryote with an expression vector as described herein. And (c) culturing the prokaryote, wherein the method comprises culturing farnesyl dibenzodiazepinone in the prokaryote.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Actinomycete
</span>
&nbsp;&nbsp;In certain embodiments, the prokaryote is Actinomycete.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;In another embodiment, the vector is SEQ ID NO: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39. 41, 43, 45, 57, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, or 89 Expresses the represented polypeptide.
</span>
    </p>
    <heading class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"></span>Detailed Description of the Invention</span>
    </heading>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ActinomycetesMicroponospora sp.Micromonospora (1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2)
</span>
&nbsp;&nbsp;The present invention relates to a novel farnesyl dibenzodiazepinone referred to herein as ECO-04601. Such ECO-04601 was isolated from Microponospora sp. 046-ECO11 strain and [S01] 046 strain, which are novel strains of Actinomycetes. These microorganisms were analyzed using gas chromatography such as fatty acid methyl ester (FAME) (FIG. 17), 6S ribosomal RNA quantification (FIG. 18) and found to belong to the genus Micromonospora. These organisms were released on March 7, 2003 and December 23, 2003, respectively, at the Department of Microbiology of the Canadian Ministry of Health, the Canadian International Depository Authority (IDAC), (1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2). Deposited as IDAC accession number 070303-01 and IDAC accession number 231203-01.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Micromonospora sp.Micromonospora
</span>
&nbsp;&nbsp;The invention further relates to pharmaceutically acceptable salts and derivatives of ECO-04601 and methods for obtaining the compounds. One method of obtaining the compound is to cultivate Micromonospora sp. 046-ECO11 strain or a mutant or mutant thereof under appropriate Micromonospora culture conditions, preferably using the fermentation protocol described below. It is a method to do.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
<br class="style-scope patent-text">

</span>The present invention also relates to a method for producing a novel polyketide compound, namely farnesyl dibenzodiazepinone, by selectively changing the genetic information of an organism. The present invention further provides isolated and purified polynucleotides. <br class="style-scope patent-text"> The polynucleotide encodes a farnesyl dibenzodiazepinone domain, ie, a polypeptide of a living organism that produces farnesyl dibenzodiazepinone and fragments thereof, vectors containing these polynucleotides, and host cells transformed with these vectors. To do. These polynucleotides and fragments thereof, and vectors containing the polynucleotides can be used as reagents in the methods described above. Portions of the polynucleotide sequences disclosed herein are also useful as primers for DNA amplification or as probes for identifying other farnesyl dibenzodiazepinone-related organismal domains.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The present invention relates to pharmaceutical compositions comprising ECO-04601 and pharmaceutically acceptable salts and derivatives thereof. ECO-04601 is particularly useful as a drug for use as an inhibitor of cancer cell growth, bacterial cell growth and mammalian lipoxygenase. The present invention relates to novel polynucleotide sequences involved in the biosynthetic pathway of ECO-04601 and proteins encoded by them.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The following detailed description discloses methods for making and using ECO-04601 and compositions comprising the compounds for inhibiting microbial growth and / or specific disease pathways.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Thus, certain embodiments of the invention include a pharmaceutical composition comprising a farnesylated dibenzodiazepinone compound of the invention and a pharmaceutically acceptable carrier, a method of using the composition to inhibit bacterial growth, And a method of using the pharmaceutical composition for treating diseases including cancer, chronic inflammation and acute inflammation.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
I<u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  
</span>I. For purposes of <u class="style-scope patent-text">definition</u> , certain terms and phrases used in the specification, examples, and appended claims are set forth below.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;As used herein, the term farnesyl dibenzodiazepinone relates to a class of dibenzodiazepinone compounds that include a farnesyl component. Such terms include the exemplified compounds of the invention, 10-farnesyl-4,6,8, trihydroxy-dibenzodiazepin-11-one, referred to herein as ECO-04601. However, it is not limited to this. As used herein, the term farnesyl dibenzodiazepinone includes this class of compounds that can be used as intermediate products in chemical synthesis. As used herein, the term alkyl refers to a straight or branched hydrocarbon group. Examples of alkyl groups include, but are not limited to, methyl, ethyl, n-propyl, isopropyl, n-butyl, pentyl, hexyl, heptyl, cyclopentyl, cyclohexyl, cyclohexylmethyl and the like. Alkyl is acyl, amino, acylamino, acyloxy, carboalkoxy, carboxy, carboxyamide, cyano, halo, hydroxyl, nitro, thio, alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, alkoxy, aryloxy, It may be optionally substituted with a substituent selected from sulfinyl, sulfonyl, oxo, guanidino, and formyl.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The term alkenyl refers to a straight, branched, or cyclic hydrocarbon group containing at least one carbon-carbon double bond. Examples of alkenyl groups include, but are not limited to, vinyl, 1-propen-2-yl, 1-buten-4-yl, 2-buten-4-yl, 1-penten-5-yl and the like. . Alkenyl is acyl, amino, acylamino, acyloxy, carboalkoxy, carboxy, carboxyamide, cyano, halo, hydroxyl, nitro, thio, alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, alkoxy, aryloxy, It may be optionally substituted with a substituent selected from sulfinyl, sulfonyl, formyl, oxo, and guanidino.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The terms cycloalkyl and cycloalkyl ring relate to saturated or partially unsaturated carbocycles in mono (single) carboxyl ring systems or fused carboxyl ring systems having 3 to 15 ring members. Examples of cycloalkyl groups include, but are not limited to, cyclopropyl, cyclobutyl, cyclohexyl, and cycloheptyl. Cycloalkyl is acyl, amino, acylamino, acyloxy, carboalkoxy, carboxy, carboxyamide, cyano, halo, hydroxyl, nitro, thio, alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, alkoxy, aryloxy , Optionally substituted with a substituent selected from sulfinyl, sulfonyl, and formyl.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  <sub class="style-scope patent-text"></sub>
</span>The terms heterocycle and heterocycle system refer to O, N, NH, NR <sub class="style-scope patent-text">x</sub> , PO 2, S, SO, in mono- (single) heterocycles or fused heterocycles having 3 to 15 ring members. Or a saturated or partially unsaturated ring containing 1 to 4 heteroatoms or heterogroups selected from SO2. Examples of a heterocyclic ring or heterocyclic ring include, but are not limited to, morpholinyl, piperidinyl, and pyrrolidinyl. Heterocycles, heterocycles, or heterocycles are acyl, amino, acylamino, acyloxy, oxo, thiocarbonyl, imino, carboalkoxy, carboxy, carboxyamide, cyano, halo, hydroxyl, nitro, thio, alkyl, alkenyl And optionally substituted with a substituent selected from alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, alkoxy, aryloxy, sulfinyl, sulfonyl, and formyl.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The term amino acid relates to any natural amino acid. All natural amino acids are well known to those skilled in the art.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The term halo relates to halogen atoms such as bromine, chlorine, fluorine and iodine.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The terms aryl and aryl ring relate to aromatic groups in mono- (single) ring systems or fused ring systems having 5 to 15 ring members. Examples of aryl include, but are not limited to, phenyl, naphthyl, biphenyl, terphenyl. Aryl is acyl, amino, acylamino, acyloxy, azide, alkthio, carboalkoxy, carboxy, carboxyamide, cyano, halo, hydroxyl, nitro, thio, alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, alkoxy , Aryloxy, sulfinyl, sulfonyl, and formyl may be optionally substituted with one or more of the substituents selected.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The terms heteroaryl and heteroaryl ring have from 5 to 15 ring members in a mono (single) ring system or fused ring system and include heteroatoms such as O, N, S, SO and SO 2. It relates to an aromatic group comprising at least one. Examples of heteroaryl groups include, but are not limited to, pyridinyl, thiazolyl, thiadiazoyl, isoquinolinyl, pyrazolyl, oxazolyl, oxadiazoyl, triazolyl, and pyrrolyl groups. Heteroaryl groups are acyl, amino, acylamino, acyloxy, carboalkoxy, carboxy, carboxyamide, cyano, halo, hydroxyl, nitro, thio, thiocarbonyl, alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, It may be optionally substituted with one or more substituents selected from alkoxy, aryloxy, sulfinyl, sulfonyl, and formyl.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The terms aralkyl and heteroaralkyl relate to an aryl or heteroaryl group bonded directly through an alkyl group such as benzyl, respectively. Aralkyl and heteroaralkyl may be optionally substituted as aryl groups or heteroaryl groups.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Similarly, the terms aralkenyl and heteroaralkenyl relate to an aryl or heteroaryl group bonded directly through an alkene group such as benzyl, respectively. Aralkyl and heteroaralkyl may be optionally substituted as aryl and heteroaryl groups.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The compounds of the present invention can have one or more asymmetric carbon atoms and can exist as optical isomers forming racemic or non-racemic mixtures. The compounds of the present invention are useful as mixtures in the form of single isomers or stereochemical isomers. Diastereoisomers, ie stereochemical isomers that are not superimposable, can be separated by conventional means such as chromatography, distillation, crystallization, or sublimation. The racemic mixture can be decomposed by a conventional method to obtain the optical isomer.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The present invention includes isolated or purified compounds. An isolated or purified compound is a compound comprising a compound of the present invention, when tested in a conventional biological assay well known to those skilled in the art, to produce an antibacterial action, a cytostatic action, At least 10%, 20%, 50%, 80%, or at least 10% of a compound of the present invention if it has a demonstrable (statistically superior) biological activity, such as a cytotoxic, anti-inflammatory or enzyme inhibitory effect, or Relates to compounds which indicate that 90% is present in the mixture.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;As used herein, the terms microorganism producing farnesyl dibenzodiazepinone and producer of farnesyl dibenzodiazepinone refer to whether an organism naturally produces farnesyl dibenzodiazepinone compounds. Regardless, it relates to a microorganism that possesses the genetic information required to produce the compound. Such terms are equally used for organisms in which the genetic information for producing a farnesyl dibenzodiazepinone compound is found in the organism so that it exists in the natural environment or in which genetic information has been introduced by recombinant technology. It is done.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Micromonospora ActinoplanesDactylosporangiumMicromonosporaceaeStreptomycesKitasatosporaStreptomycetaceaeAmycolatopsisSaccharopolysporaPseudonocardiaceaeSaccharothrixActinosynnemaActinosynnemataceae(1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2)
</span>
&nbsp;&nbsp;Specific organisms predicted herein include organisms of the family Micromonosporaceae whose preferred genera are Micromonospora Actinoplanes and Dactylosporangium, organisms of the family Streptomycetaceae whose preferred genera are Streptomyces and Kitasatospora, family Pseudonocardiaceae whose preferred genera are Amycolatopsis and Saccharopolyspora And, preferably, Actinosynnemataceae whose preferred genera are Saccharothrix and Actinosynnema. However, these terms are intended to include any organism that contains the genetic information required to produce a farnesyl dibenzodiazepinone compound. Preferred producers of farnesyl dibenzodiazepinone compounds are listed on March 7, 2003 on Health Canada, Department of Microbiology, Canadian International Depository Authority (IDAC), (1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2). , Microbial strain 046-ECO11, deposited under IDAC accession number 070303-01.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The term gene refers to a segment of DNA involved in the production of a polypeptide chain. A gene includes regions before and after the coding region (leader and trailer) and, if appropriate, intervening regions (introns) between the segments (exons) that encode each.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The terms locus, gene cluster, and biosynthetic locus relate to a group of genes or variants thereof that are involved in the biosynthesis of farnesyl benzodiazepinone compounds. The biosynthetic locus in the 046-ECO11 strain for production of ECO-04601 is often referred to herein as 046D in the figures and figures. Genetic modification of loci, gene clusters, and biosynthetic loci can be used in the art to create mutants of ECO-04601, such as mutagenesis, inactivation or nucleic acid replacement. It relates to all known gene recombination techniques.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;A DNA or nucleic acid that "encodes a sequence" or a "encoding sequence" that encodes a particular polypeptide or protein is transcribed and translated into a polypeptide or protein when placed under the control of appropriate regulatory sequences DNA sequence.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">

</span>
An oligonucleotide is generally a nucleic acid that is at least 10 nucleotides in length, preferably 15 nucleotides in length, more preferably at least 20 nucleotides in length, preferably less than 100 nucleotides in length, and is a gene, mRNA, cDNA or other The present invention relates to a nucleic acid capable of hybridizing with a genomic DNA molecule, cDNA molecule, or mRNA molecule encoding a desired nucleic acid.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;A promoter sequence is operably linked to a coding sequence recognized by RNA polymerase that initiates transcription at the promoter and transcribes the coding sequence into mRNA.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;As used herein, the term replicon means any genetic element that functions as an autonomous unit of polynucleotide replication in a cell, such as a plasmid, cosmid, chromosome or virus. An expression vector or vector is a replicon associated with another polynucleotide fragment, such as to cause replication and / or expression of the associated fragment. In the present specification, plasmid is indicated by a small letter p before or after capital letters and / or numbers. The starting plasmids disclosed herein are commercially available and formally available without limitation. Alternatively, the starting plasmid can be constructed from plasmids available according to published procedures. In addition, plasmids equivalent to those described herein are well known in the art and will be apparent to those of skill in the art.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The term express or expression means revealing or causing information contained in a gene sequence or DNA sequence. For example, it means that a protein is generated by activating a function of a cell involved in transcription or translation of a corresponding gene sequence or DNA sequence. A DNA sequence is expressed in or by a cell and forms an expression product such as a protein. The expression product itself, eg, the resulting protein, may be referred to as expressed by the cell. An expression product can be characterized as an intracellular product, an extracellular product or a secreted product.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Degradation of DNA refers to the enzymatic cleavage of DNA by restriction enzymes that act only on specific sequences of DNA. The various restriction enzymes used herein are commercially available and the reaction conditions, cofactors, and other requirements used are well known to those of ordinary skill in the art. For analytical purposes, typically 1 g of plasmid or DNA fragment is used with about 2 units of enzyme in about 20 l of buffer. For purposes of isolating DNA fragments to construct plasmids, typically 5 to 50 g of DNA is digested with 20 to 250 units of enzyme in a larger volume of buffer. The amount of buffer or substrate appropriate for a particular enzyme is specified by the manufacturer. Usually, an incubation time of about 1 hour at 37  C. is used, but may be varied according to the manufacturer's instructions. After degradation, gel electrophoresis may be performed to isolate the desired fragment.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;As used herein, the term isolated means that the material is removed from its original environment (eg, the natural environment in which the material naturally exists). For example, a naturally occurring polynucleotide or polypeptide present in the animal's body has not been isolated, but the same polynucleotide or polypeptide is separated from some or all of the coexisting substances in the natural system. If so, it is isolated. These polynucleotides can be part of the vector and / or part of the composition. Furthermore, such vectors or compositions may be isolated where they are not part of the natural environment.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">

</span>
As used herein, the term restriction fragment refers to any linear DNA made by the action of one or more restriction enzymes.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">

</span>
The term transformation means introducing a foreign gene, foreign nucleic acid, DNA sequence or RNA sequence into a host cell so that the host cell expresses the introduced gene or sequence and produces the desired substance. To do. The desired substance is usually a protein or enzyme encoded by the introduced gene or sequence. The introduced gene or sequence is also referred to as a cloned or foreign gene or sequence, depending on the restriction or control sequence such as initiation, termination, promoter, signal, secretion, etc., or the cellular gene mechanism. Other sequences used are included. These genes or sequences include non-functional sequences or sequences that have no known function. Host cells that accept and express the introduced DNA or RNA are transformed and become transformants or clones or recombinants. The DNA or RNA introduced into the host cell can be derived from any source, including cells of the same or same type as the host cell, or of different or different species.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;As used herein, the terms recombinant polynucleotide and recombinant polypeptide refer to a polypeptide that is naturally associated with or bound to a polynucleotide or polypeptide in addition to being naturally bound. Alternatively, it refers to a polynucleotide or polypeptide that is not related to all or part of the polynucleotide by origin or manipulation.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The term host cell as used herein relates to both recombinant and eukaryotic cells as indicated in the present invention. In certain embodiments, such host cells are prokaryotic.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;As used herein, the terms open reading frame and ORF relate to a region of a polynucleotide sequence that encodes a polypeptide. The region may indicate part of the coding sequence or the entire coding sequence.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Computation Molecular Biology, Lesk, A. M., eds., Oxford University Press, New York (1988)Biocomputing:Informatics and Genome Projects, Smith, D. W., ed., Academic Press, New York (1993)Sequence Analysis in Molecular Biology, von Heinje, G., Academic Press (1987);Sequence Analysis Primer, Gribskov., M. and Devereux, J., eds., M. Stockton Press, New York (1991)Carillo, H., and Lipman, D., SIAM J. Applied Math. (1998) 48:1073
</span>
&nbsp;&nbsp;As used herein and as is well known in the art, the term identity refers to a relationship between two or more polynucleotide sequences, as determined by sequence comparison. Identity also refers to the degree of sequence relatedness between polynucleotide sequences, determined by matching between strings of polynucleotide sequences. Identity can be easily calculated (eg, Computation Molecular Biology, Lesk, AM, eds., Oxford University Press, New York (1988) and Biocomputing: Informatics and Genome Projects, Smith, DW, ed., Academic Press , New York (1993), both of which are hereby incorporated by reference.) There are many ways to determine the identity between two polynucleotide sequences, and such terms are known to those skilled in the art. Is known (Sequence Analysis in Molecular Biology, von Heinje, G., Academic Press (1987); and Sequence Analysis Primer, Gribskov., M. and Devereux, J., eds., M. Stockton Press, New York ( 1991)). Commonly used methods for measuring identity between sequences include, for example, the method disclosed in Carillo, H., and Lipman, D., SIAM J. Applied Math. (1998) 48: 1073. included. As used herein, approximately the same means that there is a very high homology (preferably 100% sequence identity) between the polynucleotide sequences of interest. However, polynucleotides having greater than 90% or 95% sequence identity may be used in the present invention, and thus sequence variations that can occur due to genetic mutation, strain polymorphism, or evolutionary branching Is acceptable.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;As used herein, the term treatment treats, cures, alleviates, alleviates, changes, heals, improves, improves a disease, a symptom of the disease, or a factor of the disease, Or the use or administration of a therapeutic agent to a patient to affect them, or a tissue isolated from a patient having a disease, such as a disease or physical abnormality, a disease symptom, or a factor of the disease, or It relates to the use or administration of therapeutic agents to cell lines.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;As used herein, a pharmaceutical composition comprises a pharmaceutically effective amount of farnesyl dibenzodiazepinone and a pharmaceutically acceptable carrier. As used herein, pharmaceutically effective amount, therapeutically effective amount, or simply effective amount is intended to be a pharmacological, therapeutic, or It relates to the amount of farnesyl dibenzodiazepinone effective to produce a preventive result. For example, if a measurable parameter associated with a disease or disorder is reduced by at least 25%, and if a clinical treatment is considered effective, then the amount of drug effective to treat that disease or disorder is An amount necessary to reduce such a parameter by at least 25%.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The term pharmaceutically acceptable carrier refers to a carrier for administering a therapeutic agent. These carriers include, but are not limited to, saline, buffered saline, glucose, water, glycerol, ethanol, and combinations thereof. Such terms specifically do not include cell culture media. For orally administered drugs, pharmaceutically acceptable carriers include pharmaceutically acceptable inert diluents, disintegrants, binders, smoothing agents, sweeteners, flavoring agents, coloring agents, and preservatives. Excipients such as materials are included, but are not limited thereto. Suitable inert diluents include sodium and calcium carbonate, sodium and calcium phosphate, and lactose, and suitable disintegrants include corn starch and alginic acid. Binders may include starch and gelatin, and the smoothing agent, if present, is typically magnesium stearate, stearic acid or talc. If necessary, tablets may be coated with a substance such as glyceryl monostearate or glyceryl distearate to delay absorption in the gastrointestinal tract.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  (base addition salts)Journal of Pharmaceutical Sciences (1977) 66:2
</span>
&nbsp;&nbsp;The term pharmaceutically acceptable salts relates to both acid addition salts and base addition salts. The nature of the salt is not critical provided that it is pharmaceutically acceptable. Typical acid addition salts include hydrochloric acid, hydrobromic acid, hydroiodic acid, nitric acid, carbonic acid, sulfuric acid, phosphoric acid, formic acid, acetic acid, citric acid, tartaric acid, succinic acid, oxalic acid, malic acid, glutamic acid, propion Acid, glycolic acid, gluconic acid, maleic acid, embonic acid (pamonic acid), methanesulfonic acid, ethanesulfonic acid, 2-hydroxyethanesulfonic acid, pantothenic acid, benzenesulfonic acid, toluenesulfonic acid, sulfanilic acid, mesylic acid, Examples include, but are not limited to, cyclohexylaminosulfonic acid, stearic acid, alginic acid, -hydroxybutyric acid, malonic acid, galactaric acid, galacturonic acid, and the like. Suitable pharmaceutically acceptable group addition salts include metal salts made from aluminum, calcium, lithium, magnesium, potassium, sodium and zinc, or N, N'-dibenzylethylenediamine, chloroprocaine, choline, diethanolamine , Organic salts made from ethyleneamine, N-methylglucamine, lysine, procaine, and the like. Further examples of pharmaceutically acceptable salts are described in Journal of Pharmaceutical Sciences (1977) 66: 2. All of these salts may be prepared from farnesyl dibenzodiazepinone by conventional means by treating the compound with a suitable acid or group.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
II<u class="style-scope patent-text"></u> <br class="style-scope patent-text">

</span>II. <u class="style-scope patent-text">Farnesylated dibenzodiazepinone compounds In</u> certain embodiments, the present invention is a novel farnesyl dibenzodia, referred to herein as "ECO-04601", having a chemical structure represented by the formula: Regarding Zepinone.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="6" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
      <br class="style-scope patent-text">
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">

</span>
ECO-04601 has 10 farnesyl substituents located at the 10th nitrogen atom of the dibenzodiazepinone ring (ie, the amide nitrogen of the diazepinone ring), and the fourth, sixth, and eighth positions of the dibenzodiazepinone ring. It is described as a novel dibenzodiazepinone with three phenolic hydroxyl substituents. ECO-04601 is characterized by any one or more of the following physicochemical or spectroscopic properties such as mass, UV, NMR spectroscopy data, etc. The mass was measured with an electrospray mass spectrometer as 462.6 (FIG. 1) and UV = 230 nm (shoulder 290 nm) (FIG. 2). NMR data was collected using MeOH-d4 containing protons (FIG. 3), multidimensional pulse sequences gDQCOSY (FIG. 4), gHSQC (FIG. 5), gHMBC (FIG. 6) and NOESY (FIG. 7).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">

</span>
In another embodiment, the present invention relates to a novel class of farnesyl dibenzodiazepinone compounds represented by Formula 1.
</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="7" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">

</span>
(W1, W2, and W3 are each independently represented by the following formula:
</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="8" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
      <br class="style-scope patent-text">
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
<br class="style-scope patent-text">
<br class="style-scope patent-text">
<br class="style-scope patent-text">
<br class="style-scope patent-text">
<sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><br class="style-scope patent-text">
<sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub>
</span>Or the tricyclic side chain may be terminated with W3, W2 or W1 where W3, W2 or W1 is CHO or CH2OH, respectively; <br class="style-scope patent-text"> A is selected from -NH-, -NCH2R1, -NC (O) R1, <br class="style-scope patent-text"> R1 is selected from C1-6 alkyl, C2-6 alkene, aryl or heteroaryl; <br class="style-scope patent-text"> R2, R3 and R4 are each independently selected from H, R5, -C (O) R6; <br class="style-scope patent-text"> R5 is independently selected <sub class="style-scope patent-text">C 1-6</sub> <sub class="style-scope patent-text">alkyl, C 2-7</sub> Arukaren, aryl or heteroaryl, <br class="style-scope patent-text"> Each R6 is independently selected from H, C <sub class="style-scope patent-text">1-6</sub> alkyl, C <sub class="style-scope patent-text">2-7</sub> alkane, aryl or heteroaryl, or a pharmaceutically acceptable salt thereof).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  <br class="style-scope patent-text">

</span>In another embodiment, the invention provides Formula 1, wherein A is selected from the group consisting of NH, NCH2R1, and NC (O) R1, wherein R2 is H, R3 is H, and R4 is H. The compound represented by these is provided. In another embodiment, R2, R3 and R4 are each H and all other groups are as previously described. In a further embodiment, R2, R3 and R4 are each H, W1 is -CH = CH- and all other groups are as described above. In further embodiments, R2, R3, and R4 are each H, W2 is -CH = CH-, and all other groups are as described above. In a further embodiment, R2, R3 and R4 are each H, W3 is -CH = CH- and all other groups are as described above. In a further embodiment, A is NH, R2, R3 and R4 are each H, and all other groups are as described above. In a further embodiment, A is NH, W1, W2, and W3 are each CHCH, and all other groups are as described above. The present invention includes all pharmaceutically acceptable salts of the aforementioned compounds. <br class="style-scope patent-text"> The following are representative compounds of the present invention.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="9" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  <br class="style-scope patent-text">

</span>In certain embodiments, one or more of the compounds represented by Formula 1 are not specifically included. In certain embodiments, the compound represented by Formula 2 is not included. <br class="style-scope patent-text"> As discussed in Section V below, the compound of the present invention may be formulated into a pharmaceutical composition comprising a compound represented by Formula 1 and a pharmaceutically acceptable carrier.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
III<u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  MicromonosporaMicromonospora sp.(1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2)<br class="style-scope patent-text">
IV
</span>III. <u class="style-scope patent-text">Method for</u> Making Farnesyl Dibenzodiazepinone <u class="style-scope patent-text">by Fermentation In</u> one embodiment, ECO-04601 is obtained by culturing a new strain of Micromonospora, namely Micromonospora sp. 046-ECO11. The 046-ECO11 strain was issued on March 7, 2003 to the Department of Health, Department of Microbiology, Canadian International Depository Authority (IDAC) (1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2) as accession number 070303-01. Deposited. The deposit of strains was made based on the Budapest Treaty concerning the international recognition of the deposit of microorganisms in the patent procedure. The deposited strain cannot be canceled and will be published when the patent is granted unless there are restrictions or conditions. The deposited strain is provided merely as convenient to those skilled in the art and does not acknowledge that the deposit is required for enablement requirements, as required by 35 USC 112. <br class="style-scope patent-text"> It will be understood that the present invention is not limited to the use of the specific strain 046-ECO11. Rather, as described in Section IV below, X-ray irradiation, ultraviolet irradiation, treatment with nitrogen mustard, phage irradiation, antibiotic selection, etc., or by using recombinant genetic engineering techniques. Intended for use of other ECO-046011 producing organisms derived from ECO11, such as mutants or variants of 046-ECO11.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ActinomycetesActinomycetalesActinomycetesNocardia GeodermatophilusActinoplanesMicromonosporaNocardioidesSaccharothrixAmycolatopsisKutzneriaSaccharomonoporaSaccharopolysporaKitasatosporaStreptomycesMicrobisporaStreptosporangiumActinomaduraActinomycetesGoodfellow, Suprageneric Classification of Actinomycetes (1989); Bergeys Manual of Systematic Bacteriology, Vol. 4 (Williams and Wilkins, Baltimore, pp. 2322-2339);Embley and Stackebrandt, The molecular phylogeny and systematics of the Actinomycetes, Annu. Rev. Microbiol. (1994) 48: 257-289
</span>
&nbsp;&nbsp;The farnesyl dibenzodiazepinone compounds of the present invention may be biosynthesized by various microorganisms. Microorganisms that may biosynthesize the compounds of the present invention include, but are not limited to, Actinomycetales microorganisms, also called Actinomycetes. Examples of those belonging to the genus Actinomycetes include Nocardia, Geodermatophilus, Actinoplanes, Micromonospora, Nocardioides, Saccharothrix, Amycolatopsis, Kutzneria, Saccharomonopora, Saccharopolyspora, Kitasatospora, Streptomyces, Microbispora, Streptosporang, and Streptosporanga. The taxonomy of Actinomycetes is complex, Goodfellow, Suprageneric Classification of Actinomycetes (1989); Bergey's Manual of Systematic Bacteriology, Vol. 4 (Williams and Wilkins, Baltimore, pp. 2322-2339); and Embryy and Stackebrandt, The molecular phylogeny and systematics of the Actinomycetes, Annu. Rev. Microbiol. (1994) 48: 257-289. These are each hereby incorporated by reference in their entirety for any genus that may synthesize the compounds of the present invention.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Actinomycetes
</span>
&nbsp;&nbsp;Farnesyl dibenzodiazepinone producing microorganisms are cultured in a medium containing known nutrient sources for Actinomycetes. These media include carbon assimilation sources, nitrogen assimilation sources, optional inorganic salts, and other known growth factors having a pH of about 6-9. Suitable media include, but are not limited to, the growth media shown in Table 16. The microorganism is cultured for about 3 to 40 days at a culture temperature of about 18 to 40  C.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The medium inoculated with the farnesyl dibenzodiazepinone-producing microorganism may be aerated by culturing the inoculated medium with stirring, for example, by shaking in a rotary shaker or a shaking water bath. During culture, aeration may be effected by injecting air, oxygen or a suitable gas mixture into the seeded medium. After culturing, the medium in which the farnesyl dibenzodiazepinone compound is extracted and cultured using techniques well known to those skilled in the art and / or disclosed herein, such as, for example, centrifugation, chromatography, adsorption, filtration, etc. Can be isolated from For example, the cultured medium can be mixed with a suitable organic solvent such as n-butanol, n-butyl acetate, or 4-methyl-2-pentanone, for example by removing the solvent and then performing centrifugation. The organic layer can be separated by evaporating to dryness or by evaporating under vacuum until dry. For example, the resulting residue (residue) can be optionally reconstituted with water, ethanol, ethyl acetate, methanol or mixtures thereof, such as hexane, carbon tetrachloride, methylene chloride, or mixtures thereof. It can also be re-extracted with a suitable organic solvent such as After removal of the solvent, the compound may be further purified using standard techniques such as chromatography.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Random and / or directed chemical modifications may be optionally applied to farnesyl dibenzodiapedinone biosynthesized by microorganisms to form compounds that are derivatives or structural analogs. These derivatives or structural analogs with similar functional activity are within the scope of the present invention. The farnesyl dibenzodiapedinone compound may optionally be modified using methods known in the art and described herein.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
IV<u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  (farnesyl benzodiazepinone)
</span>IV. <u class="style-scope patent-text">In</u> another embodiment, the present invention relates to a nucleic acid molecule that encodes a protein useful for the production of farnesyl benzodiazepinone. In particular, the present invention provides recombinant DNA vectors and nucleic acid molecules that encode all or part of the biosynthetic locus of strain 046-ECO11. The biosynthetic locus is referred to herein as 046D for the production of ECO-04601. The invention further includes genetic modification of 046D using conventional genetic recombination techniques such as mutagenesis, inactivation, or nucleic acid replacement to generate a chemical variant of ECO-04601.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ActinomycetesStreptomyces
</span>
&nbsp;&nbsp;Thus, the present invention cultivates host cells under conditions that produce farnesyl benzodiazepinone using transformed host cells containing a recombinant DNA vector encoding one or more polypeptides of the present invention. A method of making a farnesyl benzodiazepinone compound is provided. Host cells are prokaryotes. In certain embodiments, the host cell is Actinomycetes. In another embodiment, the host cell is a Streptomyces host cell.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The present invention provides recombinant nucleic acids that produce a variety of farnesyl dibenzodiazepinone compounds that cannot be readily synthesized by chemical procedures alone. The present invention allows direct manipulation of the biosynthetic locus 046D through genetic engineering of enzymes involved in the biosynthesis of farnesyl benzodiazepinone according to the present invention. Biosynthetic locus 046A is described in Example 11.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  Actinomycetes
</span> <u class="style-scope patent-text">Recombinant DNA Vector</u> The <u class="style-scope patent-text">vector of the</u> present invention generally comprises DNA of an infectious pathogen into which foreign DNA has been inserted. Common methods of inserting a segment of DNA into another segment of DNA include the use of a specific enzyme called a restriction enzyme that cleaves the DNA at a specific site (specific nucleotide group) called a restriction site. . Cassette relates to DNA encoding a sequence encoding DNA or a segment of DNA encoding an expression product that can be inserted into a vector at defined restriction sites. The cassette restriction site ensures that the cassette is inserted into the appropriate reading frame. In general, a nucleic acid molecule encoding a protein useful for the production of farnesyl benzodiazepinone is inserted into one or more restriction sites in vector DNA and then transformed into a prokaryote such as Actinomycetes. Carries nucleic acid molecules (see below). A segment or sequence of DNA having inserted or added DNA, such as an expression vector, is also referred to as a DNA construct. The usual type of vector is a plasmid, which is generally a double-stranded DNA-containing molecule, usually derived from bacteria, can easily accept added (foreign) DNA, and has an appropriate It can be easily introduced into a host cell. A plasmid vector often has a coding DNA and a promoter DNA, and has one or more restriction sites suitable for introducing foreign DNA. Coding DNA is a DNA sequence that codes for a specific amino acid sequence for a specific protein or enzyme. In certain embodiments of the invention, the coding DNA is required for biosynthesis of farnesyl benzodiazepinone, SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23. 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75 , 77, 79, 81, 83, 85, 87 or 89.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Sambrook, Fritsch &amp; Maniatis, Molecular Cloning: A Laboratory Manual, Second Edition (1989) Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York Sabrook et al., 1989; DNA Cloning: A Practical Approach, Volumes I and II (D. N. Glover ed. 1985); F. M. Ausubel et al. (eds.), Current Protocols in Molecular Biology, John Wiley &amp; Sons, Inc. (1984)ActinomycetesStreptomycesActinomycetesMurakami, T., et al., (1989), J. Bacteriol, 171, 1459
</span>
&nbsp;&nbsp;Recombinant vector promoter DNA is a DNA sequence that initiates, controls, mediates, or controls expression of a coding DNA. Promoter DNA and coding form the same or different organisms. Recombinant cloning vectors may contain one or more replication systems for cloning or expression, one or more markers for selection in a host such as antibiotic resistance, and one or more expression cassettes. Many. Within the skill of the art, vector molecular constructs may be generated using conventional molecular biology and DNA recombination techniques. These techniques are explained fully in the literature. For example, Sambrook, Fritsch &amp; Maniatis, Molecular Cloning: A Laboratory Manual, Second Edition (1989) Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York (referred to herein as Sabrook et al., 1989); See DNA Cloning: A Practical Approach, Volumes I and II (DN Glover ed. 1985); FM Ausubel et al. (Eds.), Current Protocols in Molecular Biology, John Wiley &amp; Sons, Inc. (1984). Examples of promoters that function in Actinomycetes, such as Streptomyces, are taught in US Pat. Nos. 5,830,695 and 5,466,590. An example of a transcriptional promoter useful for Actinomycetes expression vectors is tipA, which is a promoter induced by the antibiotic thiostrepton (Murakami, T., et al., (1989), J. Bacteriol, 171, 1459).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">Actinomycetes</u> <br class="style-scope patent-text">
  ActinomycetesActinomycetesThompson KeiserThompson, C. J., et al., (1982), J. Bacteriol., 151, 668-677 or Keiser, T. et al. (2000), Practical Streptomyces Genetics, The John Innes Foundation, NorwichHopwood, D.A., et al., (1987), Methods in Enzymology 153, 116, Aacademic Press, New YorkActinomycetes
</span> <u class="style-scope patent-text">Transformation of Actinomycetes</u> <br class="style-scope patent-text"> Transformation methods suitable for use with Actinomycetes include forming Actinomycetes cultures into spheroplasts using lysozyme. Next, in order to introduce the vector into a host cell, for example, Thompson or Keiser (Thompson, CJ, et al., (1982), J. Bacteriol., 151, 668-677 or Keiser, T. et al. ( 2000), Practical Streptomyces Genetics, The John Innes Foundation, Norwich), a buffer containing a recombinant DNA vector and polyethylene glycol is added. The thiostrepton resistance gene is often used as a selectable marker in transformed plasmids (see Hopwood, DA, et al., (1987), Methods in Enzymology 153, 116, Aacademic Press, New York) However, the present invention is not limited to this. Another method of transformation of Actinomycetes is taught in US Pat. No. 5,393,665.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  Actinomycetes
</span> <u class="style-scope patent-text">Intermediate or farnesyl dibenzodiazepinone assay for farnesyl dibenzodiazepinone Encodes</u> one or more proteins in the farnesyl benzodiazepinone biosynthetic pathway, and thus farnesyl benzodiazepinone biosynthesis by genetic complementation of specific defects Actinomycetes that are defective in biosynthesis of farnesyl dibenzodiazepinone are transformed with one or more expression vectors that restore synthesis.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ActinomycetesActinomycetesKieselgel <sub class="style-scope patent-text"></sub>
</span>The presence or absence of farnesyl dibenzodiazepinone or intermediate products in the biosynthetic pathway of recombinant Actinomycetes (see FIGS. 13, 14 and 15) can be determined using procedures well known to those skilled in the art. For example, an ethyl acetate extract of the fermentation medium used for the cultivation of recombinant Actinomycetes is treated as described in Example 2 and the fraction containing farnesyl dibenzodiazepinone or intermediate product is washed with commercially available Kieselgel 60F <sub class="style-scope patent-text">254</sub> plates. Detected by TLC. By inspecting the dry plate under UV light or by spraying the plate with a spray containing vanillin (0.75%) and concentrated sulfuric acid (1.5%, v / v) in ethanol, followed by plate By visualizing the farnesyl dibenzodiazepinone and intermediate product compounds. The exact properties of the compounds separated by TLC are then measured using gas chromatography-mass spectrometry. Mass spectrometry is taught in published US patent application 2003/0052268.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  
</span> <u class="style-scope patent-text">Mutagenesis The</u> present invention allows the biosynthetic locus 046D to be directly manipulated by genetic engineering of enzymes involved in the biosynthesis of the farnesyl benzodiazepinone of the present invention.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Ausubel et. al. Short Protocols in Molecular Biology (1995) 3<sup class="style-scope patent-text">rd</sup>Ed. John Wiley &amp; Sons, Inc.StratageneEXSITE<sup class="style-scope patent-text">TM</sup>PCR-Based Site-directed Mutagenesis Kit (Catalog No. 200502)QUIKCHANGE<sup class="style-scope patent-text">TM</sup> Site-directed mutagenesis Kit (Catalog No. 200518)CHAMELEON(R) double-stranded Site-directed mutagenesis kit (Catalog No. 200509)
</span>Many methods are known in the art that allow random or targeted mutations of the DNA sequences of the present invention (see, eg, Ausubel et. Al. Short Protocols in Molecular Biology (1995) 3 <sup class="style-scope patent-text">rd</sup> Ed (See John Wiley &amp; Sons, Inc.). In addition, there are many commercial kits for site-directed mutagenesis, including conventional methods and PCR-based methods. Both Stratagene Inc., available from <sup class="style-scope patent-text">EXSITE TM PCR-Based Site-directed</sup> Mutagenesis Kit (Catalog No. 200502), QUIKCHANGE TM Site-directed mutagenesis Kit (Catalog No. 200518), and CHAMELEON (R) double-stranded Site -directed An example is mutagenesis kit (Catalog No. 200509).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  <br class="style-scope patent-text">

</span>The nucleotides of the present invention may also be made by insertion mutation or truncation mutation (N-terminal, internal, or C-terminal) according to procedures known to those skilled in the art. <br class="style-scope patent-text"> Conventional site-directed mutagenesis methods known in the art are by subcloning the sequence and mutating it to a vector such as the M13 bacteriophage vector. As a result, the single-stranded DNA template can be isolated. In these methods, a mutagenic primer (ie, a primer that can anneal the site of mutation, but can have one or more unmatched nucleotides at the site of mutation) is added to the single-stranded template. Annealing and then polymerizing the template complement starting from the 3 'end of the mutagenic primer. The resulting duplex is transformed into host bacteria and plaques are screened for the mutation of interest.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  (an extended-length PCR method)
</span>
&nbsp;&nbsp;Recently, PCR has been used for site-directed mutagenesis. This method has the advantage of not requiring a single-stranded template. In addition, methods have been developed that do not require subcloning. There are several issues that must be considered when PCR-based site-directed gene mutagenesis is performed. First, in these methods, it is desirable to reduce the number of PCR cycles in order to prevent an increase in undesirable mutations introduced by polymerase. Second, selection must be made to reduce the number of non-mutated parent molecules remaining in the reaction. Third, in order to be able to use the PCR primer set, an extended-length PCR method is preferable. Fourth, since end extension activity does not depend on a thermostable polymerase template, it may be necessary to incorporate an end polishing step into the procedure prior to blunt end ligation of the PCR-generated mutagenesis product. Many.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Taq Extender
</span>
&nbsp;&nbsp;The protocol described below addresses these issues through the following steps. First, the concentration of template used is about 1000 times that used in conventional PCR reactions, so the number of cycles is reduced from 25-30 to 5-10 without dramatically reducing production. Can be reduced. Second, the most common E.I. Since the E.coliDam strain methylates its DNA with the sequence 5-GATC-3, the restriction endonuclease DpnI (cognitive target sequence: 5-Gm6ATC-3 with A residue methylated) is used to select the parent DNA To do. Third, use Taq Extender with PCRmix to increase the proportion of long (ie, total plasmid length) PCR products. Finally, the end of the PCR product is polished using Pfu DNA polymerase prior to intramolecular ligation with T4 DNA ligase.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Examples of isolation of mutant polynucleotides are described in detail below, but are not limited thereto.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
    UTaq ExtenderUStratageneNelson et al. (1994)  Strategies 7: 27 Matteucci et al., 1981, J. Am. Chem. Soc. 103:3185-3191(cyanoethyl phosphoramidite)Biosearch 8700 DNA Synthesizer 
</span>
&nbsp;&nbsp;1  mutagenesis buffer (Tris-HCl 20 mM, pH 7.5; MgCl 2 8 mM; BSA 40 g / ml), 12-20 pM of each primer (the person skilled in the art will characterize oligonucleotide primer annealing as required The mutagenic primer could be designed taking into account factors such as base composition, primer length and desired buffer salt concentration that affect the And the primer (same or other) must contain 5 'phosphate to facilitate later ligation), each dNTP250M, TagDNA polymerase Ze 2.5U and Taq Extender 2.5U (available from Stratagene: Nelson et al. (1994) Strategies 7: 27, and US Pat. No. 5,556,772) A PCR cocktail containing references), added plasmid template DNA (approximately 0.5 pM). Primers can be prepared using the triester method of Matteucci et al., 1981, J. Am. Chem. Soc. 103: 3185-3191. Such methods are incorporated herein by reference. Alternatively, automated synthesis with a Biosearch 8700 DNA Synthesizer using, for example, cyanoethyl phosphoramidite chemistry may be preferred.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  U
</span>
&nbsp;&nbsp;The PCR cycle is performed as follows. 94  C. for 4 minutes, 50  C. for 2 minutes, and 72  C. for a half cycle, followed by 94  C. for 1 minute, 54  C. for 2 minutes, 72  C. for 1 minute 10 cycles. PCR generated linear DNA containing parental template DNA and mutagenic primers is treated with Dpnl (10 U) and Pfu DNA polymerase (2.5 U). This results in Dpnl degradation of the in vivo methylated parent template and hybrid DNA, and Pfu DNA polymerase removes the non-template TagDNA polymerase extended base on the linear PCR product. Such a reaction is incubated at 37  C. for 30 minutes, and further transferred to 72  C. in 30 minutes. Mutagenesis buffer (115 ul  1) containing 0.5 mM ATP is added to the Dpnl-degraded Pfu DNA polymerase polished PCR product. Mix the solution, remove 10 ul and transfer to a new microcentrifuge tube and add T4 DNA ligase (2-4 U). Incubate the ligation at 37  C for more than about 60 minutes. Finally, the treated solution is treated with competent E. coli according to standard methods. transform into E. coli.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;There are random mutagenesis methods in the art, which results in a panel of mutations in one or more random states. A panel of such mutants then produces mutants that exhibit reduced uracil detectability compared to wild-type polymerase (eg, in the presence of dUTP200M at the optimal temperature for a given DNA polymerase). Screening may be done by measuring the incorporation of 10 nM dNTP into the polymer form for 30 minutes. An example of a random mutagenesis method is the so-called variable PCR method. As the name implies, such methods amplify a given sequence under conditions where the DNA polymerase does not support high fidelity incorporation. Conditions that promote the variability uptake of different DNA polymerases will vary, but one skilled in the art will be able to determine conditions for a given enzyme. The basic variables of many DNA polymerases in amplification fidelity are, for example, the type and concentration of divalent metal ions in the buffer. Variations in manganese ions and / or magnesium ions or manganese ion concentrations may be used to affect the error rate of the polymerase.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The gene for the desired mutant polypeptide produced by mutagenesis may be sequenced to identify the site and number of mutations. For these mutants with one or more mutations, the site-specific mutagenesis of the identified mutation into the wild-type gene when isolated from other mutations of the particular mutant. By introducing, the influence of a predetermined mutation may be evaluated. The effect of the mutant alone can be measured by a single mutant screening assay thus generated.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
<u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  
</span>V. <u class="style-scope patent-text">Genes and proteins for production of ECO-04601</u> SEQ ID NOs: 3, 5, 7, 9, 11, <u class="style-scope patent-text">13, 15, 17, 19, 21, 23, 25, 27, 29, 31</u> as described in more detail below 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83 , 85, 87, and 89, using isolated, purified, or enriched nucleic acids, SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and One of the polypeptides represented by 8 may be prepared respectively, or SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, A fragment comprising at least 50, 75, 100, 200, 300, 500 or more consecutive amino acids of one of the polypeptides represented by 80, 82, 84, 86, and 88 may be prepared.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Stryer, Biochemistry 3<sup class="style-scope patent-text">rd</sup> edition, W. H. Freeman &amp; Co., New York
</span>Accordingly, another embodiment of the present invention provides SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 46, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86 and An isolated, purified or enriched nucleic acid encoding one of the polypeptides represented by 88, or SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88 One polypeptide is a fragment comprising at least 50,75,100,150,200,300 or more consecutive amino acids. As a result of the redundancy and degeneracy of the genetic code, the coding sequences of these nucleic acids are SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31. 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83 85, 87, and 89, which may coincide with one of the coding sequences of one of the nucleic acids or fragments thereof, SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, Represented by 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88 A coding sequence that encodes one of the polypeptides or SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36 , 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86 And one of the polypeptides represented by 88 may be different from a fragment comprising at least 50, 75, 100, 150, 200, 300 consecutive amino acids. The genetic code, are known to those skilled in the art, for example, can be obtained <sup class="style-scope patent-text">Stryer, Biochemistry 3 rd edition, WH</sup> Freeman &amp; Co., from New York.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, One of the polypeptides represented by 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88 Nucleic acids that are encoded, isolated, purified or enriched include (1) SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83 , 85, 87 and 89, only one coding sequence is represented by (2) Numbers 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, and 89, as well as leader sequences or proproteins, etc. And (3) SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, and 89 Coding sequence and non-coding such as 5  and / or 3  of the coding sequence Although includes columns, without limitation. Thus, as used herein, the term polynucleotide encoding a polypeptide refers to a polynucleotide that includes only the coding sequence of a polypeptide and a polynucleotide that includes other coding and / or non-coding sequences. Nucleotides.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  III
</span>
&nbsp;&nbsp;The present invention relates to SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, Poly, based on the sequences represented by 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, and 89 For nucleotides, the polynucleotide is, for example, SEQ ID NO: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, and 89 The amino acid sequence encoded by the polynucleotide to be Not to change, it has caused a change in "silent". In addition, the present invention relates to amino acids as a result of nucleotide changes, and SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34. 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84 , 86, and 88, wherein the substitution, addition, deletion, fusion or cleavage of the polypeptide occurs. Such nucleotide changes may be introduced using techniques such as site-directed mutagenesis, random chemical mutagenesis, exonuclease III deficiency, and other DNA recombination techniques.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Ausubel et al., Current Protocols in Molecular Biology, John Wiley 503 Sons, Inc. 1997Sambrook et al., Molecular Cloning: A Laboratory Manual 2d Ed., Cold Spring Harbor Laboratory Press, 1989 
</span>
&nbsp;&nbsp;SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, Isolated, purified, or represented by 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, and 89, or Concentrated nucleic acid, its complementary sequence, or SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, and 89 At least 100, 150, 200, 300, 400, or A fragment containing more than one consecutive base or a complementary sequence thereof is used as a probe, and SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28 , 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78 , 80, 82, 84, 86, and 88, respectively, may be specifically identified and isolated. In such a procedure, a genomic DNA library is constructed from a sample microorganism or a sample containing a microorganism capable of producing farnesyl dibenzodiazepinone. Next, under conditions that allow the probe to specifically hybridize to its complementary sequence, it has a coding sequence or fragment of the coding sequence and the sequences 2, 4, 6, 8, 10, 12, 14, 16, 18 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69 , 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88, a probe encoding one of the polypeptides or a fragment thereof is contacted with the genomic DNA library. In a preferred embodiment, the probe is an oligonucleotide of about 10 to about 30 nucleotides in length and is SEQ ID NO: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, Designed based on nucleic acids represented by 83, 85, 87, and 89. Next, a genomic DNA clone that hybridizes to the probe is detected and isolated. Procedures for preparing and identifying DNA clones of interest are described in Ausubel et al., Current Protocols in Molecular Biology, John Wiley 503 Sons, Inc. 1997; and Sambrook et al., Molecular Cloning: A Laboratory Manual 2d Ed., Cold Spring Harbor Laboratory Press, 1989. In another embodiment, the probe is SEQ ID NO: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, and 89 Restriction fragments or PCR amplified nucleic acids.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, and 89 Nucleic acid, its complementary sequence, or SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, and 89 At least 10, 15, 20, 25, 30, 35, 40, 50 of one sequence 75,100,150,200,300,400, or fragments or a complementary sequence thereof comprising 500 contiguous bases, and used as a probe, to identify the related nucleic acid may be isolated. In certain embodiments, the relevant nucleic acid may be the genomic DNA (or cDNA) of a potential farnesyl dibenzodiazepinone producer. In such a procedure, a sample of nucleic acid containing nucleic acid from a potential farnesyl dibenzodiazepinone producer is contacted with the probe under conditions that allow the probe to specifically hybridize to the relevant sequence. The nucleic acid sample may be a genomic DNA (or cDNA) library of potential farnesyl dibenzodiazepinone producers. Hybridization of the probe to the nucleic acid is detected using any of the methods described above.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  <sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><sub class="style-scope patent-text"></sub>
</span>Hybridization is performed under conditions of low, medium or high stringency. As an example of nucleic acid hybridization, a polymer membrane containing immobilized and denatured nucleic acid is first prepared with 0.9 M NaCl, 50 mM NaH <sub class="style-scope patent-text">2</sub> PO <sub class="style-scope patent-text">4</sub> , pH 7.0, 50 mM Na <sub class="style-scope patent-text">2</sub> EDTA, 0.5% Prehybridize with a solution of SDS, 10  Denhart, and 0.5 mg / ml polyriboadenylic acid at 45  C. for 30 minutes. Next, approximately 2  10 <sup class="style-scope patent-text">7</sup> cpm (specific activity 4-9  10 <sup class="style-scope patent-text">8</sup> cpm / ug) of <sup class="style-scope patent-text">32</sup> P end-labeled oligonucleotide probe is added to the solution. After 12-16 hours of culture, the membrane is washed with 1  SET (150 mM NaCl, 20 mM Tris-HCl, pH 7.8, 1 mM Na <sub class="style-scope patent-text">2</sub> EDTA) containing 0.5% SDS for 30 minutes at room temperature, Subsequently, the oligonucleotide probe is washed with fresh 1  SET at Tm10  C. Here, Tm is a melting temperature. Next, the membrane over the autoradiographic film is exposed to detect the hybridization signal.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Identifying nucleic acids with different levels of homology to the probe by altering the stringency of the hybridization conditions used to identify the nucleic acid that hybridizes to the detectable probe, such as genomic DNA or cDNA. Can be isolated. Stringency may be changed by performing hybridization at various temperatures below the melting temperature of the probe. The melting temperature of the probe can be calculated using the following formula:
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  <br class="style-scope patent-text">

</span>The Celsius temperature of the melting temperature (Tm) of an oligonucleotide probe of 14 to 70 nucleotides in length can be calculated using the following formula: <br class="style-scope patent-text"> Tm = 81.5 + 16.6 (log [Na +] + 0.41 (fraction G + C)  (600 / N), where N is the length of the oligonucleotide).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
<br class="style-scope patent-text">
<br class="style-scope patent-text">
Sambrook et al., supra
</span>When hybridization is performed in a solution containing formamide, the melting temperature can be calculated using the following equation: <br class="style-scope patent-text"> Tm = 81.5 + 16.6 (log [Na +] + 0.41 (fraction G + C)-(0.63% formamide)-(600 / N), where N is the length of the probe). <br class="style-scope patent-text"> 6  SSC, 5  Denhart reagent, 0.5% SDS, denatured fragmented salmon sperm DNA 0.1 mg / ml or 6  SSC, 5  Denhart reagent, 0.5% SDS, denatured fragmented salmon sperm DNA Prehybridization may be performed in 1 mg / ml, 50% formamide. The composition of SSC and Denhardt's solution is described in Sambrook et al., Supra.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Hybridization is performed by adding a detectable probe to the hybridization solution described above. When the probe contains double-stranded DNA, denaturation is performed by culturing at a high temperature before adding it to the hybridization solution and rapidly cooling. Similarly, it may be desirable to denature single-stranded probes to eliminate or reduce secondary structure formation or oligomer formation. By contacting the filter with the hybridization solution for a sufficient time, the probe can hybridize to cDNA or genomic DNA containing sequences complementary or homologous thereto. For probes longer than 200 nucleotides, hybridization is performed at 15-25  C. below the melting temperature. For short probes such as oligonucleotide probes, hybridization may be performed at a temperature 5 to 10  C lower than the melting temperature. Preferably, for short probes, hybridization may be performed with 6  SSC. Preferably, long probes are hybridized with a solution containing 50% formamide. All of the aforementioned hybridizations are considered examples of hybridization performed under conditions of high stringency.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">

</span>
Following hybridization, the filter is washed in 2  SSC, 0.1% SDS at room temperature or higher for at least 15 minutes, depending on the desired stringency. The filter is then washed with 0.1  SSC, 0.5% SDS at room temperature (again) for 30 minutes to 1 hour. Nucleic acids hybridized to the probe are identified by conventional autoradiography and non-radioactive detection methods.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The above procedure may be modified to identify nucleic acids with reduced levels of homology to the probe sequence. For example, conditions with lower stringency may be used to obtain nucleic acids with reduced homology to detectable probes. For example, the hybridization temperature of a hybridization buffer having a Na + concentration of about 1M may be decreased by 5  C. from 68  C. to 42  C. After hybridization, the filter may be washed at the hybridization temperature using 2  SSC, 0.5% SDS. These conditions are considered medium stringency conditions above 50  C. and low stringency conditions below 50  C. A specific example of medium stringency hybridization conditions is when the above-described hybridization is performed at 55  C. A specific example of low stringency hybridization conditions is when the above-described hybridization is performed at 45  C.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Alternatively, hybridization may be performed at 42  C. in a buffer such as 6  SSC containing formamide. In this case, in order to identify clones with reduced levels of homology to the probe, the formamide concentration in the hybridization buffer may be reduced by 5% from 50% to 0%. After hybridization, the filter may be washed at 50  C. using 6  SSC, 0.5% SDS. These conditions are medium stringency conditions when formamide is greater than 25% and low stringency conditions when formamide is less than 25%. A specific example of medium stringency hybridization conditions is when the above hybridization is carried out with 30% formamide. A specific example of low stringency hybridization conditions is when the above hybridization is carried out with 10% formamide. Nucleic acids hybridized to the probe are identified by conventional autoradiography and non-radioactive detection methods.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Using the method described above, SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, and 89 Nucleic acids having at least 97%, at least 95%, at least 90%, at least 85%, at least 80%, or at least 70% sequence identity to a nucleic acid sequence selected from the group consisting of: An isolated nucleic acid sequence may have a coding sequence that is a naturally occurring allelic variant of one of the coding sequences described herein. Such allelic variants are SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41. 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 66, 68, 70, 72, 75, 77, 79, 81, 83, 85, 87, and 89 One or more nucleic acids may be substituted, deleted, or added as compared to the nucleic acid or the complementary sequence thereof.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Also, SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, One of the sequences represented by 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88 At least 99%, at least 95%, at least 90%, at least 85%, at least 80%, for polypeptides having at least 50, 75, 100, 150, 200, 300 contiguous amino acids, Alternatively, the above procedure may be used to isolate nucleic acids encoding polypeptides having at least 70% identity.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Another embodiment of the present invention is SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88 An isolated or purified polypeptide comprising one of the sequences represented by: or a fragment having at least 50, 75, 100, 150, 200, 300 consecutive amino acids thereof. As described herein, a nucleic acid encoding a polypeptide is inserted into a vector so that the encoded sequence is operably linked to a sequence that can be expressed in a suitable host cell. These polypeptides may be obtained by insertion. For example, these expression vectors may contain a promoter, a ribosome binding site for initiating translation, and a transcription termination region. The vector may also contain appropriate sequences for adjusting the expression level, origin of replication, and selectable markers.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Ecoli <sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub> immediate early early and late 
</span>Suitable promoters for expressing the polypeptide or fragment thereof in bacteria include E. coli. coli lac or trp promoter, lacl promoter, lacZ promoter, T3 promoter, T7 promoter, gpt promoter, the lambda <sub class="style-scope patent-text">P R</sub> promoter, and and lambda <sub class="style-scope patent-text">P L</sub> promoter, 3-phosphoglycerate kinase (PGK) and the acid phosphatase - such lactamase promoter An operon promoter encoding a glycolytic enzyme is included. Fungal promoters include the alpha factor promoter. Eukaryotic promoters include CMV immediate early promoter, HSV thymidine kinase promoter, heat shock promoter, early and late SV40 promoter, retroviral LTR, and mouse metallothionein-I promoter. Other promoters known to control gene expression in prokaryotic or eukaryotic cells or their viruses may be used.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Mammalian expression vectors may also comprise an origin of replication, all necessary ribosome binding sites, polyadenylation sites, splice donors and acceptor sites, transcription termination sequences and 5  flanking non-transcribed sequences. In certain embodiments, DNA sequences derived from SV40 splice sites and polyadenylation sites may be used to obtain the required non-transcribed genetic elements.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;A vector for expressing a polypeptide or fragment thereof in a eukaryotic cell may contain an enhancer for improving the expression level. Enhancers are cis-acting elements of DNA, usually about 10 bp to 300 bp long, act on promoters and promote their transcription. Examples include the SV40 enhancer behind the origin of replication 100 bp to 270 bp, the cytomegalovirus early promoter enhancer, the polyoma enhancer behind the origin of replication, and the adenovirus enhancer.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Ecoli S.cerevisiae 
</span>
&nbsp;&nbsp;Furthermore, since the expression vector preferably contains one or more selectable marker genes, it is possible to select a host cell containing the vector. Examples of selectable markers used include a gene encoding dihydrofolate reductase, a gene that confers neomycin resistance to eukaryotic cell cultures, E. coli. Examples include genes that give tetracycline resistance or ampicillin resistance to the E. coli and S. cerevisiae TRP1 genes.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
Ausbel et al. Current Protocols in Molecular Biology, John Wiley 503 Sons, Inc. 1997 and Sambrook et al., Molecualr Cloning: A Laboratory Manual 2d Ed., Cold Spring Harbour Laboratory Press, 1989
</span>
The appropriate DNA sequence may be inserted into the vector by a variety of procedures. In general, the DNA sequence is ligated to a desired position in the vector after degradation of the inserted fragment or a vector having an appropriate restriction endonuclease. Alternatively, an appropriate restriction enzyme site is manipulated and inserted into DNA by PCR. Various cloning techniques are disclosed in Ausbel et al. Current Protocols in Molecular Biology, John Wiley 503 Sons, Inc. 1997 and Sambrook et al., Molecualr Cloning: A Laboratory Manual 2d Ed., Cold Spring Harbor Laboratory Press, 1989. ing. These and other procedures are considered to be within the scope of those skilled in the art.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Sambrook et al., Molecular Cloning: A Laboratory Manual, Second Edition, Cold Spring Harbor, N.Y, (1989) 
</span>
&nbsp;&nbsp;The vector may be, for example, in the form of a plasmid, viral particle, or phage. Other vectors include chromosomal, non-chromosomal and synthetic DNA sequence derivatives, viruses, bacterial plasmids, phage DNA, baculovirus, yeast plasmids, vectors derived from combinations of plasmids and phage DNA, vaccinia, adenovirus, fowlpox. Viruses and viral DNA such as pseudorabies are included. Various cloning and expression vectors for use in prokaryotic or eukaryotic hosts are disclosed in Sambrook et al., Molecular Cloning: A Laboratory Manual, Second Edition, Cold Spring Harbor, NY (1989).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  (Pharmacia Fine Chemicals, Uppsala, Sweden)(Promega Biotec, Madison, WI, USA)(Qiagen)pBluescript<sup class="style-scope patent-text">TM </sup>II (Stratagene)(Pharmacia)(Stratagene)(Pharmacia)
</span>Specific bacterial vectors used include pBR322 (ATCC 37017), pKK223-3 (Pharmacia Fine Chemicals, Uppsala, Sweden), pGEM1 (Promega Biotec, Madison, Wis., USA), pQE70, pQE60, pQE-9 (Qiagen) , PD10, phiX174, pBluescript <sup class="style-scope patent-text"></sup> IIKS, pNH8A, pNH16a, pNH18A, pNH46A (Stratagene), ptrc99a, pKK223-3, pKK233-3, pDR540, pRIT5 (Pharmacia), pKK232-8 and pCM7 Commercially available plasmids containing genetic factors are included. Specific eukaryotic vectors include pSV2CAT, pOG44, pXT1, pSG (Stratagene), pSVK3, pBPV, pMSG and pSVL (Pharmacia). However, other vectors may be used as long as they are reproducible and stable in the host cell.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  E.coliStreptomyces lividansStreptomyces griseofuscusStreptomyces ambofaciensBacillus subtilisSalmonella typhimuriumPseudomonasStreptomycesBacillusStaphylococcusDrosophila S2Spodoptera Sf9Bowes melanoma
</span>
&nbsp;&nbsp;The host cell can be any host cell known to those of skill in the art, including prokaryotic cells or eukaryotic cells. Representative examples of suitable hosts include bacterial cells such as E. coli, Streptomyces lividans, Streptomyces griseofuscus, Streptomyces ambofaciens, Bacillus subtilis, Salmonella typhimurium and Pseudomonas, various species of Streptomyces, Bacillus, Staphylococcus, etc. Fungal cells, insect cells such as Drosophila S2 and Spodoptera Sf9, and animal cells such as CHO, COS or Bowes melanoma and adenovirus. Selecting an appropriate host is within the abilities of those skilled in the art.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The vector may be introduced into the host cell using any of a variety of techniques, including electroporation transformation, transfection, transduction, viral infection, gene gun, or Ti-mediated gene transfer. Where appropriate, recombinant host cells can be cultured in conventional nutrient media modified to be suitable for promoter activation, selection of transformants, or amplification of the genes of the present invention. After transformation of the appropriate host strain and growth of the host strain to the appropriate cell density, the selected promoter is induced by suitable means (eg, temperature conversion or chemical induction), and the cells are further cycled. Culturing may be performed to allow the cells to produce the desired polypeptide or fragment thereof.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Usually, the cells are collected by centrifugation and destroyed by physical or chemical means. The resulting crude extract is retained for subsequent purification. Microbial cells used to express the protein can be disrupted by any conventional method including freeze-thaw cycles, sonication, mechanical disruption or the use of cytolytic agents. These methods are well known to those skilled in the art. Expressing the polypeptide or fragment thereof by ammonium sulfate precipitation or ethanol precipitation, acid extraction, anion or cation exchange chromatography, phosphocellulose chromatography, hydrophobic interaction chromatography, affinity chromatography, hydroxylapatite chromatography, and It can be recovered from recombinant cell culture and purified by methods involving lectin chromatography. If necessary, a protein refolding step can be used in completing the construction of the polypeptide. If necessary, high performance liquid chromatography (HPLC) can be used for final purification steps.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Gluzman, Cell, 23:175(1981)(compatible vector)
</span>
&nbsp;&nbsp;Various mammalian cell culture systems can also be employed to express recombinant protein. Examples of mammalian expression systems include monkey kidney fibroblast COS-7 strain (described in Gluzman, Cell, 23: 175 (1981)) and compatible vectors such as C127, 3T3, CHO, HeLa and BHK cell lines. Other cell lines capable of expressing the protein from (compatible vectors) are included. The construct in the host cell may be used in a conventional manner to produce the gene product encoded by the recombinant sequence. The polypeptides of the present invention may or may not contain an initiating methionine amino acid residue.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Alternatively, SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88 Its fragment containing 50, 75, 100, 150, 200, or 300 consecutive amino acids can be generated synthetically by a conventional peptide synthesizer. In another embodiment, fragments or portions of polynucleotides may be used to generate the corresponding full-length polypeptide by peptide synthesis. Therefore, the fragment is used as an intermediate product to produce a full-length polypeptide.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Using mRNA transcribed from a DNA construct comprising a promoter operably linked to a nucleic acid encoding a polypeptide or fragment thereof using a cell-free translation system, SEQ ID NOs: 2, 4, 6, 8, 10 , 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88, or at least 50, 75, 100, 150 thereof. Fragments containing 200, 300, or 300 consecutive amino acids can be generated. In certain embodiments, the DNA construct is linearized before the transcription reaction is performed in vitro. The transcribed mRNA is then cultured with a suitable cell-free translation extract, such as a rabbit reticulocyte extract, to produce the desired polypeptide or fragment thereof.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  (variant)
</span>
&nbsp;&nbsp;The present invention also includes SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88 It relates to a variant of a polypeptide, or a fragment comprising at least 50, 75, 100, 150, 200, or 300 consecutive amino acids thereof. The term variant includes derivatives or analogs of these polypeptides. In particular, variants may be represented by SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, by one or more of substitutions, additions, deletions, fusions, and truncations. 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, The polypeptide represented by 76, 78, 80, 82, 84, 86, and 88 differs in amino acid sequence. There may be any combination of such substitutions, additions, deletions, fusions and truncations.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  III(modification)
</span>
&nbsp;&nbsp;Variants occur naturally or are generated in vitro. In particular, these variants are made using genetic engineering techniques such as site-directed mutagenesis, random chemical mutagenesis, exonuclease III deletion methods, and standard cloning techniques. Alternatively, these mutants, fragments, analogs or derivatives are made using methods of chemical synthesis or modification.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  (natural isolates)
</span>
&nbsp;&nbsp;Other methods of making variants are known to those skilled in the art. These include procedures for making nucleic acids encoding polypeptides having characteristics that enhance their value in industrial or research applications by temporarily mutating nucleic acid sequences obtained from natural isolates. Is included. Many variant sequences with one or more nucleotide differences relative to sequences obtained from natural isolates are generated and characterized by these procedures. Preferably, these nucleotide differences result in amino acid changes from the natural isolate to the polypeptide encoded by the nucleic acid.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, Variants of the polypeptides represented by 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88 are SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48 , 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88 Two or more amino acid residues are conserved or non-conserved amino acid residues (preferably It is properly a mutant substituted with stored amino acid residues). The substituted amino acid residue may or may not be encoded by the genetic code.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;A conserved substitution is one in which a particular amino acid of a polypeptide is replaced with another amino acid having similar characteristics. Typical conserved substitutions include substitution of aliphatic amino acids such as Ala, Val, Leu, and lle with another aliphatic amino acid, substitution of Ser with Thr or substitution of Thr with Ser, other acidic Substitution of acidic residues such as Asp or Glu by residues, substitution of residues having amide groups such as Asn or Gln by other residues having an amide group, bases such as Lys or Arg by residues of other bases And replacement of aromatic residues such as Phe or Tyr with other aromatic residues.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Other variants are SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, With 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88 polypeptides One or more amino acid residues represented is a variant containing a substituent. Still other variants are those in which the polypeptide is associated with another compound, such as a compound that increases the half-life of the polypeptide (eg, polyethylene glycol). Additional variants are those in which the added amino acid is fused to the polypeptide, such as a leader sequence, secretory sequence, proprotein sequence, or a sequence that facilitates purification, enrichment, or stabilization of the polypeptide. is there.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;In certain embodiments, the fragments, derivatives, and analogs are SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34. 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84 , 86, and 88, which retain the same biological function or activity. In other embodiments, the fragment, derivative, or analog includes a fused heterologous sequence. This heterologous sequence facilitates the purification, enrichment, detection, stabilization, or secretion of a polypeptide that can be enzymatically cleaved, in part or in whole, from the fragment, derivative, or analog.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Another embodiment of the present invention is SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88 At least 70%, at least 80%, at least 85%, for a fragment comprising one of the polypeptides represented by or at least 50, 75, 100, 150, 200, or 300 consecutive amino acids thereof, A polypeptide or fragment thereof having at least 90% or greater than 95% identity. It will be understood that substantially identical amino acids include conservative substitutions as described above.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  <br class="style-scope patent-text">

</span>SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, One of the polypeptides represented by 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88 Or a fragment thereof containing homology to a fragment containing at least 50, 75, 100, 150, 200, or 300 consecutive amino acids or a fragment thereof using the above-described techniques May be obtained by isolating. <br class="style-scope patent-text"> Alternatively, homologous polypeptides or fragments may be obtained by biochemical condensation or purification procedures. Candidate sequences for homologous polypeptides or fragments may be determined by proteolysis, gel electrophoresis, and / or microsequencing. Candidate sequences for homologous polypeptides or fragments are represented by SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36. , 38, 41, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86 And a polypeptide comprising at least 5, 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, or 150 consecutive amino acids of one of the polypeptides represented by be able to.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 41, 42, 44, 46, 48, A polypeptide represented by 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 70, 71, 74, 76, 78, 80, 82, 84, 86, and 88, or at least its The fragments, derivatives or analogs of the invention comprising 40, 50, 75, 100, 200, or 300 consecutive amino acids may be used for various applications. As described elsewhere herein, biochemical reactions may be catalyzed, for example, using polypeptides or fragments, derivatives or analogs thereof.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
VI<u class="style-scope patent-text"></u> <br class="style-scope patent-text">

</span>VI. <u class="style-scope patent-text">Pharmaceutical composition comprising farnesyl dibenzodiazepinone In</u> another embodiment, the present invention provides farnesyl dibenzodiazepinone as described in the preceding section and a pharmaceutically acceptable carrier as described below. The present invention relates to a pharmaceutical composition comprising Pharmaceutical compositions containing farnesyl dibenzodiazepinone are useful for the treatment of various diseases and disorders including cancer, inflammation and bacterial infection.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;A compound of the invention, or a pharmaceutically acceptable salt thereof, is administered orally, intravenously, intramuscularly, subcutaneously, topically for the treatment or prophylactic treatment of diseases, in particular bacterial infections, acute inflammation, chronic inflammation and cancer. Can be formulated for oral or parenteral administration. For oral or parenteral administration, the compound of the present invention is mixed with conventional pharmaceutical carriers and excipients and used in the form of tablets, capsules, elixirs, suspensions, syrups, wafers, etc. Can do. Compositions comprising compounds of the present invention may comprise from about 0.1 to about 99.9%, from about 1 to about 98%, from about 5 to 95%, from about 10 to about 80%, or from about 15 to 60% by weight Contains active compound.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Remingtons Pharmaceutical Sciences, Mack Publishing Company, Easton, PA;  Goodman and Gilman, Pharmaceutical Basis of Therapeutics, Pergamon Press, New York, NY)(bioerodable matrices)Kent LeonardZaffaroni
</span>
&nbsp;&nbsp;The pharmaceutical formulations disclosed herein are prepared according to standard procedures and are administered at a dosage selected to reduce, prevent or eliminate bacterial infection, cancer, or inflammation (Remington's Pharmaceutical Sciences, Mack Publishing Company, Easton, PA; and Goodman and Gilman, Pharmaceutical Basis of Therapeutics, Pergamon Press, New York, NY For a summary of how to administer various antibacterial agents for human therapy, these contents are by reference. Incorporated herein). Controlled release delivery systems (such as capsules) or sustained release delivery systems (such as bioerodable matrices) can be used to deliver the compositions of the invention. Examples of drug delivery delayed release systems suitable for administration of the compositions of the invention (preferably Formula I) are described in US Pat. Nos. 4,452,775 (Kent), 5,239,660 (Leonard), No. 3,854,480 (Zaffaroni).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  (sodium starch glycolate)
</span>
&nbsp;&nbsp;The pharmaceutically acceptable compositions of this application comprise one or two non-toxic pharmaceutically acceptable carriers and / or diluents, collectively referred to herein as carrier materials, and / or Or one or more compounds of the invention related to adjuvants and / or excipients and, if necessary, related to other active ingredients. Such compositions may include common carriers and excipients such as corn starch or gelatin, lactose, sucrose, microcrystalline cellulose, kaolin, mannitol, dicalcium phosphate, sodium chloride and alginic acid. Such compositions may include croscarmellose sodium, microcrystalline cellulose, sodium starch glycolate, and alginic acid.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Possible tablet binders are gum arabic, methylcellulose, sodium carboxymethylcellulose, polyvinylpyrrolidone (Providone), hydroxypropylmethylcellulose, sucrose, starch and ethylcellulose.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  (silicon fluid)
</span>
&nbsp;&nbsp;Lubricants that can be used include magnesium stearate or other metal stearates, stearic acid, silicon fluid, talc, waxes, oils and colloidal silica.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Flavoring agents such as peppermint, winter green oil, cherry flavoring can also be used. It is desirable to add a colorant to create a more beautiful dosage form or to facilitate identification of products containing the compounds of the present invention.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;For oral use, solid preparations such as tablets and capsules are particularly useful. Sustained release formulations or enteric agents may be devised. For administration to children or the elderly, suspensions, syrups and chewable tablets are particularly suitable. For oral administration, the pharmaceutical composition takes the form of, for example, a tablet, capsule, suspension or liquid. The pharmaceutical composition is preferably made in the form of a dosage unit containing a pharmaceutically effective amount of the active ingredient. Examples of such dosage units are tablets and capsules. For treatment, tablets and capsules are shaped into active ingredients, binders such as gum arabic, gelatin, polyvinylpyrrolidone, sorbitol, or tragacanth, calcium phosphate, glycine, lactose, corn starch, sorbitol, or sucrose. Conventional carriers can be included, such as lubricants, lubricants such as magnesium stearate, polyethylene glycol, silica, or talc, tablet disintegrants such as potato starch, flavorings, colorants, or acceptable wetting agents. Oral liquid formulations are generally aqueous or oily solutions, suspensions, emulsions, syrups, or elixirs, suspensions, emulsifiers, water-insoluble agents, preservatives, colorants, and Conventional additives such as flavoring agents may be included. Examples of liquid formulation additives include gum arabic, almond oil, ethyl alcohol, coconut oil, gelatin, glucose syrup, glycerin, hydrogenated edible oil, lecithin, methylcellulose, methyl or propyl para-hydroxybenzoate, propylene glycol, sorbitol or Sorbic acid is included.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  iv
</span>
&nbsp;&nbsp;For intravenous (iv) use, the compounds of the invention can be dissolved or suspended in any of the commonly used intravenous infusions and administered by injection. Intravenous infusion includes, but is not limited to, physiological saline or Ringer's solution.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  <br class="style-scope patent-text">
(Water-for-Injection ())
</span>Parenteral dosage forms can take the form of aqueous or non-aqueous isotonic sterile injection solutions or suspensions. These solutions or suspensions can be prepared from sterile powders or microparticles with one or more carriers as described for use in dosage forms for oral administration. The compound can be dissolved in polyethylene glycol, propylene glycol, ethanol, corn oil, benzyl alcohol, sodium chloride, and / or various buffers. <br class="style-scope patent-text"> For preparation for intramuscular administration, sterile pharmaceutical preparations of the compounds of the invention, or suitable soluble salts forming the compounds, such as water-for-injection (WFI), saline or 5% glucose, etc. And can be administered in a pharmaceutical diluent. A suitable insoluble form of the compound is prepared and administered as a suspension in an aqueous base such as an ester of a long chain fatty acid such as an oleate or a pharmaceutically acceptable oil base. May be.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  (throat paints)
</span>
&nbsp;&nbsp;For topical use, the compounds of the present invention can also be prepared in a form suitable for application to the skin, nose or throat mucosa. It can also take the form of creams, ointments, liquid sprays or inhalants, medicinal drops, or throat paints. These topical dosage forms further include compounds such as dimethyl sulfoxide (DMSO) to facilitate penetration of the active ingredient into the surface.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;For eye or ear use, the compounds of the present invention are liquid or semi-fluid formulated into hydrophobic or hydrophilic bases such as ointments, creams, lotions, smears, powders, etc. It can take on a shape.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;For rectal administration, the compounds of the invention can be administered in the form of suppositories mixed with a conventional carrier such as cocoa butter, wax or other glycerides.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Alternatively, the compounds of the present invention can be in powder form for dissolution in a suitable pharmaceutically acceptable carrier at the time of delivery. In another embodiment, the dosage unit form of the compound may be such that a solution of the compound or salt thereof is added to a suitable sterilized diluent and placed in a sealed ampoule.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  (plant)
</span>
&nbsp;&nbsp;The amount of a compound of the invention in a dosage unit includes an amount effective to treat at least one active compound of the invention, but this will vary with the subject administered, the route of administration and the frequency of administration. The subject of administration refers to plants, cell cultures, or animals such as mammals including sheep or humans.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;With respect to such embodiments of the present invention, the novel compositions disclosed herein are placed in a pharmaceutically acceptable carrier and delivered to an administered subject (including a human subject) according to known drug delivery methods. To do. In general, the methods of the invention for delivering the compositions of the invention in vivo use art recognized drug delivery protocols. The only substantial protocol modification that is made is to replace the compounds of the invention with drugs according to protocols recognized in the art.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Similarly, methods of using the claimed composition to treat cells with media include cells with antibacterial agents, eg, to remove bacterial contamination of the cell culture media or to reduce the level of bacterial contamination. Use art-recognized protocols for processing the media. The only substantial procedural modification that is made is to replace the compounds of the present invention with the drugs used in an art-recognized protocol.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The compounds of the present invention provide methods for treating bacterial infections, pre-cancerous conditions or cancer diseases, and acute or chronic inflammatory diseases. As used herein, the term dosage unit relates to a therapeutically effective amount of a compound of the invention that elicits a desired therapeutic response. As used herein, the phrase therapeutically effective amount refers to preventing, reducing, or stopping progression of a bacterial infection, inflammatory disease, or precancerous or cancerous disease. Means the amount of the compound of the invention. The term treat is effective for the purpose of preventing bacterial infection, inflammation or the development of precancerous or cancerous diseases and controlling or eliminating bacterial infection, inflammation or precancerous or cancerous diseases. Defined as administering to a subject an amount of at least one of the compounds of the invention. The term desired therapeutic response relates to treating a patient with a compound of the invention such that the patient's bacterial or inflammatory disease, or pre-cancerous or cancerous disease is reversed, inhibited or prevented. .
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  <br class="style-scope patent-text">

</span>The compounds of the invention can be administered once or several times daily. Treatment regimens may require administration over extended periods such as days or 2-4 weeks. A single dose or total dose will vary depending on the type or extent of the condition, the age and general health of the subject, the tolerance of the subject to the compound and the type of bacterial infection or inflammatory disease, or the type of cancer. . <br class="style-scope patent-text"> The compounds according to the invention may be administered to the diet or feed of a patient or animal. The animal diet can be a normal diet to which the compound can be added, or the compound can be added to the premix.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The compounds of the present invention may be taken in combination with or separately from known clinically approved antibiotics, inflammatory agents or anticancer agents to treat patients in need of treatment. May be.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
VII.  <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  
</span>VII. <u class="style-scope patent-text">Method for Inhibiting Tumor Growth In</u> another embodiment, the present invention relates to a method for inhibiting tumor growth. The compounds described herein can have antitumor activity. The compounds are directed against mammalian tumor cells such as leukemia cells, melanoma cells, breast cancer cells, lung cancer cells, pancreatic cancer cells, ovarian cancer cells, kidney cancer cells, colon cancer cells, prostate cancer cells, and glioma cells. It is valid. Tumor cells are inhibited by the antitumor method of the present invention. The term inhibition, when used in conjunction with an anti-tumor method, relates to tumor cell suppression, death, quiescence, or destruction. Anti-tumor methods preferably prevent, reduce or eliminate tumor cell invasion activity and related metastases. The term effective amount when used in conjunction with an anti-tumor method relates to the amount of compound sufficient to inhibit mammalian tumor cells.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Inhibition of mammalian tumor growth by this method can be observed in several ways. First, tumor cells grown in vitro with the compound can be treated and observed to grow or die compared to the same cells cultured without the compound. A cessation of growth or a slowing (ie, doubling) of the growth rate, eg, by more than 10%, indicates that the tumor cells have been inhibited. Alternatively, tumor cell inhibition can be observed by administering the compound to an animal model of the tumor of interest. Experimental animal tumor models are known in the art and are described in the Examples herein. Tumor growth ceases (ie, does not increase in size further) or tumor size in animals treated with the compounds described herein compared to control animals not treated with the compound A decrease in either (ie, tumor volume) or cell number (eg, at least a 10% reduction) indicates that tumor growth has been inhibited.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  <br class="style-scope patent-text">

</span>To observe the effectiveness of tumor treatment in humans, measure tumor size or tumor cell titer before and after initiation of treatment, and either tumor size or tumor cell titer has not grown further Or if the tumor size or tumor cell value is at least 10% or more (eg 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90% or 100%) If (decrease) decreases, the treatment is considered effective. Methods for measuring tumor size or tumor cell value in vivo vary with the type of tumor and include not only histological techniques and flow cytometry, but also, for example, the field of medical imaging or medical oncology Various imaging techniques (MRI, CAT, PET, etc.) known to those skilled in the art are included. <br class="style-scope patent-text"> With respect to the antitumor methods of the present invention, the effective dosage of the compound administered orally or parenterally is generally about 5 to about 100 mg / kg of the subject's body weight, and the daily dosage Is about 15 to about 300 mg / kg of the subject's body weight.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
VIII.  <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  <sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub>(ischemic neuronal injury)<sub class="style-scope patent-text"></sub>(hapatoxic agent)
</span>VIII in. <u class="style-scope patent-text">How</u> another embodiment <u class="style-scope patent-text">inhibition of lipoxygenase,</u> the present invention is a mammal, in particular diseased condition of the human patient, in particular 5-lipoxygenase system and / or leukotriene B <sub class="style-scope patent-text">4</sub> and leukotriene C <sub class="style-scope patent-text"> <sub class="style-scope patent-text"> <sub class="style-scope patent-text">4,</sub> </sub> </sub> D <sub class="style-scope patent-text">4,</sub> E <sub class="style-scope patent-text">4</sub> and method of treating inflammation caused by the synthesis of F <sub class="style-scope patent-text">4</sub> is also provided. Such methods include administering to the patient an effective amount of ECO-04601. Compound ECO-04601 may be used alone to treat or prevent morbidity related to inflammation, including pulmonary abnormalities, inflammation, cardiovascular abnormalities, central nervous system abnormalities or skin abnormalities. It may be used in combination with an inflammatory compound. More specific diseases include gastritis, erosive esophagitis, inflammatory bowel disease, hemorrhagic erosion due to ethanol, liver ischemia, ischemic neuronal injury, liver due to harmful substances, pancreas, kidney, failure or neuronal necrosis or myocardial tissue, CCl <sub class="style-scope patent-text">4</sub> and D- galactosamine like liver harmful substances by (hapatoxic agent) liver parenchyma disorders, ischemic renal failure, liver damage due to disease, trauma or stress due to cell damage, asthma , Multiple sclerosis, ischemia reperfusion, edema, rheumatoid arthritis, viral encephalitis, bacterial pneumonia, neurodegeneration, Alzheimer's disease and renal failure due to glycerol.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;For the methods of the invention relating to the 5-lipoxygenase system and / or leukotriene biosynthesis, an effective dosage of ECO-04601 administered orally or parenterally is generally about 5 to about the body weight of the subject. 100 mg / kg, and the daily dose is about 15-300 mg / kg of the subject's body weight.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Inhibition of the lipoxygenase enzyme is observed by methods known in the art, as described in the examples herein. A decrease in enzyme activity of at least 10% compared to the activity without the compounds described herein indicates that lipoxygenase activity is effectively inhibited.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  (leukocyte exudation)(Robbins et al., Pathologic Basis of Disease, 6<sup class="style-scope patent-text">th</sup> Ed., W.B. Saunders Co., Philadelphia, PA)
</span>Useful farnesyl dibenzodiazepinone compounds according to the present invention can be used to reduce or prevent inflammation. Prominent features of local acute inflammation include fever, redness, swelling, pain and loss of function. Many of these changes are induced by changes in blood flow, vascular inner diameter, vascular permeability and leukocyte exudation (Robbins et al., Pathologic Basis of Disease, 6 <sup class="style-scope patent-text">th</sup> Ed., WB Saunders Co., Philadelphia, PA). Anti-inflammatory therapies performed with the useful compounds of the present invention can observe the success of the treatment by following any of these changes. For example, reduced swelling (eg, at least 10% reduction after treatment), or reported pain (eg, 10 most severe pain felt before treatment in connection with the disease, 0 if no pain) In steps 1-10, the pain reported by the patient can be used to indicate a successful treatment using a sustained decrease of 1 point or more.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Other measurable inflammatory features include leukocyte wetting and inflammatory cytokine levels. These features can be observed by biopsy of the affected tissue. A leukocyte wetting in fixed and colored tissue is reduced by more than 10% compared to wetting in similar tissue prior to treatment, indicating that the treatment is effective. Similarly, if the level of a given inflammatory cytokine is reduced by 10% or more compared to the pre-treatment level, this indicates that the treatment is effective. One skilled in the art can readily analyze the levels of inflammatory cytokines in tissue, blood, or other fluid samples. Alternatively, systemic inflammation indicator levels such as C-reactive protein levels and erythrocyte sedimentation rates can be observed. Each of these establishes a normal range of drug, and after one or more of these indicators change from an abnormal range to a normal range after the start of treatment, the treatment is considered successful.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">IX. </u> <br class="style-scope patent-text">
  
</span> <u class="style-scope patent-text">IX. Methods of Inhibiting Bacterial Growth In</u> another embodiment, the invention relates to a method of treating a bacterial infection in a mammalian subject in need of treatment. Such methods comprise administering to the mammal a therapeutically effective amount of a compound described herein, Compound ECO-04601, or a pharmaceutically acceptable derivative or prodrug thereof.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;In another embodiment, the present invention provides a method for reducing the amount of bacteria in a biological sample. Such methods comprise contacting a biological sample with ECO-04601, a compound described herein, or a pharmaceutically acceptable derivative or prodrug thereof. At least 10%, preferably more than 10% after contacting the biological sample with compound ECO-04601, or a pharmaceutically acceptable derivative or prodrug thereof, which is a compound described herein. Such a method is effective when the bacterial count is reduced by, for example, 25%, 50%, or even 100%.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;ECO-04601, a compound described herein, or a pharmaceutically acceptable derivative or prodrug thereof, and a pharmaceutically acceptable carrier in an amount sufficient to determine a reduction in bacterial mass. These pharmaceutical compositions effective for treating or preventing bacterial infections are another embodiment of the present invention. As used herein, the term sufficient to measure a reduction in bacterial load means a measurable change in the number of bacteria between a sample with an inhibitor and a sample without an inhibitor.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  /Vaara, M. in Microbiological Reviews (1992) pp. 395-411Tsubery, H., et al, in J. Med. Chem. (2000) pp. 3085-3092
</span>
&nbsp;&nbsp;Agents that increase the susceptibility of bacterial organisms to antibiotics are known. For example, US Pat. No. 5,523,288, US Pat. No. 5,783,561 and US Pat. No. 6,140,306 are sterilized to increase the antibiotic susceptibility of gram positive and gram negative bacteria. Describes a method of using enhanced permeability / permeability protein (BPI). Agents that increase the permeability of the outer membrane of bacterial organisms are described in Vaara, M. in Microbiological Reviews (1992) pp. 395-411, and sensitization of gram-negative bacteria is described in Tsubery, H., et al, in J. Med. Chem. (2000) pp. 3085-3092.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Effectiveness of Compound ECO-04601 described herein, or a pharmaceutically acceptable derivative or prodrug thereof, administered orally or parenterally with respect to the methods of the invention for the treatment of subjects infected with bacteria A typical dosage is about 5 to about 100 mg / kg of the subject's body weight, and a daily dosage is about 15 to 300 mg / kg of the subject's body weight.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Another preferred embodiment of the invention relates to a method of treating a bacterial infection in a mammal in need of treatment, as described above. However, such embodiments further comprise the step of administering to the mammal an agent that enhances the susceptibility of the bacterial organism to the antibiotic.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;According to another preferred embodiment, the present invention provides a method for reducing the amount of bacteria in a biological sample, as described above. However, such embodiments further comprise contacting the biological sample with an agent that enhances the susceptibility of the bacterial organism to antibiotics.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;After contacting the biopsy sample with compound ECO-04601, a pharmaceutically acceptable derivative or prodrug thereof, which is a compound described herein, at least 10%, preferably more than 10%, such as 25 When the number of bacteria decreases, such as%, 50%, 75%, or 100%, a method of reducing the amount of bacteria is effective.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Streptococcus pneumoniaeStreptococcus pyrogenesEnterocuccus facalisEnterococcus faeciumKlebsiella pneumoniaeEnterobacter spp., Proteus spp., Pseudomonas aeruginosaE.coliSerratia marcesensStaphylococcus aureusCoagulase negative StaphylococcusHaemophilus infuenzaeBacillus anthracisMycroplasma pneumoniaeStaphylococcus epidermidis
</span>
&nbsp;&nbsp;The pharmaceutical compositions and methods of the invention are generally useful for controlling bacterial infection in vivo. Examples of bacterial organisms that may be controlled with the compositions and methods of the present invention include Streptococcus pneumoniae, Streptococcus pyrogenes, Enterocuccus facalis, Enterococcus faecium, Klebsiella pneumoniae, Enterobacter spp., Proteus spp., Pseudomonas aeruginosa, E .coli, Serratia marcesens, Staphylococcus aureus, Coagulase negative Staphylococcus, Haemophilus infuenzae, Bacillus anthracis, Mycroplasma pneumoniae and Staphylococcus epidermidis. Thus, the compositions and methods are effective in controlling, treating or reducing the progression, extent, or impact of nosocomial or out-of-hospital infections. In-hospital use includes, but is not limited to, patients with urethral infection, pneumonia, surgical wound infection, bacteremia, and febrile neutropenia. Out-of-hospital use includes, but is not limited to, ureteral infections, pneumonia, prostatitis, skin infections, soft tissue infections, and intraperitoneal infections.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;In addition to the compounds of the present invention, the pharmaceutically acceptable derivatives or prodrugs of the present invention may be used in compositions for treating or preventing the above-mentioned diseases.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Pharmaceutically acceptable derivative or prodrug means a pharmaceutically acceptable salt, ester, ester salt or other derivative of a compound of the invention when administered to a receptor. The compounds of the present invention or inhibitory active metabolites or residues thereof can be provided directly or indirectly. When these compounds are used in mammals (eg, by making the orally administered compound more readily absorbed into the blood) or compared to the parent species, the compound is in a biological compartment (eg, brain A particularly preferred derivative or prodrug when enhancing the transmission of the parent compound to the lymphatic system) is a derivative or prodrug that increases the bioavailability of the compound of the invention.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  <br class="style-scope patent-text">
<sub class="style-scope patent-text"></sub>
</span>Pharmaceutically acceptable prodrugs of the compounds of this invention include, without limitation, esters, amino acid esters, phosphate esters, metal salts and sulfate esters. <br class="style-scope patent-text"> Unless indicated otherwise, all numbers indicating molecular weights, reaction conditions, material amounts or attributes such as IC <sub class="style-scope patent-text">50</sub> used in the specification and claims are modified by the word about in all examples. It will be understood. Accordingly, unless indicated to the contrary, the numerical variables set forth in this specification and the appended claims are approximations. Rather than trying to limit the application of the doctrine to the claims, each numeric variable must be interpreted at least using the usual rounding technique and in light of the number of significant figures. . The numerical ranges and numerical variables indicating the wide range of the present invention are approximate values, but the numerical values shown in the examples, tables and figures are described as accurately as possible. Every numerical value inherently contains certain errors resulting from variability in experiments, test measurements, statistical analysis, etc.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although methods and materials similar or equivalent to those described in the present invention can be used in the practice or testing of the present invention, suitable methods and materials are described below. All publications, patent applications, patents and other references cited herein are hereby incorporated by reference in their entirety. In case of conflict, the present specification, including definitions, will control. In addition, the materials, methods, and examples are illustrative only and not intended to be limiting.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
Sigma Chemical(St. Louis, MO), (Aldrich)Micromonospora spp.(Difco Laboratories, Detroit, MI)<sub class="style-scope patent-text"></sub>Micromonospora spp.(production phase)<sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub>
</span> <u class="style-scope patent-text">Example</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">Example 1: Production culture preparation</u> All reagents were purchased from Sigma Chemical (St. Louis, MO), (Aldrich) unless otherwise stated. Micromonospora spp. (IDAC deposit accession number 070303-01) was maintained on an agar plate of ISP2 agar (Difco Laboratories, Detroit, MI). A 125 mL flask containing 24 mL of potato dextrin, 3 g of beef extract, 5 g of bactocaditone, 5 g of glucose, 5 g of yeast extract, and 4 g of CaCO <sub class="style-scope patent-text">3</sub> , and containing 25 mL of sterile medium (pH 7.0) made up to 1 liter by adding distilled water, A production phase inoculum was prepared by transferring Micromonospora spp. Grown on the surface from an agar plate. The culture was cultured on a rotary shaker set at 250 rpm for about 60 hours at about 28  C. After culturing, sterility at pH 7.0 containing 20 g / L of potato dextrin, 20 g / L of glycerol, 10 g / L of fish meal, 5 g / L of bactopeptone, 2 g / L of CaCO <sub class="style-scope patent-text">3 and</sub> 2 g / L of (NH <sub class="style-scope patent-text">4</sub> ) <sub class="style-scope patent-text">2</sub> SO <sub class="style-scope patent-text">4</sub> 10 mL of the culture was transferred to a 2 L baffle flask containing 500 mL of production medium. The production culture was cultured at 28  C. for 1 week in a rotary shaker set at 250 rpm to prepare a fermentation broth.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
<sub class="style-scope patent-text"></sub>
</span> <u class="style-scope patent-text">Example 2: Isolation To</u> 500 mL of fermentation broth prepared as described in Example 1 above, 500 mL of ethyl acetate was added. The mixture was stirred for 30 minutes with a 200 rpm orbital shaker to prepare an emulsion. The layers were separated by centrifugation and decanting. 4-5 g of anhydrous MgSO <sub class="style-scope patent-text">4</sub> was added to the organic layer, then filtered and the solvent removed in vacuo.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;A 2 L fermented ethyl acetate extract and HP-20 resin (100 mL; Mitsubishi Kasei, Tokyo, Japan) were mixed in water (300 mL). The ethyl acetate was removed in vacuo, the resin was filtered through a Buchner funnel and the filtrate was discarded. The absorbed HP-20 resin was then washed twice with 125 mL 50% acetonitrile, twice with 125 mL 75% acetonitrile, each in water, and then twice with 125 mL acetonitrile.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  II(Kromaton Technologies, Angers, France)IIKieselgel<sub class="style-scope patent-text"></sub>IIII
</span>The fraction containing the compound represented by Formula II was evaporated to dryness, and 100 mg was digested in 5 mL of the upper layer of a mixture prepared from chloroform, cyclohexane, methanol and water at a volume ratio of 5: 2: 10: 5. did. A 200 mL cartridge was attached and the sample was pre-filled in the upper layer of a bilayer system, a high-speed countercurrent (HSCC) system (Kromaton Technologies, Angers, France), and centrifugal partition chromatography was performed using such a system. HSCC was performed in a low mobile phase and the compound of formula II was eluted at approximately half the column volume. Fractions were collected and the compound of formula II was detected by TLC on aliquots of fractions on commercially available Kieselgel 60F <sub class="style-scope patent-text">254</sub> plates. By inspecting the dried plate under UV light or by spraying the plate with a spray containing vanillin (0.75%) and concentrated sulfuric acid (1.5%, v / v) in ethanol, followed by The compound could be visualized by heating the plate. The fraction, although highly colored, contained very pure compound of formula II. A light tan sample could be obtained by high performance liquid chromatography (HPLC) as follows.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
    )WatersMilford, MA<sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub>
</span>6 mg of the sample was dissolved in acetonitrile, and injected into a preparative HPLC column (XTerra ODS (10 m), 19  150 mm, Waters, Milford, Mass.) At a flow rate of 9 mL / min and UV peak detection of 300 nm. The column was eluted with acetonitrile / buffer (20 mM NH <sub class="style-scope patent-text">4</sub> HCO <sub class="style-scope patent-text">3</sub> ) with the following gradient shown in Table 1.</span>
    </p>
    <p class="style-scope patent-text">
      <tables num="1" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </tables>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
II
</span>
Fractions containing the compound of Formula II were eluted at about 11: 0 minutes, mixed, concentrated and lyophilized to give a yield of 3.8 mg of compound.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  II<sub class="style-scope patent-text"></sub>
</span> <u class="style-scope patent-text">Alternative protocol 1</u> <br class="style-scope patent-text"> The compound of formula II was isolated according to the following alternative protocol. At the end of the culture period, the fermentation broth of the baffle flask of Example 1 was centrifuged and the supernatant was decanted from the pellet containing the bacterial mycelium. 100 mL of 100% MeOH was added to the mycelium pellet and the sample was stirred for 10 minutes and centrifuged for 15 minutes. The methanol supernatant was decanted and set aside. Next, 100 mL of acetone was added to the mycelium pellet, stirred for 10 minutes, and then centrifuged for 15 minutes. The acetone supernatant was decanted and mixed with the methanol supernatant. Finally, 100 mL of 20% MeOH / H <sub class="style-scope patent-text">2</sub> O was added to the mycelium pellet, stirred for 10 minutes, and centrifuged for 15 minutes. The supernatant was mixed with the acetone supernatant and the methanol supernatant.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  <sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub>
</span>The mixed supernatant was added to 400 mL of HP-20 resin in 1000 mL of water and the organics were removed in vacuo. The resulting slurry was filtered through a Buchner funnel and the filtrate was discarded. The absorbed HP-20 resin was washed in succession twice with 500 mL 50% MeOH / H <sub class="style-scope patent-text">2</sub> O, twice with 500 mL 75% MeOH / H <sub class="style-scope patent-text">2</sub> O, and twice with 500 mL MeOH.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  II  )Waters Milford, MA
</span>
&nbsp;&nbsp;Each wash was collected separately and analyzed by TLC as described above. These fractions containing the compound of formula II were evaporated to near dryness and lyophilized. The lyophilized product was dissolved in methanol and injected into a preparative HPLC column (XTerra ODS (10 m), 19  150 mm, Waters, Milford, Mass.) At a flow rate of 9 mL / min and ultraviolet peak detection at 300 nm.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
<sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub>
</span>The column was eluted with acetonitrile / buffer (5 mM NH <sub class="style-scope patent-text">4</sub> HCO <sub class="style-scope patent-text">3</sub> ) with the gradient shown in Table 2.</span>
    </p>
    <p class="style-scope patent-text">
      <tables num="2" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </tables>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
II
</span>
Fractions containing the compound of formula II were combined, concentrated and lyophilized to yield approximately 33.7 mg of compound.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  <sub class="style-scope patent-text"></sub>
</span> <u class="style-scope patent-text">Alternative protocol 2</u> <br class="style-scope patent-text"> Extract 10 liters of the total broth from Example 1 twice with an equal volume of ethyl acetate, mix the two extracts and condense to dryness. Weigh the dried extract and add 100 mL MeOH-H <sub class="style-scope patent-text">2</sub> O (2: 1, v / v) and 100 mL hexane per gram of dry extract. Stir the mixture gently and dissolve. Separate the two layers and wash the aqueous layer with 100 mL of hexane. The two hexane layers are mixed and the combined hexane solution is washed with 100 mL methanol: water (2: 1, v / v). Mix two layers of methanol: water and treat with 200 mL EtOAc and 400 mL water. The layers are separated and the aqueous layer is extracted two more times with 200 mL portions of EtOAc. Mix the EtOAc layers and condense. The resulting residue is suitable for final purification using either HSCC or HPLC as described above. According to this extraction process, 10 times more accuracy is obtained compared to the extraction protocol used above.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">II</u> <br class="style-scope patent-text">
  II
</span> <u class="style-scope patent-text">Example 3: Elucidation of the structure of the compound represented by Formula II The structure of the</u> compound represented by Formula II was derived from spectroscopic data including mass spectrometry, UV (ultraviolet absorption) and NMR (nuclear magnetic resonance) spectroscopy. did. It was measured by electrospray mass spectrometry that the mass was 462.6 (FIG. 1), the maximum ultraviolet ray amount was 230 nm, and the shoulder was 290 nm (FIG. 2). The NMR data dissolved in MeOH-d4 containing protons was collected (Fig. 3), and the multidimensional pulse sequenced gDQCOSY (Fig. 4), gHSQC, (Fig. 5), gHMBC (Fig. 6) and NOESY (Fig. 7). is doing.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The number of cross peaks in the two-dimensional spectrum of ECO-04601 is a clue in determining the structure. For example, in a gHMBC experiment, the farnesyl chain is placed on the amide nitrogen by a strong cross peak between 4.52 ppm of the methylene proton signal at the farnesyl chain end and 170 ppm of the amide carbonyl carbon. This conclusion is evidenced by the NOESY Spectra cross-peak between the same methylene signal of 4.52 ppm and the aromatic proton signal of 6.25 ppm with one of the tetra protons replaced with a benzenoid ring. The
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  II
</span>
&nbsp;&nbsp;Based on mass spectrometry, UV and NMR data, the structure of the compound was determined to be that of formula II.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  (Methods for Dilution Antimicrobial Susceptibility Test for Bacteria That Grow Aerobically; Approved Standard-Fifth Edition. NCCLS document M7-A5 (ISBN 1-56238-394-9). NCCLS, 940 West Valley Road, Suite 1400 Wayne, Pennsylvania 19087-1898 USA) Bacillus subtilisMicrococcus luteus
</span> <u class="style-scope patent-text">Example 4: Antibacterial activity (determination of minimum inhibitory concentration)</u> <br class="style-scope patent-text"> The minimum inhibitory concentration (MIC) is defined as the lowest concentration of an agent that inhibits more than 99% of the bacterial count. Methods for Dilution Antimicrobial Susceptibility Test for Bacteria That Grow Aerobically; Approved Standard-Fifth Edition.NCCLS document M7-A5 (ISBN 1-56238-394-9). NCCLS, 940 West Valley Road, Suite 1400 Wayne, Pennsylvania 19087-1898 USA) was used to determine the MIC of ECO-04601 against bacterial strains (Bacillus subtilis-ATCC 23857, Micrococcus luteus-ATCC 9341).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u>
</span> <u class="style-scope patent-text">Test compound preparation:</u> Test substance ECO-04601 is prepared as a 100-fold stock solution in DMSO with a concentration range of 3.2 mg / ml to 0.0625 mg / ml (2-fold serial dilution greater than 10 points). 0.5 mg of each test substance was resuspended in 156.25 l DMSO to prepare a first dilution (3.2 mg / ml). The stock solution is then serially diluted by 2-fold attenuation to obtain the desired concentration range.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u>(Bacillus subtilis; Micrococcus luteus)McFarland<sup class="style-scope patent-text"></sup>
</span> <u class="style-scope patent-text">Inoculum adjustment: From</u> overnight cultures in Muller Hilton (MH) broth, the cell density of each indicator strain (Bacillus subtilis; Micrococcus luteus) was adjusted to 0.5 McFarland units in 0.85% saline, followed by Was further diluted 1/100 with the appropriate assay medium (1  10 <sup class="style-scope patent-text">6</sup> cells / ml).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u>
</span> <u class="style-scope patent-text">MIC determination:</u> 100-fold ECO-04601 solution was diluted 50-fold with MH broth and dispensed into 96-well plates. One test concentration per column of well, for a total of 10 columns. The eleventh column of the well contained MH broth containing 1% DMSO, and the twelfth column of the well contained 100 l of broth alone. A final cell dilution of 50 l of each indicator strain was added to each corresponding well of a microplate containing 50 l of diluted drug or medium alone. The assay plate was incubated at 35  C. for 24 hours.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;As shown in Table 3, the MIC results for compound ECO-04601 represent a range of antibacterial effects.
</span>
    </p>
    <p class="style-scope patent-text">
      <tables num="3" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </tables>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text"> <u class="style-scope patent-text"></u><sub class="style-scope patent-text"></sub>
</span> <u class="style-scope patent-text">Example 5: In vitro anti-cancer activity against human and animal tumor cell lines of various tissues</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">Culture conditions</u> : The cell lines listed in Table 4 were used to characterize the cytotoxicity of ECO-04601 against human and animal tumor cell lines. These cell lines were found not to be infected with mycoplasma and were added to a suitable medium (Table 4) supplemented with 10% heat-inactivated fetal calf serum and 1% penicillin streptomycin under 5% CO <sub class="style-scope patent-text">2</sub> at 37  C. Maintained at  C. Cells were subcultured 2 to 3 times per week. Viability was examined by coloring with 0.25% trypan blue and only flasks with cell viability&gt; 95% were used in this study.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u><sup class="style-scope patent-text"></sup><sub class="style-scope patent-text"></sub>
</span> <u class="style-scope patent-text">Cell line amplification and plating</u> : 96-well flat bottom microtiter plates seeded with tumor cells (1-3  10 <sup class="style-scope patent-text">3</sup> cells per 100 L), 5% in medium without drug supplemented with 10% serum Incubate at 37  C. for 16 hours under CO <sub class="style-scope patent-text">2</sub> before treatment.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub>
</span> <u class="style-scope patent-text">Evaluation of inhibitory activity on cell proliferation</u> : The cells were cultured for 96 hours at a concentration of 6 log <sub class="style-scope patent-text">10</sub> times the test substance starting from 10 g / ml (20 M). A stock solution of the test substance (5 mg / mL) was previously diluted 1/70 times in a medium supplemented with serum. Similarly, other concentrations were obtained by serially diluting 1/10 times with supplemented medium. Cell viability was assessed after 96 hours by replacing the medium with 150 l of fresh medium containing 10 mM 4- (2-hydroxyethyl) -1-piperazineethanesulfonic acid buffer at pH 7.4. Next, 50 L of 2.5 mg / mL 3- (4,5-dimethylthiazo-2-yl) -2,5-diphenyltetrazolium bromide (MTT) at pH 7.4 in phosphate buffer was added. Three to four hours after culturing at 37  C., the medium and soluble MTT were removed, 200 L of dimethyl sulfoxide was added to dissolve the reduced MTT precipitate, and then glycine buffer (glycine 0.1 M + NaCl 0 .1M, pH 10.5) 25 L was added. Absorbance was measured at 570 nm using a microplate reader. Results were expressed as the concentration of drug that inhibits 50% of cell growth (IC <sub class="style-scope patent-text">50</sub> ). The IC <sub class="style-scope patent-text">50</sub> values shown in Table 4 indicate the pharmaceutically significant cytotoxic activity of ECO-04601 against various tumor types such as leukemia, melanoma, pancreatic cancer and breast cancer.</span>
    </p>
    <p class="style-scope patent-text">
      <tables num="4" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </tables>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  <sub class="style-scope patent-text"></sub>Bethesda, Maryland, USA
</span> <u class="style-scope patent-text">Example 6:</u> To determine the concentration of ECO-04601 required to obtain 50% inhibition (CI <sub class="style-scope patent-text">50</sub> ) <u class="style-scope patent-text">of anticancer active</u> cell proliferation in <u class="style-scope patent-text">vitro against various human tumor cell lines of the National Cancer Institute panel</u> . A study to measure the in vitro anticancer activity of ECO-04601 against a panel of human cancer cell lines was conducted by the National Cancer Institute (National Institutes of Health, Bethesda, Maryland, USA). This unique screening procedure uses leukemia, melanoma, and 50 different human tumor cell lines represented by lung cancer, colon cancer, brain cancer, ovarian cancer, breast cancer, prostate cancer, and kidney cancer.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  
</span> <u class="style-scope patent-text">Culture conditions and plating:</u> <br class="style-scope patent-text"> The human tumor cell line of the cancer screening panel was cultured in a RPMI 1640 medium containing 5% fetal bovine serum and 2 mM L-glutamine. For a typical screening experiment, cells were seeded in 100 L 96-well microtiter plates at a concentration of 5000 to 40,000 cells / well depending on the doubling time of each cell line (Table 5). After seeding, before adding the experimental drug, the microtiter plate was incubated at 37  C. for 24 hours at 5%, air 95%, and relative humidity 100%. Twenty-four hours later, two plates of each cell line were fixed in situ using TCA to show a measurement of the number of cells in each cell line at the time of drug addition (Tz).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  <sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup>
</span> <u class="style-scope patent-text">Evaluation of inhibitory activity on cell proliferation:</u> <br class="style-scope patent-text"> ECO-04601 was provided as a lyophilized powder with an estimated purity of 90 +%. The compound was stored at 20  C. until the day of use. ECO-04601 was solubilized in dimethyl sulfoxide 400 times the desired final maximum test concentration. At the time of drug addition, aliquots of frozen concentrated material were thawed and diluted to 2 times the desired final maximum test concentration in complete medium containing 50 g / mL gentamicin. Further, serial dilutions of 4 times, 10 times or 1/2 log were performed to obtain a total of 5 drug concentrations and controls. 100 l aliquots of these different drug dilutions were added to appropriate microtiter wells already containing 100 l of media, resulting in the required final drug concentration (from 8.0  10 <sup class="style-scope patent-text">5</sup> M to 8. 0  10 <sup class="style-scope patent-text">9</sup> M).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  <sub class="style-scope patent-text"></sub>(Sulforhodamine) Btrizma base
</span>Following drug addition, the plates were incubated for an additional 48 hours at 37  C., 5% CO <sub class="style-scope patent-text">2</sub> , 95% air, and 100% relative humidity. For adherent cells, the assay was terminated by adding cold TCA (trichloroacetic acid). Cells were fixed in situ by gently adding 50 l of cold 50% (w / v) TCA (final concentration, 10% TCA) and incubated for 60 minutes at 4  C. The supernatant was discarded and the plate was washed 5 times with tap water and air dried. 0.4% (w / v) Sulforhodamine B (SRB) solution (100 l) in 1% acetic acid was added to each well and the plate was incubated at room temperature for 10 minutes. After coloring, it was washed 5 times with 1% acetic acid to remove unbound dye and the plate was air dried. Subsequently, the bound stain was solubilized with 10 mM trizma base, and the absorbance was read at a wavelength of 515 nm using an automatic plate reader. For suspended cells, the procedure was the same except that 50 l of 80% TCA (final concentration, TCA 16%) was gently added to fix the established cells to the bottom of the wells and terminate the assay.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  <sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub>
</span>The growth inhibitory activity of ECO-04601 was measured by GI <sub class="style-scope patent-text">50</sub> values using NCL instead of conventional IC <sub class="style-scope patent-text">50</sub> values. The GI <sub class="style-scope patent-text">50</sub> value emphasizes the correction of the cell number at zero, with seven absorbance measurements ((zero (Tz), control growth (C), and in the presence of five concentration levels of the drug). GI <sub class="style-scope patent-text">50</sub> is calculated as [(TiTz) / (CTz)]  100 = 50, which is the net protein increase in control cells during drug culture. Drug concentration (measured by SRB staining) resulting in a 50% reduction.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">

</span> <u class="style-scope patent-text">result:</u> <br class="style-scope patent-text"> As revealed by NCL screening, ECO-04601 shows significant anti-tumor activity against several types of tumors. The results of the screening are shown in Table 5, and more detailed results regarding the activity against glioma are shown in Example 7 (Table 6).</span>
    </p>
    <p class="style-scope patent-text">
      <tables num="5" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </tables>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;The results show that ECO-04601 was effective against most of the human tumor cell lines analyzed in the NCI screening panel, with broad anti-cancer against several types of human cancers Activity is suggested.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  <sub class="style-scope patent-text"></sub>
</span> <u class="style-scope patent-text">Example 7: In vitro anti-proliferative studies on a panel of glioma cell lines As</u> shown in Table 6, the panel of glioma cancer cell lines was used to evaluate the anti-cancer activity of ECO-04601 and 50% of cell proliferation. Inhibition (IC <sub class="style-scope patent-text">50</sub> ) was measured.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  <sub class="style-scope patent-text"></sub>
</span> <u class="style-scope patent-text">Culture conditions:</u> <br class="style-scope patent-text"> The cell lines listed in Table 6 appear to be not infected with mycoplasma, DMEM medium supplemented with 10% heat-inactivated fetal calf serum and 1% penicillin streptomycin at 37  C. under 5% CO <sub class="style-scope patent-text">2</sub> (Table 4). Maintained. Cells were subcultured once a week. Prior to use, such cells were counted from the culture flasks by treatment with trypsin for 5-10 minutes and examined for viability by the 0.25% trypan blue exclusion method. Only flasks with cell viability&gt; 95% were used for this study.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  <sup class="style-scope patent-text"></sup>
</span> <u class="style-scope patent-text">Cell line amplification and plating:</u> <br class="style-scope patent-text"> In 100 L of medium containing no drug and supplemented with 10% serum, 5  10 <sup class="style-scope patent-text">3</sup> cells per well were seeded in 96-well flat bottom microtiter plates and cultured at 37  C. for 48 hours before treatment. .</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u><br class="style-scope patent-text">
  (triplicate well)
</span> <u class="style-scope patent-text">Assessment of inhibitory activity on cell proliferation</u> : <br class="style-scope patent-text"> These cells (in triplicate wells) were cultured for 96 hours in media containing different concentrations of ECO-04601 starting at 5.0 g / ml (10 M). The compound was used in 1% DMSO solution in D-MEN or RPMI medium (or other equivalent medium). The concentrations of ECO-04601 are 10 M (5.0 g / ml), 1 M (0.50 g / ml), 0.5 M (0.25 g / ml), 0.1 M (0.050 g / ml), 0.5 M. (0.025 g / ml), 0.01 M (0.0050 g / ml), and 0.001 M (0.00050 g / ml). Cells treated with vehicle alone (1% DMSO in medium) served as negative controls. Cells treated with cisplatin (CDDP) at increasing concentrations of 4 to 6 served as positive controls (data not shown). In order to measure the growth rate of each cell line, the optical density of the culture was measured before the culture (0 hour) and during the subsequent 96 hours of culture with the test compound.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  <sub class="style-scope patent-text"></sub>
</span>At the end of the treatment, the cell medium was replaced with 150 l of fresh medium containing 10 mM of pH 7.4 4- (2-hydroxyethyl) -1-piperazineethanesulfonic acid buffer. Next, 50 l of 2.5 mg / ml of 3- (4,5-dimethylthiazo-2-yl) -2,5-diphenyltetrazolium bromide at pH 7.4 in PBS is added to each well and the culture plate is left for 4 hours. Cultured at 37  C. The resulting supernatant was removed and formazan crystals were dissolved in 200 l DMSO followed by 25 l glycine buffer (glycine 0.1 M + NaCl 0.1 M, pH 10.5). The optical density of each well was read at 570 nm using a single wavelength spectrophotometer plate reader. Results were expressed as the concentration of drug that inhibits cell growth by 50% (IC <sub class="style-scope patent-text">50</sub> ). Each cell line was tested in at least 3 independent experiments.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  IV
</span>
&nbsp;&nbsp;The results shown in Table 6 confirmed the activity of ECO-04601 against different brain cancer cell lines including the most malignant type of glioblastoma of the type IV pleomorphic glioblastoma. Gliosarcoma is a combination of glial cells and endothelial cells and is resistant to any chemotherapy.
</span>
    </p>
    <p class="style-scope patent-text">
      <tables num="6" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </tables>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">

</span> <u class="style-scope patent-text">Example 8 Effect of Human Lipoxygenase (5-LO) on Enzymatic Activity</u> 5-Lipoxygenase catalyzes the oxidative metabolism of arachidonic acid to 5-hydroxyeicosatetraenoic acid (5-HETE). In this initial reaction, leukotriene is formed. Eicosanoids generated from arachidonic acid by the action of lipoxygenase or cycloxygenase are not only various carcinogenic steps including neurodegeneration (Alzheimer's disease), aging and tumor promotion, progression, metastasis, but also acute inflammatory diseases and chronic inflammation It has been found to be involved in disease (ie, asthma, multiple sclerosis, rheumatoid arthritis, ischemia, edema).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Carter et al (1991) J.Pharmacol. Exp. Ther. 256(3):929-937Safayhi (2000), Planta Medica 66:110-113
</span>
&nbsp;&nbsp;The task of this study is to confirm whether ECO-04601 can prevent the formation of leukotrienes by inhibiting the enzyme activity of human 5-LO. The method used is based on Carter et al (1991) J. Pharmacol. Exp. Ther. 256 (3): 929-937 and Safayhi (2000), Planta Medica 66: 110-113, which are Which is incorporated herein by reference in its entirety.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  (Ficoll-Paque density gradient)<sup class="style-scope patent-text"></sup>
</span> <u class="style-scope patent-text">Experimental design</u> Human peripheral blood mononuclear cells (PMN) were isolated using the Ficoll-Paque density gradient. A23187 (final concentration 30 M) was added to stimulate PMN. Stimulated PMN was adjusted to a density of 5  10 <sup class="style-scope patent-text">6</sup> cells / mL with HBBS medium, vehicle control (DMSO), (final concentrations 0.1, 0.5, 1, 2.5, 5, and 10 M) Incubated with ECO-04601 and NDGA as a positive control (final concentrations of 3, 1, 0.3, 0.1, and 0.03 M) for 15 minutes at 37  C. After incubation, the sample was neutralized with NaOH and centrifuged. The leukotriene B4 content of the supernatant was measured using enzyme immunoassay (EIA).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  <sub class="style-scope patent-text"></sub>
</span> <u class="style-scope patent-text">result:</u> <br class="style-scope patent-text"> Clearly IC <sub class="style-scope patent-text">50</sub> = 0.93 M (vs. 0.1 M for the positive control NDGA) and the results shown in FIG. 8 indicate that ECO-04601 inhibited the activity of human 5-LO. Yes. Accordingly, anti-inflammatory properties are shown.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  
</span> <u class="style-scope patent-text">Example 9: In vivo efficacy in a glioma model The</u> purpose <u class="style-scope patent-text">of</u> this study is to: i. p. To test whether ECO-04601 administered by route prevents or delays tumor growth in mice with C6 glioblastoma cells, and to determine an effective dosing regimen.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  Mus musculus Ethical guidelines of animal experimentation (Charte du comite dethique du CNRS, Juillet 2003)the English guidelines for the welfare of animals in experimental neoplasia (WORKMAN, P., TWENTYMAN, P., BALKWILL, F., et al. (1998). United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Guidelines for the welfare of animals in experimental neoplasia (Second Edition, July 1997; British Journal of Cancer 77: 1-10) 
</span> <u class="style-scope patent-text">animal:</u> <br class="style-scope patent-text"> A total of 60 6 week old female mice (Mus musculus nude mice) weighing 18-25 g were observed for 7 days prior to treatment. Ethical guidelines of animal experimentation (Charte du comite d'ethique du CNRS, Juillet 2003), and the English guidelines for the welfare of animals in experimental neoplasia (WORKMAN, P., TWENTYMAN, P., BALKWILL, F., et al. (1998). Animal experiments were conducted according to the United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Guidelines for the welfare of animals in experimental neoplasia (Second Edition, July 1997; British Journal of Cancer 77: 1-10). All mice or apparently affected mice were quickly removed and replaced with healthy mice, affected mice were euthanized immediately after removal from the cage, temperature (23  2  C.), humidity (45  5%) ), Photoperiod (light period 12 hours / dark period 12 hours), and animals were maintained in the room under control of ventilation conditions, polycarbonate cages (5 / l) equipped with water and food supply facilities Cage) Animals were housed, the animal bed was made of sterilized sawdust and changed every other day, food was placed in a metal lid on the top of the cage, and was optionally supplied. The water bottle was equipped with a rubber stopper and a straw tube, the water bottle was cleaned, sterilized and replaced once a week. Each cage was labeled with a specific code.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  Premont et al.Premont J, Benda P, Jard S., [3H] Biochim Biophys Acta. 1975 Feb 13; 381(2):386-76N-nitrosomethyurea
</span> <u class="style-scope patent-text">Tumor cell lines:</u> <br class="style-scope patent-text"> After a series of separate cultures and subcultures of animals, norepinephrine binding by rat glial cells in Premont et al. (Premont J, Benda P, Jard S., [3H] culture. Binding and adenylation cyclase activation and C6 cell line was cloned from rat glial tumors induced by N-nitrosomethyurea (NMU) by Biochim Biophys Acta. 1975 Feb 13; 381 (2): 386-76).</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  (adherent monolayers)<sub class="style-scope patent-text"></sub>
</span>Cells were cultured as adherent monolayers at 37  C. in a humidified atmosphere (CO <sub class="style-scope patent-text">2</sub> 5%, air 95%). The medium was DMEM supplemented with 2 mM L-glutamine and 10% fetal calf serum. For use in the experiment, the tumor cells were separated from the culture flask by treatment with trypsin-versin for 10 minutes. Cells were counted with a haemocytometer and their viability was examined by 0.25% trypan blue exclusion.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  (vehicle solution)
</span> <u class="style-scope patent-text">Test substance preparation:</u> <br class="style-scope patent-text"> For the test substance, the following procedure was then performed for reconstitution (performed immediately before injection). The medium is a mixture consisting of benzyl alcohol (1.5%), ethanol (8.5%), propylene glycol (27%), PEG400 (27%), dimethylacetamide (6%), and water (30%). Was composed. First, the vehicle solution was vortexed to obtain the same type of liquid. 0.6 mL of vortexed media solution was added to each vial containing the test substance (ECO-04601). Vortex for 1 minute to mix the vial well, invert and shake vigorously. The vials were mixed again before injecting each animal.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
<sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><sup class="style-scope patent-text"></sup>
</span> <u class="style-scope patent-text">Inoculation</u> &lt;br/&gt; experiment <u class="style-scope patent-text">to tumor cells the animals</u> began on day 0 (D <sub class="style-scope patent-text">0).</sub> At D <sub class="style-scope patent-text">0</sub> , intramuscular injection of C6 tumor cells (5  10 <sup class="style-scope patent-text">5</sup> cells) was performed in the upper right hind limb of mice with 0.1 mL DMEM complete medium.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  <sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup>
</span> <u class="style-scope patent-text">Treatment methods and results:</u> <br class="style-scope patent-text"> In the first series of experiments, treatment started 24 hours after C6 cell inoculation. On the day of treatment, 100 L of test substance or control substance is administered i. p. Each mouse was injected slowly by route. All groups were treated until the tumor size of mice treated with physiological saline (Group 1) was approximately 3 cm <sup class="style-scope patent-text">3</sup> (around 16 days). Group 1 mice were treated daily with a physiological isotonic solution for 16 days. Group 2 mice were treated daily with vehicle solution for 16 days. Group 3 mice were treated daily with 10 mg / kg ECO-04601 for 16 days. Group 3 mice were treated with 30 mg / kg ECO-04601 once every 2 days for 16 days for a total of 8 treatments. Group 5 mice were treated with 30 mg / kg ECO-04601 once every 3 days for 16 days for a total of 6 treatments. Immediately after the tumor became palpable, measurement of tumor size was started (&gt; 100 mm <sup class="style-scope patent-text">3</sup> ; around 11 days after inoculation) and measured every other day until the treatment using the caliper was completed. As shown in FIGS. 7 and 9, the mean tumor size (6 / group) of all groups treated with ECO-04601 is the one-way analysis of variance (Anova) test and subsequent treatments. There was a marked decrease as shown by the nonparametric Dunnett multiple comparison test comparing the group with the saline group. An asterisk in the P value column of Table 7 indicates a statistically significant value, and ns means not significant.</span>
    </p>
    <p class="style-scope patent-text">
      <tables num="7" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </tables>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  <sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup>
</span>In the next series of experiments, treatment began on day 10 after inoculation of C6 cells when the tumor became palpable (approximately 100-200 mm <sup class="style-scope patent-text">3</sup> ). The treatment was repeated every day for 5 consecutive days. On the day of treatment, 100 L of ECO-04601 was added i. p. Each mouse was injected slowly by route. Group 1 mice were treated daily with a physiological isotonic solution. Group 2 mice were treated daily with vehicle solution. Group 3 mice were treated daily with 20 mg / kg ECO-04601. Group 4 mice were treated daily with 30 mg / kg ECO-04601. Mice were treated until the tumor size of the control mice (Group 1) treated with saline was approximately 4 cm <sup class="style-scope patent-text">3</sup> . Tumor size was measured every other day until treatment with calipers was completed. As shown in FIGS. 8 and 10, ECO-04601 shows a one-way analysis of variance (Anova) test and subsequent non-parametric Dunnet multiple comparison test comparing treatment group and saline group. The mean tumor size (6 animals / group) of all groups treated was significantly reduced. An asterisk in the P value column of Table 8 indicates a statistically significant value, and ns means not significant.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Histological analysis of tumor sections showed a clear morphological change between ECO-04601 treated tumors and the control group. In tumors treated with ECO-04601 (20-30 mg / kg), the cell density decreased and the nuclei of the remaining tumor cells increased and appeared to be nuclei-enriched, but in mice treated with vehicle, These changes were not seen (FIG. 11).
</span>
    </p>
    <p class="style-scope patent-text">
      <tables num="8" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </tables>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  IIILIXAdvanced Organic Chemistry, 3<sup class="style-scope patent-text">rd</sup> Edition by Jerry March (1985) T. H. Greene and P. G. M. Wuts, Protective Groups in Organic Synthesis, 3<sup class="style-scope patent-text">rd</sup> Edition, John Wiley &amp; Sons, New York (1999)
</span> <u class="style-scope patent-text">Example 10: Production of ECO-04601 Variants of the Invention A</u> standard approach of organic chemistry <u class="style-scope patent-text">produces a variant of the</u> ECO-04601 molecule, eg, a variant identified herein as Formulas III-LIX. can do. The principles of organic chemistry, including functional groups, reactivity and general protocols, necessary to make and manipulate the compounds described herein can be found in, for example, Advanced Organic Chemistry, 3 <sup class="style-scope patent-text">rd</sup> Edition by Jerry March ( 1985), which is incorporated herein by reference in its entirety. Further, those skilled in the art will appreciate that various protecting groups may be used in the synthetic methods described herein without special description. As used herein, a protecting group is one or more functional groups such as reactive groups containing oxygen, sulfur, or nitrogen so that the reaction occurs selectively at another reactive site of the polyfunctional compound. Means a group used to block a group. In principle the use of protecting groups, availability and use of a particular functional group, for example TH Greene and PGM Wuts, Protective Groups in Organic Synthesis, 3 rd Edition, John Wiley &amp; Sons, according to New York (1999) Has been.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  II(epoxidizing reagent)VIIXIV
</span> <u class="style-scope patent-text">Scheme 1: Epoxide variant.</u> <br class="style-scope patent-text"> From the compound of formula II (ECO-04601), any of a number of epoxidizing reagents such as perbenzoic acid, monoperphthalic acid, or more preferably tetrahydrofuran (THF) dichloromethane or 1,2- Treatment with m-chloroperbenzoic acid in an inert solvent such as dichloroethane produces the epoxide compounds of the invention (e.g., compounds represented by Formulas VII-XIV as examples). Those skilled in the art will appreciate that for epoxidation reagents slightly larger than one molecular equivalent, the yield of monoepoxide is maximized and the rate of formation of a particular monoepoxide is determined by the reagent, solvent, concentration and reaction temperature. Will be understood. It will also be appreciated that the monoepoxide is an enantiomeric mixture, diepoxides and triepoxides can be made as diasteromers, and the yield is determined by the reaction conditions. One skilled in the art will understand that, under most reaction conditions, the product will be a mixture of all possible epoxides, which are separated by standard methods of chromatography. Examples of approaches related to the production of monoepoxides, diepoxides and triepoxides are given below.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
IIVIIVIIIIX
</span>
A) Monoepoxides of formulas VII, VIII and IX by epoxidation of compounds of formula II.
</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="10" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  IISephadex 2VIIVIIIIXVIIVIIIXIXIIVIIVIIIIX<br class="style-scope patent-text">
IIXIXII
</span>To a solution of the compound of formula II dissolved in tetrahydrofuran (THF), 1.1 equivalent of meta-chloroperbenzoic acid is added. The reaction is cooled in an ice bath and stirred at 0  C. for 1-2 hours. The reaction mixture is then evaporated to dryness, redissolved in methanol, liquid chromatographed on a Sephadex LH-20 column and contaminated with non-reactive starting materials, diepoxides and triepoxides. And a mixture mainly containing the compound of IX. The compounds of formula VII, VIII and XIX are separated and the compound of formula II is purified by HPLC using the system described in Example 2. For each compound of formula VII, VIII and IX, yields of 15-25% are obtained in standard experiments. <br class="style-scope patent-text"> B) Synthesis of compounds of formula X, XI and XII by di-epoxidation of compounds of formula II.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="11" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  IISephadex 2XIXIIXIXIIIIXIXII<br class="style-scope patent-text">
IIXII
</span>To a solution of the compound of formula II dissolved in tetrahydrofuran (THF), 2.3 equivalents of meta-chloroperbenzoic acid are added. The reaction is cooled in an ice bath and stirred at 0  C. for 1-2 hours. The reaction mixture is then evaporated to dryness, redissolved in methanol and liquid chromatographed on a Sephadex LH-20 column, contaminated with traces of non-reactive starting materials and monoepoxides and triepoxides. A mixture containing mainly compounds of the formulas X, XI and XII is isolated. The compounds of formula X, XI and XII are separated and the compound of formula II is purified by HPLC using the system described in Example 2. In standard experiments, yields of 15-25% are obtained for each compound of formula X, XI and XII. <br class="style-scope patent-text"> C) Synthesis of the compound of formula XII by tri-epoxidation of the compound of formula II.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="12" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  IISephadex 2XIII
</span>
&nbsp;&nbsp;To a solution of the compound of formula II dissolved in tetrahydrofuran (THF), 3.5 equivalents of meta-chloroperbenzoic acid are added. The reaction is cooled in an ice bath and stirred at 0  C. for 1-2 hours. The reaction mixture is then evaporated to dryness, redissolved in methanol, subjected to liquid chromatography on a Sephadex LH-20 column and the compound of formula XIII is isolated as a mixture of diasteromers in 80 +% yield. To do.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u>IIIII
</span> <u class="style-scope patent-text">Scheme 2</u> : Synthesis of a compound represented by Formula III by N-acetylation of a compound represented by Formula II.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="13" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  IIIII
</span>
&nbsp;&nbsp;To a solution of the compound of formula II dissolved in tetrahydrofuran (THF), 1.2 equivalents of acetic anhydride and 2-3 drops of triethylamine are added. The reaction mixture is allowed to stand at room temperature for 1-2 hours and then the reaction mixture is evaporated to dryness under reduced pressure to give the compound of formula III in a very quantitative form in almost quantitative yield.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u>IIIV
</span> <u class="style-scope patent-text">Scheme 3</u> : Synthesis of compounds of formulas IV and V by N-alkylation of compounds of formula II.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="14" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  IIIVVI
</span>
&nbsp;&nbsp;To a solution of the compound represented by Formula II dissolved in tetrachloroethylene, 1.2 equivalents of an appropriate alkyl bromide (benzyl bromide for compounds represented by Formula IV or odor for compounds represented by Formula V) Ethyl chloride) is added. The reaction mixture is heated under reflux for 1-2 hours and then the reaction mixture is evaporated to dryness under reduced pressure to give the compounds of formula VI or V, respectively, in very pure form and in almost quantitative yield.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u>IIXLXLIXLII
</span> <u class="style-scope patent-text">Scheme 4</u> : Synthesis of compounds of formulas XL, XLI, and XLII by catalytic reduction of compounds of formula II.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="15" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  II(over reduced product)XLXLIXLIIXLXLIXLII
</span>
&nbsp;&nbsp;A solution of the compound of formula II (462 mg) in ethanol (200 ml) containing palladium on carbon (5 mg of 25 mg) is shaken in a hydrogenator under a hydrogen atmosphere. Carefully measure the hydrogen uptake by the reaction, stop shaking when 1 mM of hydrogen is consumed, quickly empty the vessel, and replace the atmosphere with nitrogen. Remove the catalyst by filtration, concentrate the filtrate, and unpurify the compounds of formula XL, XLI, and XLII contaminated with non-reactive starting materials and a small amount of over reduced product A mixture is obtained. In order to obtain about 100 mg of each of the compounds of the formulas XL, XLI and XLII, the product of interest is separated and purified by HPLC or HSCC chromatography using the system described in Example 2 above. Also good.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u>IIXLIIIXLIVXLV
</span> <u class="style-scope patent-text">Scheme 5</u> : Synthesis of compounds of formulas XLIII, XLIV and XLV by catalytic reduction of compounds of formula II.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="16" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  II(under and over reduced product)XLIIIXLIVXLVXLIIIXLIVXLV
</span>
&nbsp;&nbsp;A solution of the compound of formula II (462 mg) in ethanol (200 ml) containing palladium on carbon (5 mg of 25 mg) is shaken in a hydrogenator under a hydrogen atmosphere. Carefully measure the uptake of hydrogen by the reaction, stop shaking when 2 mM of hydrogen is consumed, quickly empty the vessel and replace the atmosphere with nitrogen. The catalyst is removed by filtration, the filtrate is concentrated, and the formulas XLIII, XLIV, and XLV contaminated with a small amount of non-reactive starting material and a small amount of under-reducing or over-reduced product. To obtain a crude mixture of the compounds represented by: The desired product may be separated and purified by HPLC or HSCC chromatography using the system of Example 2 above to obtain about 100 mg of each of the compounds of formula XLIII, XLIV and XLV.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u>IIXLVI
</span> <u class="style-scope patent-text">Scheme 6</u> : Synthesis of a compound represented by Formula XLVI by catalytic reduction of a compound represented by Formula II.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="17" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  IIIIXLVI
</span>
&nbsp;&nbsp;A solution of Formula II Compound II (462 mg) in ethanol (200 ml) containing palladium on carbon (5 mg of 25 mg) is shaken in a hydrogenator under a hydrogen atmosphere. Carefully measure the hydrogen uptake by the reaction, stop shaking when 3 mM hydrogen is consumed, empty the vessel quickly, and replace the atmosphere with nitrogen. The catalyst is removed by filtration and the filtrate is concentrated to obtain a very pure sample of the compound of formula XLVI.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u>IIVI
</span> <u class="style-scope patent-text">Scheme 7</u> : Synthesis of a compound represented by Formula VI by peracetylation of a compound represented by Formula II.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="18" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
IIVI<br class="style-scope patent-text">
<u class="style-scope patent-text"></u>VII(opening the epoxide)<u class="style-scope patent-text">LIII</u><br class="style-scope patent-text">
 
</span>A solution of the compound of formula II (100 mg) in acetic anhydride (5 ml) is treated with pyridine (250 l). The reaction mixture is allowed to stand overnight at room temperature and then diluted with toluene (100 mL). Such a toluene solution is washed thoroughly with 5% aqueous sodium bicarbonate solution, followed by water, and finally concentrated under reduced pressure to obtain a very pure sample of the compound of formula VI in almost quantitative yield. . <br class="style-scope patent-text"> <u class="style-scope patent-text">Scheme 8</u> : Synthesis of compound of formula <u class="style-scope patent-text">LIII</u> by opening the epoxide of the compound of formula VII. <br class="style-scope patent-text"> </span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="19" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
      <br class="style-scope patent-text">
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
VII<u class="style-scope patent-text">LIII</u><br class="style-scope patent-text">
<u class="style-scope patent-text"></u>IIXLVIIXLIXLI<br class="style-scope patent-text">
 
</span>A solution of the compound of formula VII (100 mg) in tetrahydrofuran (50 ml) is treated with a 1N hydrochloric acid solution (5 ml). The reaction mixture is stirred at room temperature overnight, diluted with toluene (100 ml) followed by water (200 ml). The toluene layer is separated and the aqueous layer is further extracted with 100 ml of toluene. The combined toluene layer is washed once more with water (50 ml), separated and dried in vacuo to give the vicinal glycol compound of formula <u class="style-scope patent-text">LIII</u> . <br class="style-scope patent-text"> <u class="style-scope patent-text">Scheme 9</u> : Synthesis of compounds of formulas XLVII, XLIX and LI by ozonolysis of compounds of formula II. <br class="style-scope patent-text"> </span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="20" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  IIXLVIIXLIXLI
</span>
&nbsp;&nbsp;A solution of the compound of formula II (462 g) in dry ethyl acetate (200 ml) is cooled to below -20  C. with an ozonolysis apparatus. Ozone containing oxygen flows into such a solution from an ozone generator calibrated in advance so that the ozone generation rate is known. In order to obtain a compound mainly represented by the formula XLVII, the ozone pathway is stopped after 0.9 mM of ozone is generated. In order to obtain the compound represented mainly by the formula XLIX, the ozone pathway is stopped after the generation of 2 mM ozone, and 3.3 mM ozone is generated to obtain the compound represented by the formula LI as the main product. .
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  XLVIIXLIXLI
</span>
&nbsp;&nbsp;When ozonolysis is complete, the reaction mixture is transferred to a hydrogenator and 5% palladium calcium carbonate catalyst (0.2 g) is added to the hydrogenated reaction mixture maintained below -20  C. When the hydrogen uptake is complete, the hydrogen atmosphere is replaced with nitrogen, the reaction mixture is allowed to reach room temperature, filtered to remove the catalyst, and the filtrate is concentrated. In order to obtain the compounds of the formulas XLVII, XLIX and LI, using the system described in Example 2 and either HPLC or HSCC, chromatographic crude production depending on the amount of ozone used. The product is purified.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u>XLVIIXLVIII
</span> <u class="style-scope patent-text">Scheme 10</u> : Synthesis of compound of formula XLVIII by reduction of aldehyde of compound of formula XLVII.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="21" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  XLVIIIXLVII
</span>
&nbsp;&nbsp;A solution of the compound of formula XLVIII (50 mg) in isopropanol (5 ml) is cooled in an ice-salt bath, sodium borate (10 mg) is added and the mixture is stirred for 20 minutes. It is then diluted with water (20 ml) and extracted twice with toluene (10 ml portion) at ambient temperature. The combined toluene extract is filtered and the filtrate is concentrated to give the compound of formula XLVII.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u>XLIIXIVXV
</span> <u class="style-scope patent-text">Scheme 11</u> : Synthesis of compounds of formulas XIV and XV by epoxidation of compounds of formula XLII.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="22" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  XLIISephadex 2XIVXVIIXIVXVXIVXV
</span>
&nbsp;&nbsp;To a solution of the compound of formula XLII dissolved in tetrahydrofuran (THF), 1.1 equivalent of meta-chloroperbenzoic acid is added. The reaction is cooled in an ice bath and stirred at 0  C. for 1-2 hours. The reaction mixture is then evaporated to dryness, redissolved in methanol, liquid chromatographed on a Sephadex LH-20 column and mixed with non-reactive starting materials and compounds of formulas XIV and XV contaminated with diepoxide. The mixture is mainly isolated. Using one of the methods described in Example 2 for purification of the compound of Formula II, the compounds of Formula XIV and XV are separated and purified using HPLC or HSCC. In a typical experiment, a yield of 35-40% is obtained for each of the compounds of formulas XIV and XV.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u>XLXIX
</span> <u class="style-scope patent-text">Scheme 12</u> : Synthesis of compound of formula XIX by epoxidation of compound of formula XL.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="23" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  XLSephadex 2XIX
</span>
&nbsp;&nbsp;To a solution of the compound of formula XL dissolved in tetrahydrofuran (THF), 2.2 equivalents of meta-chloroperbenzoic acid are added. The reaction is cooled in an ice bath and stirred at 0  C. for 1-2 hours. The reaction mixture is then evaporated to dryness, redissolved in methanol and subjected to liquid chromatography on a Sephadex LH-20 column to isolate a very pure, high yield compound of formula XIX.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u>IIXXVIXXVIIXXVIII
</span> <u class="style-scope patent-text">Scheme 13</u> : Synthesis of compounds of formulas XXVI, XXVII and XXVIII by esterification of compounds of formula II.</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="24" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  IIXXVIXXVIIXXVIIIIIXXVIXXVIIXXVIIIXXVIXXVIIXXVIII
</span>
&nbsp;&nbsp;To a solution of the compound of formula II dissolved in toluene (9 parts) tetrahydrofuran (1 part) and cooled in an ice bath, 1.1 equivalents of acetic anhydride and 2 drops of boron trifluoride ether are added. . The reaction is kept cold in an ice bath and stirred at 0  C. for 1-2 hours. The reaction mixture is poured into 5% aqueous sodium bicarbonate and shaken to remove the toluene layer. Re-extract the aqueous layer with toluene and concentrate the combined toluene layers to make a mixture mainly containing compounds of formulas XXVI, XXVII, and XXVIII mixed with non-reactive starting materials and diacetate. . Using one of the methods described in Example 2 for purification of the compound of formula II, the compounds of formula XXVI, XXVII, and XXVIII are separated and purified using HPLC or HSCC. . In typical experiments, yields of 25-30% are obtained for each of the compounds of formula XXVI, XXVII, and XXVIII.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u>IIXXXIIIXXXIVXXXV
</span> <u class="style-scope patent-text">Scheme 14</u> : Synthesis of compounds of formula XXXIII, XXXIV and XXXV by methylation of compounds of formula II</span>
    </p>
    <p class="style-scope patent-text">
      <chemistry id="" num="25" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </chemistry>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  II(over-methylated derivatives)XXXIIIXXXIVXXXVXXXIIIXXXIVXXXV
</span>
&nbsp;&nbsp;A solution of the compound of formula II (1 g) in 50 ml of tetrahydrofuran was titrated with exactly 1 equivalent of sodium methoxide, allowed to stand at room temperature for 30 minutes and 1.2 equivalents of dimethyl sulfate. Process with. The mixture is heated at reflux for 1 hour, cooled to room temperature and poured into a mixture of toluene (200 ml) and water (200 ml). The layers are separated and the aqueous layer is extracted again with an equal volume of toluene. The combined toluene layer is washed once with 1N acetic acid solution and concentrated to the crude product. This crude product is a mixture mainly comprising compounds of formula XXXIII, XXXIV and XXXV, together with non-reactive starting materials and small amounts of over-methylated derivatives. The desired product is isolated and purified by HPLC or HSCC chromatography using the method described in Example 2 to give about 200 g of compounds of formula XXXIII, XXXIV and XXXV, respectively.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text"></u> <br class="style-scope patent-text">
  Micromonospora sp.1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2)Zazopoulos et. al., Nature Biotechnol., 21, 187-190 (2003) IIMicromonospora sp.
</span> <u class="style-scope patent-text">Example 11: Gene and protein for producing the compound represented by the formula</u> <br class="style-scope patent-text"> Micromonospora sp. 046-ECO11 strain is a representative of microorganisms useful for producing the compounds of the present invention. On March 7, 2003, the 046-ECO11 strain was deposited at Health Canada, Department of Microbiology, Canadian International Depository Authority (IDAC), 1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2). The IDAC accession number is 070303-01. Using the genome scanning method described in US Patent No. 10 / 232,370, Canadian Patent No. 2,352,451, and Zazopoulos et. Al., Nature Biotechnol., 21, 187-190 (2003) Thus, a biosynthetic locus for producing a compound represented by the formula II was identified in the genome of Micromonospora sp. 046-ECO11 strain.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  II
</span>
&nbsp;&nbsp;The biosynthetic locus spans approximately 52,400 base pairs of DNA and encodes 43 proteins. DNA sequences longer than 10 kilobases were analyzed on each side of the locus, and these regions were considered to contain primary genes or genes not involved in the synthesis of the compound represented by Formula II. As shown in FIG. 12, the locus is contained in three sequences of consecutive base pairs. That is, it has 36,602 consecutive base pairs represented by SEQ ID NO: 1, and ORF 1 to 31 (SEQ ID NOs: 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, and 63). Contig 2 containing ORF 32 to 35 (SEQ ID NOs: 66, 68, 70, and 72) and 9,762 base pairs represented by SEQ ID NO: 73 And Contig 3 including ORFs 36 to 43 (SEQ ID NOs: 75, 77, 79, 81, 83, 85, 87, and 89). The order, relative position, and orientation of 43 open reading frames representing proteins at the biosynthetic locus are schematically shown in FIG. The upper line in FIG. 12 shows base pair memory. The gray horizontal line represents three DNA contigs (SEQ ID NOs: 1, 64, and 73) that span the locus. The white arrow indicates 43 open reading frames of the biosynthetic locus. Black arrows indicate the two cosmid clones deposited across the locus.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Micromonospora sp.
</span>
&nbsp;&nbsp;A further understanding of the biosynthetic locus can be obtained by reference to the sequence listing showing the nucleotide sequence of the contig and the deduced amino acid sequence of the locus of Micromonospora sp. 046-ECO11. Contig's nucleotide sequence is that contig 1 (SEQ ID NO: 1) is close to the 5 'end of contig 2 (SEQ ID NO: 64) as well as contig 3 (SEQ ID NO: 73) as seen in the biosynthetic locus. Are arranged to be. The ORF is shown in FIG. 12 and shows a sequence listing representing the open reading frame deduced from the nucleotide sequences of contigs 1, 2, and 3 (SEQ ID NO: 1, 64, and 73). Regarding the sequence listing, ORF1 (SEQ ID NO: 3) is a polynucleotide derived from residues 2139 to 424 of SEQ ID NO: 1, and SEQ ID NO: 2 represents a polypeptide deduced from SEQ ID NO: 3. ORF2 (SEQ ID NO: 5) is a polynucleotide derived from residues 2890-4959 of SEQ ID NO: 1, and SEQ ID NO: 4 represents a polypeptide deduced from SEQ ID NO: 5. ORF3 (SEQ ID NO: 7) is a polynucleotide derived from residues 7701 to 5014 of SEQ ID NO: 1, and SEQ ID NO: 6 represents a polypeptide deduced from SEQ ID NO: 7. ORF4 (SEQ ID NO: 9) is a polynucleotide derived from residues 8104 to 9192 of SEQ ID NO: 1, and SEQ ID NO: 8 represents a polypeptide deduced from SEQ ID NO: 9. ORF5 (SEQ ID NO: 11) is a polynucleotide derived from residues 9192-10256 of SEQ ID NO: 1, and SEQ ID NO: 10 represents a polypeptide deduced from SEQ ID NO: 11. ORF6 (SEQ ID NO: 13) is a polynucleotide derived from residues 10246 to 11286 of SEQ ID NO: 1, and SEQ ID NO: 12 represents a polypeptide deduced from SEQ ID NO: 13. ORF7 (SEQ ID NO: 15) is a polynucleotide derived from residues 11283 to 12392 of SEQ ID NO: 1, and SEQ ID NO: 14 represents a polypeptide deduced from SEQ ID NO: 15. ORF8 (SEQ ID NO: 17) is a polynucleotide derived from residues 12389-13471 of SEQ ID NO: 1, and SEQ ID NO: 16 represents a polypeptide deduced from SEQ ID NO: 17. ORF9 (SEQ ID NO: 19) is a polynucleotide derived from residues 13468 to 14523 of SEQ ID NO: 1, and SEQ ID NO: 18 represents a polypeptide deduced from SEQ ID NO: 19. ORF10 (SEQ ID NO: 21) is a polynucleotide derived from residues 14526 to 15701 of SEQ ID NO: 1, and SEQ ID NO: 20 represents a polypeptide deduced from SEQ ID NO: 21. ORF11 (SEQ ID NO: 23) is a polynucleotide derived from residues 15770-16642 of SEQ ID NO: 1, and SEQ ID NO: 22 represents a polypeptide deduced from SEQ ID NO: 23. ORF12 (SEQ ID NO: 25) is a polynucleotide derived from residues 16756 to 17868 of SEQ ID NO: 1, and SEQ ID NO: 24 represents a polypeptide deduced from SEQ ID NO: 25. ORF13 (SEQ ID NO: 27) is a polynucleotide derived from residues 17865 to 18527 of SEQ ID NO: 1, and SEQ ID NO: 26 represents a polypeptide deduced from SEQ ID NO: 27. ORF14 (SEQ ID NO: 29) is a polynucleotide derived from residues 18724 to 19119 of SEQ ID NO: 1, and SEQ ID NO: 28 represents a polypeptide deduced from SEQ ID NO: 29. ORF15 (SEQ ID NO: 31) is a polynucleotide derived from residues 19175 to 19639 of SEQ ID NO: 1, and SEQ ID NO: 30 represents a polypeptide deduced from SEQ ID NO: 31. ORF16 (SEQ ID NO: 33) is a polynucleotide derived from residues 19636 to 21621 of SEQ ID NO: 1, and SEQ ID NO: 32 represents a polypeptide deduced from SEQ ID NO: 33. ORF17 (SEQ ID NO: 35) is a polynucleotide derived from residues 21632 to 22021 of SEQ ID NO: 1, and SEQ ID NO: 34 represents a polypeptide deduced from SEQ ID NO: 35. ORF18 (SEQ ID NO: 37) is a polynucleotide derived from residues 22658-22122 of SEQ ID NO: 1, and SEQ ID NO: 36 represents a polypeptide deduced from SEQ ID NO: 37. ORF19 (SEQ ID NO: 39) is a polynucleotide derived from residues 24665 to 22680 of SEQ ID NO: 1, and SEQ ID NO: 38 represents a polypeptide deduced from SEQ ID NO: 39. ORF20 (SEQ ID NO: 41) is a polynucleotide derived from 24880 to 26163 residues of SEQ ID NO: 1, and SEQ ID NO: 40 is a polypeptide deduced from SEQ ID NO: 41. ORF21 (SEQ ID NO: 43) is a polynucleotide derived from residues 26179 to 27003 of SEQ ID NO: 1, and SEQ ID NO: 42 represents a polypeptide deduced from SEQ ID NO: 43. ORF22 (SEQ ID NO: 45) is a polynucleotide derived from residues 27035 to 28138 of SEQ ID NO: 1, and SEQ ID NO: 44 represents a polypeptide deduced from SEQ ID NO: 45. ORF23 (SEQ ID NO: 47) is a polynucleotide derived from residues 28164 to 28925 of SEQ ID NO: 1, and SEQ ID NO: 46 represents a polypeptide deduced from SEQ ID NO: 47. ORF24 (SEQ ID NO: 49) is a polynucleotide derived from 28922-30238 residues of SEQ ID NO: 1, and SEQ ID NO: 48 represents a polypeptide deduced from SEQ ID NO: 49. ORF25 (SEQ ID NO: 51) is a polynucleotide derived from residues 30249 to 31439 of SEQ ID NO: 1, and SEQ ID NO: 50 represents a polypeptide deduced from SEQ ID NO: 51. ORF26 (SEQ ID NO: 53) is a polynucleotide derived from residues 31439 to 32224 of SEQ ID NO: 1, and SEQ ID NO: 52 represents a polypeptide deduced from SEQ ID NO: 53. ORF27 (SEQ ID NO: 55) is a polynucleotide derived from residues 32257 to 32931 of SEQ ID NO: 1, and SEQ ID NO: 54 represents a polypeptide deduced from SEQ ID NO: 55. ORF28 (SEQ ID NO: 57) is a polynucleotide derived from residues 32943 to 33644 of SEQ ID NO: 1, and SEQ ID NO: 56 represents a polypeptide deduced from SEQ ID NO: 57. ORF29 (SEQ ID NO: 59) is a polynucleotide derived from residues 34377 to 33637 of SEQ ID NO: 1, and SEQ ID NO: 58 represents a polypeptide deduced from SEQ ID NO: 59. ORF30 (SEQ ID NO: 61) is a polynucleotide derived from residues 34572 to 32907 of SEQ ID NO: 1, and SEQ ID NO: 60 represents a polypeptide deduced from SEQ ID NO: 61. ORF31 (SEQ ID NO: 63) is a polynucleotide derived from residues 34904 to 36583 of SEQ ID NO: 1, and SEQ ID NO: 62 represents a polypeptide deduced from SEQ ID NO: 63. ORF32 (SEQ ID NO: 66) is a polynucleotide derived from residues 23 to 1621 of SEQ ID NO: 64, and SEQ ID NO: 65 represents a polypeptide deduced from SEQ ID NO: 66. ORF33 (SEQ ID NO: 68) is a polynucleotide derived from residues 1702 to 2973 of SEQ ID NO: 64, and SEQ ID NO: 67 represents a polypeptide deduced from SEQ ID NO: 68. ORF34 (SEQ ID NO: 70) is a polynucleotide derived from residues 3248 to 4270 of SEQ ID NO: 64, and SEQ ID NO: 69 represents a polypeptide deduced from SEQ ID NO: 70. ORF35 (SEQ ID NO: 72) is a polynucleotide derived from residues 4452 to 5933 of SEQ ID NO: 64, and SEQ ID NO: 71 represents a polypeptide deduced from SEQ ID NO: 72. ORF36 (SEQ ID NO: 75) is a polynucleotide derived from residues 30 to 398 of SEQ ID NO: 73, and SEQ ID NO: 74 represents a polypeptide deduced from SEQ ID NO: 75. ORF37 (SEQ ID NO: 77) is a polynucleotide derived from residues 395 to 1372 of SEQ ID NO: 73, and SEQ ID NO: 76 represents a polypeptide deduced from SEQ ID NO: 77. ORF38 (SEQ ID NO: 79) is a polynucleotide derived from residues 3388 to 1397 of SEQ ID NO: 73, and SEQ ID NO: 78 represents a polypeptide deduced from SEQ ID NO: 79. ORF39 (SEQ ID NO: 81) is a polynucleotide derived from residues 3565 to 5286 of SEQ ID NO: 73, and SEQ ID NO: 80 represents a polypeptide deduced from SEQ ID NO: 81. ORF40 (SEQ ID NO: 83) is a polynucleotide derived from residues 5283 to 7073 of SEQ ID NO: 73, and SEQ ID NO: 82 represents a polypeptide deduced from SEQ ID NO: 83. ORF41 (SEQ ID NO: 85) is a polynucleotide derived from residues 7108 to 8631 of SEQ ID NO: 73, and SEQ ID NO: 84 represents a polypeptide deduced from SEQ ID NO: 85. ORF42 (SEQ ID NO: 87) is a polynucleotide derived from residues 9371 to 8673 of SEQ ID NO: 73, and SEQ ID NO: 86 represents a polypeptide deduced from SEQ ID NO: 87. ORF43 (SEQ ID NO: 89) is a polynucleotide derived from residues 9762 to 9364 of SEQ ID NO: 73, and SEQ ID NO: 88 represents a polypeptide deduced from SEQ ID NO: 89.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Stryer BioChemistry 3<sup class="style-scope patent-text">rd</sup> edition, 1998, W.H. Freeman and Co., New York, pp. 752-754 
</span>Several open reading frames shown in the sequence listing, namely ORF2 (SEQ ID NO: 5), ORF5 (SEQ ID NO: 11), ORF12 (SEQ ID NO: 25), ORF13 (SEQ ID NO: 27), ORF15 (SEQ ID NO: 31), ORF17 ( SEQ ID NO: 35), ORF19 (SEQ ID NO: 39), ORF20 (SEQ ID NO: 41), ORF22 (SEQ ID NO: 45), ORF24 (SEQ ID NO: 49), ORF26 (SEQ ID NO: 53), and ORF27 (SEQ ID NO: 55) are standard It begins with a non-standard start codon (eg, GTG-valine or CTG-leucine) rather than the typical start codon ATG methionine. To illustrate the specificity of the first codon of the ORF, all ORFs with appropriate M, V or L amino acids at the amino terminal position are listed. However, even when the encoding start codon gene encoding the non-standard protein synthesis in bacteria begin with methionine (formylmethionine) <sup class="style-scope patent-text">(e.g., Stryer BioChemistry 3 rd edition, 1998</sup> , WH Freeman and Co., New York, pp. 752-754), in any case, the biosynthesized protein is in any case a methionine residue, more specifically a formylmethionine residue, at its amino terminal position. Is expected to contain.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;ORF32 (SEQ ID NO: 65) is incomplete and amino acids 10-20 are truncated from the carboxy terminus. This is because the sequence information between contigs 2 and 3 is incomplete (SEQ ID NOs: 64 and 73, respectively).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Micromonospora sp.IIIIE.coli(1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2)
</span>
&nbsp;&nbsp;Micromonospora sp. 046-ECO11 strain of a compound represented by formula II, each containing a cosmid clone of a partial biosynthetic locus (shown as 046KM and 046KQ, respectively in FIG. 12), both of which are represented by formula II The E. coli DH10B vector, which spans the entire length of the biosynthetic locus for the production of Escherichia coli, was obtained on February 25, 2003 from the Canadian Department of Health Canada International Depository Authority (IDAC) (1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2 ). The cosmid clone designated 046KM was deposited as IDAC accession number 250203-06, and the cosmid clone designated 046KQ was deposited as IDAC accession number 250203-07. Cosmid 046KM covers residues 1 to 32,250 of contig 1 (SEQ ID NO: 1). Cosmid 046KQ covers from 21,700 residues of contig 1 (SEQ ID NO: 1) to 9,762 residues of contig 3 (SEQ ID NO: 73). In case of conflict with any of the sequence descriptions herein, the polynucleotide sequence contained in the deposited strain and any amino acid sequence of the polypeptide encoded thereby are controlled.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;Deposits of strains were made in accordance with the Budapest Treaty on the International Approval of Deposits of Microorganisms in Patent Procedures. Deposited shares cannot be canceled and will be published when the patent is granted, unless there are restrictions or conditions. The deposited strain is provided merely as is convenient to those skilled in the art and does not acknowledge that the deposit is required for enablement requirements as required by 35 USC 112. Permission is required for making, using, or selling the deposited strain and compounds derived from the deposited strain, and there is no such permission granted by this specification.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  II(nonredundant protein database)<sup class="style-scope patent-text"></sup>
</span>Using the BLASTP version 2.2.10 algorithm with default parameters to identify the function of the protein encoded by the gene that forms the biosynthetic locus to produce the compound of formula II , ORF1-43 gene products, ie SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 65, 67, 69, 71, 74, 76, 78, 80, 82, 84, 86 and 88, national Biotechnology Information Center (NCBI) nonredundant protein database and DECIPHE of microbial genes, pathways and natural products <sup class="style-scope patent-text">R</sup> database were compared (Ekopia Bioscience ink, Saint Laurent, Quebec, Canada) and.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  <sup class="style-scope patent-text"></sup>Altschul et al. J. Mol. Biol., 215, 403-410 (1990) 
</span>Table 14 shows the upper ranks of GenBank <sup class="style-scope patent-text"></sup> accession numbers that were hit in this BLAST analysis, along with the corresponding E values. The E value relates to a predicted value of chance alignment, where the alignment score is at least equal to the observed alignment score. An E value of 0.00 indicates a complete homologue. E values are calculated as described in Altschul et al. J. Mol. Biol., 215, 403-410 (1990). The E value supports the determination of whether two sequences show sufficient similarity to prove homology reasoning.</span>
    </p>
    <p class="style-scope patent-text">
      <tables num="14" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </tables>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  II
</span>
&nbsp;&nbsp;ORFs that encode proteins involved in the biosynthesis of compounds of formula II are assigned putative functions and grouped together in families based on sequences similar to known proteins. To correlate structure and function, the four letter designations used throughout the specification and drawings are given to protein families as shown in Table 15. The meaning of the four-character designation is as follows. AAKD is amino acid kinase, ABCA and ABCC are ABC transporters, ADSA is amide synthase, ALDB is aldolase function, CSMB is chorismate transaminase, DAHP is 3,4-dideoxy-4-amino-D-arabino-heptulosonate 7-phosphorus Acid synthase activity, DHBS is 2,3-dihydro-2,3-dihydroxybenzoate synthase activity, DMDA is diphosphomevalonate decarboxylase, EFFT is efflux protein, HMGA is 3-hydroxy-3-methylglutaryl-CoA reductase, HOXV Is monooxygenase activity, HOYH is hydroxylase / decarboxylase activity, HYDK is hydrolase activity, IDSA is isopentenyl diphosphate synthase, IPPI is isopentenyl diphosphate Acid isomerase, IPTN is isoprenyl transferase, KASH is 3-hydroxy-3-methylglutaryl-CoA synthase, MVKA is mevalonate kinase, MVPK is phosphomevalonate kinase, OXAH is acyl CoA oxidase, OXDS is oxidoreductase, RECH, RECI , REGD, REGG and RREB are regulators, SDRA is a dehydrogenase / ketoliductase, SPKG is a sensitive protein kinase, UNES, UNEZ, UNFA, UNFC, UNFD, UNFE, UNFJ and UNIQ are proteins with unknown functions.
</span>
    </p>
    <p class="style-scope patent-text">
      <tables num="15" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </tables>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  II
</span>
&nbsp;&nbsp;The biosynthesis of the compound of formula II is then condensed to form the final compound (Figure 15), the three building blocks of the compound: the farnesyl diphosphate component (Figure 13), 3-hydroxy With the action of various enzymes that synthesize the anthranilic acid-adenylate component (FIG. 14a) and the 2-amino-6-hydroxy-benzoquinone component (FIG. 14b).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  Actinomycete(Takagi et al., J Bacteriol. 182, 4153-4157, (2000))
</span>
&nbsp;&nbsp;Farnesyl-diphosphate biosynthesis is accompanied by concerted actions of seven enzymes (FIG. 13). ORF10 (KASH) (SEQ ID NO: 20) catalyzes the aldol addition of acetyl-CoA to acetoacyl-CoA to produce 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) Encodes CoA synthase. This product is then reduced by the action of ORF9 (HMGA) (SEQ ID NO: 18) to form mevalonic acid (MVA). ORF5 (MVKA) (SEQ ID NO: 10) phosphorylates mevalonic acid to 5'-phosphomevalonic acid using ATP as the phosphate donor. The next step in farnesyl diphosphorylation biosynthesis is the phosphorylation of 5'-phosphomevalonic acid to 5'-pyrophosphomevalonic acid (DPMVA), which is catalyzed by ORF7 (MVKP) (SEQ ID NO: 14). Is done. This is followed by the decarboxylation reaction of 5'-pyrophosphomevalonic acid catalyzed by ORF6 (DMDA) (SEQ ID NO: 12) resulting in isopentenyl diphosphate (IPP). This is then converted to dimethylallyl diphosphate (DMADP) by the action of ORF8 (IPPI) (SEQ ID NO: 16), which has isomerase enzyme activity. The final step of farnesyl diphosphate biosynthesis involves the condensation of one molecule of dimethylallyl diphosphate with two molecules of isopentenyl diphosphate catalyzed by isoprenyl diphosphate synthase ORF4 (IDSA) (SEQ ID NO: 8). That is. The pathway involved in the biosynthesis of farnesyl diphosphate described is completely different from the related mevalonate pathway described in other Actinomycete species (Takagi et al., J Bacteriol. 182, 4153-4157, (2000)). Match.
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  isochorismatase
</span>
&nbsp;&nbsp;Biosynthesis of the 3-hydroxy-anthranilic acid component involves the use of precursors derived from the shikimic acid pathway (FIG. 14a). Chorismate is transaminated by the action of ORF19 (CSMB) (SEQ ID NO: 38) to form aminodeoxyisochorismate. This enzyme is similar to anthranilate synthase and appears to specifically catalyze the transfer of amino groups using glutamine as the amino donor. The next step involves isochorismatase activity and is mediated by ORF27 (DHBS) (SEQ ID NO: 54). The significance of this reaction is to remove the pyruvate side chain from aminodeoxyisochorismic acid to form 6-amino-5-hydroxy-cyclohexa-1,3-dienecarboxylic acid. The compound is then oxidized by the action of ORF26 (SDRA) (SEQ ID NO: 52) to produce 3-hydroxy-anthranilic acid. ORF24 (ADSA) (SEQ ID NO: 48) catalyzes the activation of 3-hydroxy-anthranilic acid by adenylation to produce a 3-hydroxy-anthranilic acid-adenylate component (FIG. 14a).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  IIMicromonospora sp.
</span>
&nbsp;&nbsp;Biosynthesis of the 2-amino-6-hydroxy-benzoquinone component of the compound represented by Formula II requires components derived from the amino shikimate pathway. FIG. 14b illustrates a series of enzymatic reactions involved in the biosynthesis of this component. ORF21 (ALDB) (SEQ ID NO: 42) is a precursor of D-erythrose-4-phosphate that is part of the aminoshikimate pathway used to produce 2-amino-6-hydroxy [1,4] -benzoquinone. Similar to aldolase involved in the production of substances. ORF33 (DAHP) (SEQ ID NO: 67) is a 3,4-dideoxy-4-amino-D-arabino-heptulosonic acid 7-phosphate of phosphoenolpyruvate (PEP) and erythose 4-phosphate (E-4Ph) Catalyze the first step in the aminoshikimate pathway, corresponding to the formation of (aminoDAHP). The next reaction leading to 3-amino-5-hydroxy-benzoic acid is catalyzed by an enzyme provided by the primary metabolic biosynthetic pathway present in Micromonospora sp. 046-ECO11 strain. ORF25 (HOXV) (SEQ ID NO: 50) hydroxylates 3-amino-5-hydroxy-benzoic acid at site 2 to produce 3-amino-2,5-dihydroxy-benzoic acid. This intermediate product is further modified by ORF32 (HOYH) (SEQ ID NO: 65), which catalyzes the decarboxylation oxidation reaction to produce 6-amino-benzene-1,2,4-triol. The final oxidation reaction producing 2-amino-6-hydroxy- [1,4] -benzoquinone (FIG. 14b) is performed by ORF16 (OXDS) (SEQ ID NO: 32).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  IIII
</span>
&nbsp;&nbsp;A set of three components resulting in a compound of formula II is catalyzed by ORFs 24 and 11 (FIG. 15). ORF24 (ADSA) (SEQ ID NO: 48) catalyzes the condensation of adenylated 3-hydroxy-anthranilic acid with a 2-amino-6-hydroxy [1,4] -benzoquinone component. Spontaneous condensation occurs between the free amino group of 3-hydroxy-anthranilic acid and one of the carbonyl groups present in the 2-amino-6-hydroxy- [1,4] -benzoquinone component, resulting in intermediate formation of dibenzodiazepinone Things arise. This compound was further modified by transferring the farnesyl group of the farnesyl diphosphate intermediate to the nitrogen of the amide of dibenzodiazepinone catalyzed by ORF11 (IPTN) (SEQ ID NO: 22), and represented by Formula II Is produced (FIG. 15).
</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  IIII
</span>
&nbsp;&nbsp;Further ORFs, namely ORF2 (RECH) (SEQ ID NO: 4), ORF3 (REGD) (SEQ ID NO: 6), ORF12 (SPKG) (SEQ ID NO: 24), ORF13 (RREB) (SEQ ID NO: 26), ORF34 (REGG) ( SEQ ID NO: 69) and ORF36 (RECI) (SEQ ID NO: 74) are involved in the control of the biosynthetic locus encoding the compound represented by Formula II. The other ORFs, ORF1 (ABCC) (SEQ ID NO: 2), ORF31 (EFFT) (SEQ ID NO: 62), ORF39 and 40 (ABCA) (SEQ ID NO: 80 and 82, respectively), and ORF42 (SEQ ID NO: 86) Involved in. Other ORFs involved in the biosynthesis of the compound of formula II include ORFs 14, 15, 17, 18, 22, 29, 30, 35, 37, 41 and 43 (SEQ ID NO: 28, respectively) whose functions are unknown. , 30, 34, 34, 44, 58, 60, 71, 76, 84, and 88), ORF20 (AAKD) (SEQ ID NO: 40), ORF23 (HYDK) (SEQ ID NO: 46), ORF38 (OXAH) ( SEQ ID NO: 78) is included.
</span>
    </p>
    <p class="style-scope patent-text">
      <tables num="16" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text">
          <span class="google-src-text style-scope patent-text">
            <span class="patent-image-not-available style-scope patent-text"></span>
          </span>
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
      </tables>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  <br class="style-scope patent-text">
<sup class="style-scope patent-text"></sup><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub>  <br class="style-scope patent-text">
<sup class="style-scope patent-text">*</sup><sub class="style-scope patent-text"></sub>
</span>Unless otherwise specified, all component units are gm / L. <br class="style-scope patent-text"> <sup class="style-scope patent-text">* 3 For the</sup> trace element solution, ZnCl <sub class="style-scope patent-text">2</sub> (40 mg), FeCl <sub class="style-scope patent-text">3</sub> 6H <sub class="style-scope patent-text">2</sub> O (200 mg), CuCl <sub class="style-scope patent-text">2</sub> 2H <sub class="style-scope patent-text">2</sub> O (10 mg), MnCl <sub class="style-scope patent-text">2</sub> . <sub class="style-scope patent-text"> <sub class="style-scope patent-text"> <sub class="style-scope patent-text"> <sub class="style-scope patent-text">4H 2 O, Na 2 B 4</sub> </sub> </sub> </sub> O 7. <sub class="style-scope patent-text"> <sub class="style-scope patent-text"> <sub class="style-scope patent-text">10H 2 O (10mg), (</sub> </sub> </sub> NH 4) 6 MO 7 O 24. 4H <sub class="style-scope patent-text">2</sub> O (10 mg) is included. <br class="style-scope patent-text"> <sup class="style-scope patent-text">* 5 The</sup> pH is adjusted before addition of CaCo <sub class="style-scope patent-text">3</sub> as described.</span>
    </p>
    <p class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  
</span>
&nbsp;&nbsp;All patents, patent applications, and references cited herein are hereby incorporated by reference in their entirety. While the invention has been particularly shown and described by reference to preferred embodiments, it will be understood that various changes in form and detail may be made without departing from the scope of the invention as encompassed by the appended claims. The merchant will understand.
</span>
    </p>
  </disclosure>
  <description-of-drawings class="style-scope patent-text">
    <p class="style-scope patent-text">
      <figref num="1" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"></span>FIG. 1 shows the mass of ECO-04601 determined by electrospray mass spectrometry as 462.6.</span>
      </figref>
      <figref num="2" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"></span>FIG. 2 shows the absorption spectrum of purified ECO-04601 with a UVmax of 230 nm and a shoulder of 290 nm.</span>
      </figref>
      <figref num="3" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"><sub class="style-scope patent-text"></sub></span>Figure 3 shows the proton NMR data of the compound was dissolved in <sub class="style-scope patent-text">MeOH-d 4.</sub> </span>
      </figref>
      <figref num="4" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"></span>FIG. 4 shows a gDQCOSY multidimensional pulse sequence.</span>
      </figref>
      <figref num="5" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"></span>FIG. 5 shows a gHSQC multidimensional pulse sequence.</span>
      </figref>
      <figref num="6" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"></span>FIG. 6 shows a gHMBC multidimensional pulse sequence.</span>
      </figref>
      <figref num="7" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"></span>FIG. 7 shows a NOESY multidimensional pulse sequence.</span>
      </figref>
      <figref num="8" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"><sub class="style-scope patent-text"></sub></span>FIG. 8 shows the in vitro anti-inflammatory activity of ECO-04601. The graph shows the percent inhibition of 5-lipoxygenase activity versus Log M concentrations of ECO-04601 and NDGA. The graph shows that the EC <sub class="style-scope patent-text">50 of</sub> ECO-04601 is 0.93 M.</span>
      </figref>
      <figref num="9" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"></span>FIG. 9 shows that tumor growth was inhibited as a result of administering 10-30 mg / kg ECO-04601 1 day after tumor cell inoculation to mice with glial buds.</span>
      </figref>
      <figref num="10" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"></span>FIG. 10 shows that 20 to 30 mg / kg ECO-04601 was administered to mice with glial bud seeds 10 days after tumor cell inoculation, resulting in inhibition of tumor growth.</span>
      </figref>
      <figref num="11" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"></span>FIG. 11 shows micrographs of tumor fragments of mice with glial bud tumors and treated with saline or ECO-04601. The cell density of tumors treated with ECO-04601 appears to decrease, and the nuclei of ECO-04601-treated tumor cells are larger and more concentrated. This indicates cytotoxicity.</span>
      </figref>
      <figref num="12" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Micromonospora sp.</span>Figure 12 shows the biosynthetic locus of ECO-04601 isolated from Micromonospora sp. 046-ECO11 strain and containing the positions of cosmids 046KM and 046KQ.</span>
      </figref>
      <figref num="13" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"></span>FIG. 13 shows a schematic diagram of the biosynthetic pathway for the production of farnesyl-diphosphate groups by biosynthetic enzymes with ORF numbers and family names.</span>
      </figref>
      <figref num="14" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"></span>FIG. 14 shows (a) 3-hydroxy-anthranilic acid-adenylate component and (b) 2-amino-6-hydroxy- [1,4] identified by the ORF present at the locus encoding ECO-04601. 1 shows a schematic diagram of the biosynthetic pathway for the production of benzoquinone components. Biosynthetic enzymes are indicated by ORF number and family name.</span>
      </figref>
      <figref num="15" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"></span>FIG. 15 shows a schematic diagram of the biosynthetic pathway of the assembly of ECO-04601 precursor, farnesyl-diphosphate, 3-hydroxy-anthranilic acid-adenylate, and 2-amino-6-hydroxy- [1,4] benzoquinone. Show. Biosynthetic enzymes are indicated by ORF number and family name.</span>
      </figref>
      <figref num="16" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"></span>FIG. 16 shows a sequence listing showing the sequence number and function of each open reading frame (ORF) of the 046D biosynthetic locus and the gene products corresponding to them.</span>
      </figref>
      <figref num="17" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Micromonospora sp..</span>FIG. 17 shows the results of fatty acid analysis of Micromonospora sp. 046ECO11. Strain (IDAC Accession No. 070303-01). Analysis was performed using fatty acid methyl ester (FAME) using gas chromatography.</span>
      </figref>
      <figref num="18" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Micromonospora sp.Micromonospora sp.  Micromonospora chalcea</span>FIG. 18 shows 16S ribosomal RNA analysis of Micromonospora sp. 046 ECO11 strain (IDAC accession number 070303-01). The arrangement of the 16S ribosomal RNA sequence shows a phylogenetic relationship of Micromonospora sp. 046ECO11 strain (shown as MID352 ECOPIA # 1con) to Micromonospora chalcea.</span>
      </figref>
      <figref num="19" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup></span>FIG. 19 shows the complete <sup class="style-scope patent-text">1</sup> H and <sup class="style-scope patent-text">13</sup> C NMR configuration of ECO-04601 as measured by MeOH-d4.</span>
      </figref>
    </p>
  </description-of-drawings>
</description>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
            <div class="flex flex-width style-scope patent-result">
              <section id="claims" class="style-scope patent-result">
                <h3 class="style-scope patent-result">
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Claims <span class="style-scope patent-result">(28)</span></div>
                    <div class="collapse style-scope patent-result">
                      Hide Dependent <iron-icon style="height: 15px; width: 15px;" icon="expand-less" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 8l-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </div>
                  </div>
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result"></div>
                    <div class="righthead style-scope patent-result">translated from Japanese</div>
                  </div>
                </h3>
                <patent-text name="claims" enable-text-selection="" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><claims mxw-id="PCLM40549636" lang="EN" load-source="google" class="style-scope patent-text">
  <claim num="1" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"><br class="style-scope patent-text">
<chemistry id="" num="1" class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </chemistry> </span>A compound represented by the following formula or a pharmaceutically acceptable salt thereof. <br class="style-scope patent-text"> <chemistry id="" num="1" class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </chemistry> </span>
    </claim-text>
  </claim>
  <claim num="2" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"><br class="style-scope patent-text">
<chemistry id="" num="2" class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </chemistry> </span>A pharmaceutical composition comprising a compound represented by the following formula or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier. <br class="style-scope patent-text"> <chemistry id="" num="2" class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </chemistry> </span>
    </claim-text>
  </claim>
  <claim num="3" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">I<br class="style-scope patent-text">
<chemistry id="" num="3" class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </chemistry><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><br class="style-scope patent-text">
<chemistry id="" num="4" class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </chemistry><sub class="style-scope patent-text"></sub><br class="style-scope patent-text">
<sub class="style-scope patent-text"></sub><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><br class="style-scope patent-text">
<sup class="style-scope patent-text"></sup><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub>(alkene)<br class="style-scope patent-text">
<sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><br class="style-scope patent-text">
<sup class="style-scope patent-text"></sup><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub>(alkalene)<br class="style-scope patent-text">
<sup class="style-scope patent-text"></sup><sub class="style-scope patent-text"></sub><sub class="style-scope patent-text"></sub></span>Compound of formula I <br class="style-scope patent-text"> <chemistry id="" num="3" class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </chemistry> (W <sup class="style-scope patent-text">1</sup> , W <sup class="style-scope patent-text">2</sup> and W <sup class="style-scope patent-text">3</sup> are each independently represented by the following formula: <br class="style-scope patent-text"> <chemistry id="" num="4" class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </chemistry> Or the side chain from the tricycle may be terminated with W3, W2 or W1, wherein W3, W2 or W1 is CHO or CH <sub class="style-scope patent-text">2</sub> OH, respectively, <br class="style-scope patent-text"> A is selected from NH, NCH <sub class="style-scope patent-text">2</sub> R <sup class="style-scope patent-text">1</sup> , NC (O) R <sup class="style-scope patent-text">1</sup> , <br class="style-scope patent-text"> R <sup class="style-scope patent-text">1</sup> is selected from C <sub class="style-scope patent-text">1-6</sub> alkyl, C <sub class="style-scope patent-text">2-6</sub> alkene, aryl or heteroaryl; <br class="style-scope patent-text"> R <sup class="style-scope patent-text">2</sup> , R <sup class="style-scope patent-text">3</sup> and R <sup class="style-scope patent-text">4</sup> are each independently selected from H, R <sup class="style-scope patent-text">5</sup> , C (O) R <sup class="style-scope patent-text">6</sup> ; <br class="style-scope patent-text"> Each R <sup class="style-scope patent-text">5</sup> is independently selected from C <sub class="style-scope patent-text">1-6</sub> alkyl, C <sub class="style-scope patent-text">2-7</sub> alkalene, aryl or heteroaryl; <br class="style-scope patent-text"> Each R <sup class="style-scope patent-text">6</sup> is independently selected from H, C <sub class="style-scope patent-text">1-6</sub> alkyl, C <sub class="style-scope patent-text">2-7</sub> alkane, aryl or heteroaryl, or a pharmaceutically acceptable salt thereof).</span>
    </claim-text>
  </claim>
  <claim num="4" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"></span>The compound or pharmaceutically acceptable salt thereof according to claim 3, wherein A is NH.</span>
    </claim-text>
  </claim>
  <claim num="5" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"><sub class="style-scope patent-text"></sub><sup class="style-scope patent-text"></sup></span>Compound or a pharmaceutically acceptable salt thereof according to claim 3, characterized in that A is -NCH <sub class="style-scope patent-text">2</sub> R <sup class="style-scope patent-text">1.</sup> </span>
    </claim-text>
  </claim>
  <claim num="6" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"><sup class="style-scope patent-text"></sup></span>The compound or pharmaceutically acceptable salt thereof according to claim 3, wherein A is -NC (O) R <sup class="style-scope patent-text">1</sup> .</span>
    </claim-text>
  </claim>
  <claim num="7" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"><sup class="style-scope patent-text"></sup></span>Compound or a pharmaceutically acceptable salt thereof according to claim 3 in which R <sup class="style-scope patent-text">2</sup> is equal to or is H.</span>
    </claim-text>
  </claim>
  <claim num="8" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"><sup class="style-scope patent-text"></sup></span>The compound according to claim 3 or a pharmaceutically acceptable salt thereof, wherein R <sup class="style-scope patent-text">3</sup> is H.</span>
    </claim-text>
  </claim>
  <claim num="9" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"><sup class="style-scope patent-text"></sup></span>The compound according to claim 3, wherein R <sup class="style-scope patent-text">4</sup> is H, or a pharmaceutically acceptable salt thereof.</span>
    </claim-text>
  </claim>
  <claim num="10" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup></span>The compound according to claim 3 or a pharmaceutically acceptable salt thereof, wherein R <sup class="style-scope patent-text">2</sup> , R <sup class="style-scope patent-text">3</sup> and R <sup class="style-scope patent-text">4</sup> are each H.</span>
    </claim-text>
  </claim>
  <claim num="11" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup></span>The compound according to claim 3 or a pharmaceutically acceptable salt thereof, wherein R <sup class="style-scope patent-text">2</sup> , R <sup class="style-scope patent-text">3</sup> and R <sup class="style-scope patent-text">4</sup> are each H, and W <sup class="style-scope patent-text">1</sup> is CHCH.</span>
    </claim-text>
  </claim>
  <claim num="12" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup></span>The compound according to claim 3 or a pharmaceutically acceptable salt thereof, wherein R <sup class="style-scope patent-text">2</sup> , R <sup class="style-scope patent-text">3</sup> and R <sup class="style-scope patent-text">4</sup> are each H, and W <sup class="style-scope patent-text">2</sup> is CHCH.</span>
    </claim-text>
  </claim>
  <claim num="13" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup></span>The compound according to claim 3 or a pharmaceutically acceptable salt thereof, wherein R <sup class="style-scope patent-text">2</sup> , R <sup class="style-scope patent-text">3</sup> and R <sup class="style-scope patent-text">4</sup> are each H, and W <sup class="style-scope patent-text">3</sup> is CHCH.</span>
    </claim-text>
  </claim>
  <claim num="14" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup></span>The compound according to claim 3 or a pharmaceutically acceptable salt thereof, wherein A is NH and R <sup class="style-scope patent-text">2</sup> , R <sup class="style-scope patent-text">3</sup> and R <sup class="style-scope patent-text">4</sup> are each H.</span>
    </claim-text>
  </claim>
  <claim num="15" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup><sup class="style-scope patent-text"></sup></span>The compound according to claim 3 or a pharmaceutically acceptable salt thereof, wherein A is NH, and W <sup class="style-scope patent-text">1</sup> , W <sup class="style-scope patent-text">2,</sup> and W <sup class="style-scope patent-text">3</sup> are each CHCH.</span>
    </claim-text>
  </claim>
  <claim num="16" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"><br class="style-scope patent-text">
<chemistry id="" num="5" class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </chemistry> <span class="patent-image-not-available style-scope patent-text"></span>
<span class="patent-image-not-available style-scope patent-text"></span>
<span class="patent-image-not-available style-scope patent-text"></span>
<span class="patent-image-not-available style-scope patent-text"></span>
<span class="patent-image-not-available style-scope patent-text"></span>
<span class="patent-image-not-available style-scope patent-text"></span>
</span>A compound selected from the following group. <br class="style-scope patent-text"> <chemistry id="" num="5" class="style-scope patent-text"> <span class="patent-image-not-available style-scope patent-text"></span> </chemistry> <span class="patent-image-not-available style-scope patent-text"></span> <span class="patent-image-not-available style-scope patent-text"></span> <span class="patent-image-not-available style-scope patent-text"></span> <span class="patent-image-not-available style-scope patent-text"></span> <span class="patent-image-not-available style-scope patent-text"></span> <span class="patent-image-not-available style-scope patent-text"></span> </span>
    </claim-text>
  </claim>
  <claim num="17" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  </span>Incubating micromonospora sp having IDAC accession number 070303-01 in a medium comprising at least one carbon atom source and at least one nitrogen atom source, and A method for producing the compound, comprising the step of isolating and purifying the compound.</span>
    </claim-text>
  </claim>
  <claim num="18" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  </span>Culturing a micromonospora sp having IDAC (Canadian International Depository Authority) accession number 231203-01 in a medium comprising at least one carbon atom source and at least one nitrogen atom source, and A method for producing the compound, comprising the step of isolating and purifying the compound.</span>
    </claim-text>
  </claim>
  <claim num="19" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"></span>The method according to claim 18, wherein the culturing is performed under aerobic conditions.</span>
    </claim-text>
  </claim>
  <claim num="20" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"></span>19. The method of claim 18, wherein the carbon atom source and the nitrogen atom source are selected from the components shown in Table 16.</span>
    </claim-text>
  </claim>
  <claim num="21" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"></span>The method according to claim 18, wherein the culturing is performed at a temperature of 18 to 40  C.</span>
    </claim-text>
  </claim>
  <claim num="22" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"></span>The method according to claim 18, wherein the culture is performed at pH 6-9.</span>
    </claim-text>
  </claim>
  <claim num="23" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  </span>Micromonospora SP with IDAC (Canadian International Depositary Authority) accession number 231203-01 or IDAC accession number 070303-01.</span>
    </claim-text>
  </claim>
  <claim num="24" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"><u class="style-scope patent-text"></u><u class="style-scope patent-text"></u> <br class="style-scope patent-text">
<u class="style-scope patent-text"></u> <br class="style-scope patent-text">
<u class="style-scope patent-text"></u></span>A method for inhibiting the growth <u class="style-scope patent-text">of</u> cancer cells in <u class="style-scope patent-text">vitro, comprising the</u> step of contacting the cancer cells with a compound according to claim 1 to inhibit the growth <u class="style-scope patent-text">of</u> cancer cells <u class="style-scope patent-text">,</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">Or</u> <br class="style-scope patent-text"> <u class="style-scope patent-text">A method for inhibiting the growth of a cancer cell of a non-human mammal comprising the step of contacting the cancer cell of a non-human mammal with the compound of claim 1 to inhibit the growth of the cancer cell of the non-human mammal.</u> .</span>
    </claim-text>
  </claim>
  <claim num="25" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"></span>A cancer cell growth inhibitor in a mammal comprising the compound according to claim 1.</span>
    </claim-text>
  </claim>
  <claim num="26" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"></span>A therapeutic agent for a precancerous condition or cancer disease in a mammal, comprising the compound according to claim 1.</span>
    </claim-text>
  </claim>
  <claim num="27" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"></span>A therapeutic agent for bacterial infection in mammals comprising the compound according to claim 1.</span>
    </claim-text>
  </claim>
  <claim num="28" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"></span>An inhibitor of inflammation in a mammal, comprising the compound according to claim 1.</span>
    </claim-text>
  </claim>
</claims>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
          </div>

          <div class="footer style-scope patent-result">

            
            <h3 id="patentCitations" class="scroll-target style-scope patent-result">
              Patent Citations (18)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5541181A/en"><a id="link" href="#" class="style-scope state-modifier">US5541181A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1994-05-26</span>
                    <span class="td style-scope patent-result">1996-07-30</span>
                    <span class="td style-scope patent-result">Bristol-Myers Squibb Company</span>
                    <span class="td style-scope patent-result">Compound produced by a strain of micromonospora 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US3854480A/en"><a id="link" href="#" class="style-scope state-modifier">US3854480A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1969-04-01</span>
                    <span class="td style-scope patent-result">1974-12-17</span>
                    <span class="td style-scope patent-result">Alza Corp</span>
                    <span class="td style-scope patent-result">Drug-delivery system 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4452775A/en"><a id="link" href="#" class="style-scope state-modifier">US4452775A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1982-12-03</span>
                    <span class="td style-scope patent-result">1984-06-05</span>
                    <span class="td style-scope patent-result">Syntex (U.S.A.) Inc.</span>
                    <span class="td style-scope patent-result">Cholesterol matrix delivery system for sustained release of macromolecules 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5039660A/en"><a id="link" href="#" class="style-scope state-modifier">US5039660A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1988-03-02</span>
                    <span class="td style-scope patent-result">1991-08-13</span>
                    <span class="td style-scope patent-result">Endocon, Inc.</span>
                    <span class="td style-scope patent-result">Partially fused peptide pellet 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0354727A3/en"><a id="link" href="#" class="style-scope state-modifier">EP0354727A3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1988-08-08</span>
                    <span class="td style-scope patent-result">1990-11-22</span>
                    <span class="td style-scope patent-result">Eli Lilly And Company</span>
                    <span class="td style-scope patent-result">Novel single stranded phasmid vectors and methods for transforming streptomyces and other actinomycetes 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5283173A/en"><a id="link" href="#" class="style-scope state-modifier">US5283173A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-01-24</span>
                    <span class="td style-scope patent-result">1994-02-01</span>
                    <span class="td style-scope patent-result">The Research Foundation Of State University Of New York</span>
                    <span class="td style-scope patent-result">System to detect protein-protein interactions 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0618972A1/en"><a id="link" href="#" class="style-scope state-modifier">EP0618972A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-12-16</span>
                    <span class="td style-scope patent-result">1994-10-12</span>
                    <span class="td style-scope patent-result">E.I. Du Pont De Nemours And Company</span>
                    <span class="td style-scope patent-result">CONSTITUTIVE EXPRESSION OF P450SOY AND FERREDOXIN-SOY IN $i(STREPTOMYCES), AND BIOTRANSFORMATION OF CHEMICALS BY RECOMBINANT ORGANISMS 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU695814B2/en"><a id="link" href="#" class="style-scope state-modifier">AU695814B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-09-22</span>
                    <span class="td style-scope patent-result">1998-08-20</span>
                    <span class="td style-scope patent-result">Xoma Corporation</span>
                    <span class="td style-scope patent-result">Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein product and antibiotic 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5556772A/en"><a id="link" href="#" class="style-scope state-modifier">US5556772A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-12-08</span>
                    <span class="td style-scope patent-result">1996-09-17</span>
                    <span class="td style-scope patent-result">Stratagene</span>
                    <span class="td style-scope patent-result">Polymerase compositions and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DK0754050T3/en"><a id="link" href="#" class="style-scope state-modifier">DK0754050T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1994-01-14</span>
                    <span class="td style-scope patent-result">2002-10-21</span>
                    <span class="td style-scope patent-result">Xoma Technology Ltd</span>
                    <span class="td style-scope patent-result">
  Anti-gram-positive bacterial methods and materials
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5561122A/en"><a id="link" href="#" class="style-scope state-modifier">US5561122A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1994-12-22</span>
                    <span class="td style-scope patent-result">1996-10-01</span>
                    <span class="td style-scope patent-result">Arizona Board Of Regents Acting On Behalf Of Arizona State University</span>
                    <span class="td style-scope patent-result">Combretastatin A-4 prodrug 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CZ291991B6/en"><a id="link" href="#" class="style-scope state-modifier">CZ291991B6</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-11-29</span>
                    <span class="td style-scope patent-result">2003-07-16</span>
                    <span class="td style-scope patent-result">Sankyo Company Limited</span>
                    <span class="td style-scope patent-result">Actinomycete promoter 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6333322B1/en"><a id="link" href="#" class="style-scope state-modifier">US6333322B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-03-13</span>
                    <span class="td style-scope patent-result">2001-12-25</span>
                    <span class="td style-scope patent-result">Eisai Co., Ltd.</span>
                    <span class="td style-scope patent-result">Nitrogen-containing tricyclic compounds and drugs containing the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7257562B2/en"><a id="link" href="#" class="style-scope state-modifier">US7257562B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-10-13</span>
                    <span class="td style-scope patent-result">2007-08-14</span>
                    <span class="td style-scope patent-result">Thallion Pharmaceuticals Inc.</span>
                    <span class="td style-scope patent-result">High throughput method for discovery of gene clusters 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1392824B1/en"><a id="link" href="#" class="style-scope state-modifier">EP1392824B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-06</span>
                    <span class="td style-scope patent-result">2008-08-20</span>
                    <span class="td style-scope patent-result">DSM IP Assets B.V.</span>
                    <span class="td style-scope patent-result">Improved isoprenoid production 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2352451C/en"><a id="link" href="#" class="style-scope state-modifier">CA2352451C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-07-24</span>
                    <span class="td style-scope patent-result">2003-04-08</span>
                    <span class="td style-scope patent-result">Ecopia Biosciences Inc.</span>
                    <span class="td style-scope patent-result">High throughput method for discovery of gene clusters 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6683300B2/en"><a id="link" href="#" class="style-scope state-modifier">US6683300B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-17</span>
                    <span class="td style-scope patent-result">2004-01-27</span>
                    <span class="td style-scope patent-result">Science &amp; Engineering Services, Inc.</span>
                    <span class="td style-scope patent-result">Method and apparatus for mass spectrometry analysis of common analyte solutions 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/NZ561169A/en"><a id="link" href="#" class="style-scope state-modifier">NZ561169A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-01-21</span>
                    <span class="td style-scope patent-result">2008-06-30</span>
                    <span class="td style-scope patent-result">Thallion Pharmaceuticals Inc</span>
                    <span class="td style-scope patent-result">Farnesyl dibenzodiazepinones, processes for their production and their use as pharmaceuticals 
     </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner,  Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="citedBy" class="scroll-target style-scope patent-result">
              Cited By (17)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/NZ561169A/en"><a id="link" href="#" class="style-scope state-modifier">NZ561169A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-01-21</span>
                    <span class="td style-scope patent-result">2008-06-30</span>
                    <span class="td style-scope patent-result">Thallion Pharmaceuticals Inc</span>
                    <span class="td style-scope patent-result">Farnesyl dibenzodiazepinones, processes for their production and their use as pharmaceuticals 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7297524B2/en"><a id="link" href="#" class="style-scope state-modifier">US7297524B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-01-21</span>
                    <span class="td style-scope patent-result">2007-11-20</span>
                    <span class="td style-scope patent-result">Thallion Pharmceuticals Inc.</span>
                    <span class="td style-scope patent-result">Polynucleotides for production of farnesyl dibenzodiazepinones 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7186713B2/en"><a id="link" href="#" class="style-scope state-modifier">US7186713B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-01-21</span>
                    <span class="td style-scope patent-result">2007-03-06</span>
                    <span class="td style-scope patent-result">Ecopia Biosciences, Inc.</span>
                    <span class="td style-scope patent-result">Farnesyl dibenzodiazepinones and methods of treating cancer using same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2008514551A/en"><a id="link" href="#" class="style-scope state-modifier">JP2008514551A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-09-27</span>
                    <span class="td style-scope patent-result">2008-05-08</span>
                    <span class="td style-scope patent-result">    </span>
                    <span class="td style-scope patent-result">
  Dibenzodiazepinone analogues, their production and use as pharmaceuticals
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1733758A1/en"><a id="link" href="#" class="style-scope state-modifier">EP1733758A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-05-16</span>
                    <span class="td style-scope patent-result">2006-12-20</span>
                    <span class="td style-scope patent-result">Ecopia Biosciences Inc.</span>
                    <span class="td style-scope patent-result">Methods for administration of a farnesyl dibenzodiazepinone 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7763604B2/en"><a id="link" href="#" class="style-scope state-modifier">US7763604B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-05-16</span>
                    <span class="td style-scope patent-result">2010-07-27</span>
                    <span class="td style-scope patent-result">Thallion Pharma Ceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Methods for administration of a farnesyl dibenzodiazepinone 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1898920A1/en"><a id="link" href="#" class="style-scope state-modifier">EP1898920A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-06-02</span>
                    <span class="td style-scope patent-result">2008-03-19</span>
                    <span class="td style-scope patent-result">Thallion Pharmaceuticals Inc.</span>
                    <span class="td style-scope patent-result">Formulation comprising farnesyl dibenzodiazepinone and a pharmaceutically acceptable surfactant 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20090186878A1/en"><a id="link" href="#" class="style-scope state-modifier">US20090186878A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-01-31</span>
                    <span class="td style-scope patent-result">2009-07-23</span>
                    <span class="td style-scope patent-result">Thallion Pharmaceuticals Inc.</span>
                    <span class="td style-scope patent-result">Crystalline forms of a farnesyl dibenzodiazepinone 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2007118320A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2007118320A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-04-14</span>
                    <span class="td style-scope patent-result">2007-10-25</span>
                    <span class="td style-scope patent-result">Thallion Pharmaceuticals Inc.</span>
                    <span class="td style-scope patent-result">Process for producing farnesylated dibenzodiazepinone by fermentation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20100144715A1/en"><a id="link" href="#" class="style-scope state-modifier">US20100144715A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-02-28</span>
                    <span class="td style-scope patent-result">2010-06-10</span>
                    <span class="td style-scope patent-result">Hoyt Scott B</span>
                    <span class="td style-scope patent-result">Substituted Benzodiazepinones, Benzoxazepinones and Benzothiazepinones as Sodium Channel Blockers 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20090170837A1/en"><a id="link" href="#" class="style-scope state-modifier">US20090170837A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-08-17</span>
                    <span class="td style-scope patent-result">2009-07-02</span>
                    <span class="td style-scope patent-result">Thallion Pharmaceuticals Inc.</span>
                    <span class="td style-scope patent-result">Methods for treating ras driven cancer in a subject 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20090062255A1/en"><a id="link" href="#" class="style-scope state-modifier">US20090062255A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-08-17</span>
                    <span class="td style-scope patent-result">2009-03-05</span>
                    <span class="td style-scope patent-result">Thallion Pharmaceuticals Inc.</span>
                    <span class="td style-scope patent-result">Tumor-targeting evaluation methodology and compounds related thereto 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2729486B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2729486B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-07-09</span>
                    <span class="td style-scope patent-result">2017-12-13</span>
                    <span class="td style-scope patent-result">The Regents of The University of California</span>
                    <span class="td style-scope patent-result">Leukemia stem cell targeting ligands and methods of use 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2019082125A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2019082125A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-10-27</span>
                    <span class="td style-scope patent-result">2019-05-02</span>
                    <span class="td style-scope patent-result">Amo Pharma Ltd.</span>
                    <span class="td style-scope patent-result">Methods of treating phelan mcdermid syndrome using farnesyl dibenzodiazepinones 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN109504689B/en"><a id="link" href="#" class="style-scope state-modifier">CN109504689B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-01-16</span>
                    <span class="td style-scope patent-result">2021-09-17</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Transporter coding gene involved in regulating and controlling ACT yield in streptomycete 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR102087786B1/en"><a id="link" href="#" class="style-scope state-modifier">KR102087786B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-08-19</span>
                    <span class="td style-scope patent-result">2020-03-12</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Micromonospora sp. M2 isolated from Monochoria korsakowii in fresh water having antibacterial and anticancer activity and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2021281280A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2021281280A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020-05-29</span>
                    <span class="td style-scope patent-result">2023-01-05</span>
                    <span class="td style-scope patent-result">Amo Pharma Ltd</span>
                    <span class="td style-scope patent-result">Methods of synthesizing farnesyl dibenzodiazepinones 
     </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>

              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner,  Cited by third party,  Family to family citation</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="similarDocuments" class="scroll-target style-scope patent-result">
              Similar Documents
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication</span>
                    <span class="th style-scope patent-result">Publication Date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP4913588B2/en"><a id="link" href="#" class="style-scope state-modifier">JP4913588B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-04-11</span>
                    <span class="td style-scope patent-result">
  Process for producing farnesyl benzodiazepinone and its use as a drug
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9138447B2/en"><a id="link" href="#" class="style-scope state-modifier">US9138447B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-09-22</span>
                    <span class="td style-scope patent-result">Antimicrobial agent and method for the production thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/PT1979375E/en"><a id="link" href="#" class="style-scope state-modifier">PT1979375E</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-03-06</span>
                    <span class="td style-scope patent-result">Lantibiotic biosynthetic gene clusters from a. garbadinensis and a. liguriae 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20080182302A2/en"><a id="link" href="#" class="style-scope state-modifier">US20080182302A2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-07-31</span>
                    <span class="td style-scope patent-result">The Gene Cluster Involved in Safracin Biosynthesis and Its Uses for Genetic Engineering 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1585752B1/en"><a id="link" href="#" class="style-scope state-modifier">EP1585752B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-11-21</span>
                    <span class="td style-scope patent-result">Polyene polyketides, processes for their production and their use as a pharmaceutical 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/17080285851883547199"><a id="link" href="#" class="style-scope state-modifier">Jayasuriya et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007</span>
                    <span class="td style-scope patent-result">Isolation and structure elucidation of thiazomycin</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/6795996976670966929"><a id="link" href="#" class="style-scope state-modifier">Igarashi et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008</span>
                    <span class="td style-scope patent-result">Pargamicin A, a novel cyclic peptide antibiotic from Amycolatopsis sp.</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2008501342A/en"><a id="link" href="#" class="style-scope state-modifier">JP2008501342A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-01-24</span>
                    <span class="td style-scope patent-result">
  Biosynthetic gene cluster for generating complex polyketides
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2010513512A/en"><a id="link" href="#" class="style-scope state-modifier">JP2010513512A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-30</span>
                    <span class="td style-scope patent-result">
  Aminothiazole macrocycles, their use as antimicrobial compounds and their preparation
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN110041187B/en"><a id="link" href="#" class="style-scope state-modifier">CN110041187B</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023-04-14</span>
                    <span class="td style-scope patent-result">Novel aromatic polyketone compounds, preparation method and application thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20190127313A1/en"><a id="link" href="#" class="style-scope state-modifier">US20190127313A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-05-02</span>
                    <span class="td style-scope patent-result">Antimicrobial agents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8058455B2/en"><a id="link" href="#" class="style-scope state-modifier">US8058455B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-11-15</span>
                    <span class="td style-scope patent-result">Compound signamycin, method for production thereof, and use thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7300921B2/en"><a id="link" href="#" class="style-scope state-modifier">US7300921B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-11-27</span>
                    <span class="td style-scope patent-result">Polyene polyketides and methods of production 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2321322B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2321322B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-12-19</span>
                    <span class="td style-scope patent-result">Streptospirole derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2538147A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2538147A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-08-09</span>
                    <span class="td style-scope patent-result">Farnesyl dibenzodiazepinone, processes for its production and its use as a pharmaceutical 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015145152A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015145152A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-10-01</span>
                    <span class="td style-scope patent-result">Antimicrobial agents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US11912742B2/en"><a id="link" href="#" class="style-scope state-modifier">US11912742B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2024-02-27</span>
                    <span class="td style-scope patent-result">Heterologous production of leupeptin protease inhibitors and analogs thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2012093192A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2012093192A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-07-12</span>
                    <span class="td style-scope patent-result">Coly-mycin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ZA200504214B/en"><a id="link" href="#" class="style-scope state-modifier">ZA200504214B</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-08-30</span>
                    <span class="td style-scope patent-result">Farnesyl dibenzodiazepinones, processes for their production and their use as phamaceuticals 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2012062906A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2012062906A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-05-18</span>
                    <span class="td style-scope patent-result">Peptides as bioactive compounds 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="relatedApplications" class="scroll-target style-scope patent-result">Priority And Related Applications</h3>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="appsClaimingPriority" class="scroll-target style-scope patent-result">
              Applications Claiming Priority (7)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US44112603P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2003-01-21</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US60/441,126<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2003-01-21</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US49299703P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2003-08-07</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US60/492,997<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2003-08-07</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US51828603P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2003-11-10</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US60/518,286<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2003-11-10</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004065591A1/en"><a id="link" href="#" class="style-scope state-modifier">PCT/CA2004/000069</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2004-01-21</span>
                    <span class="td style-scope patent-result">Farnesyl dibenzodiazepinones, processes for their production and their use as pharmaceuticals 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="legalEvents" class="scroll-target style-scope patent-result">
              Legal Events
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Date</span>
                    <span class="th style-scope patent-result">Code</span>
                    <span class="th style-scope patent-result">Title</span>
                    <span class="th style-scope patent-result">Description</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2006-03-01</span>
                    <span class="td nowrap style-scope patent-result">A521</span>
                    <span class="td nowrap style-scope patent-result">Request for written amendment filed</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A523</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20060228</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2007-01-11</span>
                    <span class="td nowrap style-scope patent-result">A621</span>
                    <span class="td nowrap style-scope patent-result">Written request for application examination</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A621</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20070110</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2009-07-30</span>
                    <span class="td nowrap style-scope patent-result">A711</span>
                    <span class="td nowrap style-scope patent-result">Notification of change in applicant</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A712</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20090729</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-04-13</span>
                    <span class="td nowrap style-scope patent-result">A131</span>
                    <span class="td nowrap style-scope patent-result">Notification of reasons for refusal</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A131</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20100412</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-06-30</span>
                    <span class="td nowrap style-scope patent-result">A601</span>
                    <span class="td nowrap style-scope patent-result">Written request for extension of time</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A601</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20100629</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-07-07</span>
                    <span class="td nowrap style-scope patent-result">A602</span>
                    <span class="td nowrap style-scope patent-result">Written permission of extension of time</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A602</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20100706</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-07-31</span>
                    <span class="td nowrap style-scope patent-result">A601</span>
                    <span class="td nowrap style-scope patent-result">Written request for extension of time</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A601</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20100730</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-08-09</span>
                    <span class="td nowrap style-scope patent-result">A602</span>
                    <span class="td nowrap style-scope patent-result">Written permission of extension of time</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A602</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20100806</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-09-01</span>
                    <span class="td nowrap style-scope patent-result">A601</span>
                    <span class="td nowrap style-scope patent-result">Written request for extension of time</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A601</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20100831</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-09-08</span>
                    <span class="td nowrap style-scope patent-result">A602</span>
                    <span class="td nowrap style-scope patent-result">Written permission of extension of time</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A602</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20100907</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-10-09</span>
                    <span class="td nowrap style-scope patent-result">A521</span>
                    <span class="td nowrap style-scope patent-result">Request for written amendment filed</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A523</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20101008</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2011-02-04</span>
                    <span class="td nowrap style-scope patent-result">A02</span>
                    <span class="td nowrap style-scope patent-result">Decision of refusal</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A02</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20110203</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2011-06-03</span>
                    <span class="td nowrap style-scope patent-result">A521</span>
                    <span class="td nowrap style-scope patent-result">Request for written amendment filed</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A523</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20110602</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2011-06-18</span>
                    <span class="td nowrap style-scope patent-result">A521</span>
                    <span class="td nowrap style-scope patent-result">Request for written amendment filed</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A821</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20110602</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2011-08-02</span>
                    <span class="td nowrap style-scope patent-result">A911</span>
                    <span class="td nowrap style-scope patent-result">Transfer to examiner for re-examination before appeal (zenchi)</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A911</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20110801</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2011-08-30</span>
                    <span class="td nowrap style-scope patent-result">A131</span>
                    <span class="td nowrap style-scope patent-result">Notification of reasons for refusal</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A131</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20110830</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2011-11-30</span>
                    <span class="td nowrap style-scope patent-result">A521</span>
                    <span class="td nowrap style-scope patent-result">Request for written amendment filed</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A523</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20111129</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2011-12-28</span>
                    <span class="td nowrap style-scope patent-result">TRDD</span>
                    <span class="td nowrap style-scope patent-result">Decision of grant or rejection written</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2012-01-10</span>
                    <span class="td nowrap style-scope patent-result">A01</span>
                    <span class="td nowrap style-scope patent-result">Written decision to grant a patent or to grant a registration (utility model)</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A01</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20120110</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2012-01-12</span>
                    <span class="td nowrap style-scope patent-result">A01</span>
                    <span class="td nowrap style-scope patent-result">Written decision to grant a patent or to grant a registration (utility model)</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A01</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2012-01-26</span>
                    <span class="td nowrap style-scope patent-result">A61</span>
                    <span class="td nowrap style-scope patent-result">First payment of annual fees (during grant procedure)</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A61</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20120119</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2012-01-27</span>
                    <span class="td nowrap style-scope patent-result">R150</span>
                    <span class="td nowrap style-scope patent-result">Certificate of patent or registration of utility model</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref document number</strong>: 4913588</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Country of ref document</strong>: JP</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: R150</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: R150</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2012-01-30</span>
                    <span class="td nowrap style-scope patent-result">FPAY</span>
                    <span class="td nowrap style-scope patent-result">Renewal fee payment (event date is renewal date of database)</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: PAYMENT UNTIL: 20150127</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Year of fee payment</strong>: 3</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2015-01-13</span>
                    <span class="td nowrap style-scope patent-result">R250</span>
                    <span class="td nowrap style-scope patent-result">Receipt of annual fees</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: R250</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2016-01-12</span>
                    <span class="td nowrap style-scope patent-result">R250</span>
                    <span class="td nowrap style-scope patent-result">Receipt of annual fees</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: R250</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2017-01-10</span>
                    <span class="td nowrap style-scope patent-result">R250</span>
                    <span class="td nowrap style-scope patent-result">Receipt of annual fees</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: R250</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-01-09</span>
                    <span class="td nowrap style-scope patent-result">R250</span>
                    <span class="td nowrap style-scope patent-result">Receipt of annual fees</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: R250</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2019-01-08</span>
                    <span class="td nowrap style-scope patent-result">R250</span>
                    <span class="td nowrap style-scope patent-result">Receipt of annual fees</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: R250</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2020-01-07</span>
                    <span class="td nowrap style-scope patent-result">R250</span>
                    <span class="td nowrap style-scope patent-result">Receipt of annual fees</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: R250</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2021-01-04</span>
                    <span class="td nowrap style-scope patent-result">R250</span>
                    <span class="td nowrap style-scope patent-result">Receipt of annual fees</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: R250</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2021-12-24</span>
                    <span class="td nowrap style-scope patent-result">R250</span>
                    <span class="td nowrap style-scope patent-result">Receipt of annual fees</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: R250</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2023-01-04</span>
                    <span class="td nowrap style-scope patent-result">R250</span>
                    <span class="td nowrap style-scope patent-result">Receipt of annual fees</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: R250</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2024-01-21</span>
                    <span class="td nowrap style-scope patent-result">EXPY</span>
                    <span class="td nowrap style-scope patent-result">Cancellation because of completion of term</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
              <h3 id="concepts" class="scroll-target layout horizontal style-scope patent-result">
                <div class="flex style-scope patent-result">Concepts</div>
                <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
              </h3>
              <div class="layout horizontal style-scope patent-result">
                <div class="flex style-scope patent-result">
                  <span id="conceptsWarning" class="righthead tooltip-hint style-scope patent-result">machine-extracted</span>
                  <overlay-tooltip positioning-target="#conceptsWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The concepts are extracted by a computer and may be incomplete or incorrect.
    </div>
  </overlay-tooltip>
                </div>
                <span class="headerButton style-scope patent-result"><a href="#" target="_blank" style="display: inline-block;" class="style-scope patent-result"><iron-icon icon="icons:file-download" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M19 9h-4V3H9v6H5l7 7 7-7zM5 18v2h14v-2H5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download</a></span>
                <span class="style-scope patent-result">
                  <dropdown-menu multi="true" label="Filter table" show-label="true" change-action="RESULT_CONCEPT_MENU" class="style-scope patent-result">
    
    <span class="label style-scope dropdown-menu">
      <span class="style-scope dropdown-menu">Filter table</span>
      <span id="selected" class="style-scope dropdown-menu" hidden="">
        <span style="margin: 0 4px 0 2px" class="style-scope dropdown-menu"></span>
        <span class="style-scope dropdown-menu"></span>
      </span>
      <iron-icon icon="icons:arrow-drop-down" class="style-scope dropdown-menu x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 10l5 5 5-5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><iron-icon icon="icons:arrow-drop-up" class="style-scope dropdown-menu x-scope iron-icon-0" hidden=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
    </span>
    <iron-dropdown allow-outside-scroll="" horizontal-align="left" vertical-align="top" class="style-scope dropdown-menu" aria-disabled="false" aria-hidden="true" style="outline: none; display: none;">
    

    <div id="contentWrapper" class="style-scope iron-dropdown">
      <div class="dropdown-content style-scope dropdown-menu" slot="dropdown-content" id="menu" multi="">
        <div class="style-scope dropdown-menu">
          
            <div class="item style-scope dropdown-menu">Anatomy</div>
          
            <div class="item style-scope dropdown-menu">Chemical class</div>
          
            <div class="item style-scope dropdown-menu">Chemical compound</div>
          
            <div class="item style-scope dropdown-menu">Chemical group</div>
          
            <div class="item style-scope dropdown-menu">Diseases</div>
          
            <div class="item style-scope dropdown-menu">Drugs</div>
          
            <div class="item style-scope dropdown-menu">Effects</div>
          
            <div class="item style-scope dropdown-menu">Human genes</div>
          
            <div class="item style-scope dropdown-menu">Inorganic materials</div>
          
            <div class="item style-scope dropdown-menu">Methods</div>
          
            <div class="item style-scope dropdown-menu">Natural products</div>
          
            <div class="item style-scope dropdown-menu">Nutrition</div>
          
            <div class="item style-scope dropdown-menu">Polymers</div>
          
            <div class="item style-scope dropdown-menu">Proteins</div>
          
            <div class="item style-scope dropdown-menu">Species</div>
          
            <div class="item style-scope dropdown-menu">Substances</div>
          
            <div class="item style-scope dropdown-menu">Toxicity</div>
          <template is="dom-repeat" class="style-scope dropdown-menu"></template>
        </div>
      </div>
    </div>
  </iron-dropdown>
  </dropdown-menu>
                </span>
              </div>
              <div class="responsive-table style-scope patent-result">
                <div class="table style-scope patent-result">
                  <div class="thead style-scope patent-result">
                    <div class="tr style-scope patent-result">
                      <span class="th style-scope patent-result">Name</span>
                      <span class="th style-scope patent-result">Image</span>
                      <span class="th style-scope patent-result">Sections</span>
                      <span class="th style-scope patent-result">Count</span>
                      <span class="th style-scope patent-result">Query match</span>
                    </div>
                  </div>
                  <div class="tbody style-scope patent-result">
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">method</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">title,claims,description</span>
                        <span class="td nowrap style-scope patent-result">132</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">farnesyl benzodiazepinone</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">title,claims,description</span>
                        <span class="td nowrap style-scope patent-result">39</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">drug</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">title,claims,description</span>
                        <span class="td nowrap style-scope patent-result">28</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">drug</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">title,description</span>
                        <span class="td nowrap style-scope patent-result">22</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">process</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">title,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical class style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">compounds</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">262</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Neoplasm</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">49</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical class style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">salts</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">41</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">aryl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">28</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">diseases, disorders, signs and symptoms</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">28</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">heteroaryl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">23</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">manufacturing process</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">23</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">hydrogen</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">20</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cancer</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">19</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">culturing</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">19</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">nitrogen</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">19</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Species style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Mammalia</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">18</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">alkyl group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">17</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">inhibitory effect</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">17</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Bacterial infection</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">16</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">bacterial infectious disease</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">16</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">pharmaceutical composition</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">16</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">drug carrier</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">13</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Inflammation</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Species style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Micromonospora</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">inflammatory process</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">carbon</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">growth</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">in vitro</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">nitrogen atom</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">tungsten</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cancer growth</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cell growth</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">inhibitor</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">therapeutic agent</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">carbon atom</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Precancerous Conditions</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical class style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">aliphatic alkanes</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical class style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">alkenes</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">growth inhibitor</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    <template is="dom-repeat" initial-count="25" class="style-scope patent-result"></template>
                    
                      <div class$="tr layout horizontal conceptDomain" class="style-scope patent-result">
                        <a href="#" class="td flex style-scope patent-result">
                          Show all concepts from the description section
                        </a>
                      </div>
                    <template is="dom-if" class="style-scope patent-result"></template>
                  </div>
                </div>
              </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <div id="notices" class="vertical layout center style-scope patent-result">
              
                <span class="style-scope patent-result">Data provided by IFI CLAIMS Patent Services</span>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
          </div>
          <div class="bottombar style-scope patent-result">
            <bottom-bar class="style-scope patent-result"><template is="dom-if" class="style-scope bottom-bar"></template>
</bottom-bar>
          </div>
        </div>
      </div>
      <template is="dom-if" class="style-scope patent-result"></template>
    </div>
  </patent-result>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
  </result-container>
        </div>
      </div>
    
        </div>
      </div>
      <search-footer class="style-scope search-ui">
    
    

    <div id="footer" class="vertical layout center style-scope search-footer">
        <span class="links style-scope search-footer">
          <overlay-tooltip positioning-target="#footerAbout" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Learn more about data coverage, search syntax and other features.
    </div>
  </overlay-tooltip>
          <a id="footerAbout" data-proto="ABOUT" href="https://support.google.com/faqs/answer/6390996" target="_blank" class="style-scope search-footer">About</a>
          <overlay-tooltip positioning-target="#footerFeedback" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Send feedback about technical issues or feature requests for Google Patents.
    </div>
  </overlay-tooltip>
          <a id="footerFeedback" data-proto="SEND_FEEDBACK" href="#" onclick="sendFeedback();" class="style-scope search-footer">Send Feedback</a>
          <a data-proto="PUBLIC_DATASETS" href="https://console.cloud.google.com/marketplace/product/google_patents_public_datasets/google-patents-public-data" target="_blank" class="style-scope search-footer">Public Datasets</a>
          <a data-proto="TERMS" href="https://www.google.com/policies/terms/" target="_blank" class="style-scope search-footer">Terms</a>
          <a data-proto="PRIVACY_POLICY" href="https://www.google.com/privacy/privacy-policy.html" target="blank" class="style-scope search-footer">Privacy Policy</a>
          <a data-proto="SEARCH_HELP" href="https://support.google.com/websearch/" target="_blank" class="style-scope search-footer">Help</a>
        </span>
    </div>
  </search-footer>
    </div>

  </search-ui>
  </search-result>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <paper-toast id="toast" duration="3000" class="style-scope search-app x-scope paper-toast-0" aria-hidden="true" style="outline: none; display: none;">
    

    <span id="label" class="style-scope paper-toast"></span>
    
      <div id="noticeContent" class="style-scope search-app"></div>
    
  </paper-toast>
  </search-app>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  

<iframe id="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.3622360128" name="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.3622360128" style="width: 1px; height: 1px; position: absolute; top: -100px; display: none;" src="https://scone-pa.clients6.google.com/static/proxy.html?usegapi=1&amp;jsh=m%3B%2F_%2Fscs%2Fabc-static%2F_%2Fjs%2Fk%3Dgapi.lb.en.IKZeRvoAYNY.O%2Fam%3DAAAQ%2Fd%3D1%2Frs%3DAHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw%2Fm%3D__features__#parent=https%3A%2F%2Fpatents.google.com&amp;rpctoken=1241765625" tabindex="-1" aria-hidden="true"></iframe><iron-a11y-announcer>
    
    <div class="style-scope iron-a11y-announcer" aria-live="polite"></div>
  </iron-a11y-announcer></body></html>